| 8650475 | CV127050 | single nucleotide variant | NM_014729.2(TOX):c.103-4942T>A | Lung cancer [RCV000107537] | uncertain significance | 8 | 58964950 | 58964950 | Human | | name |
| 15192008 | CV777763 | microsatellite | NM_014729.3(TOX):c.412-44TATT[8] | not provided [RCV000954942] | benign | 8 | 58851810 | 58851817 | Human | | name |
| 156074529 | CV2264047 | single nucleotide variant | NM_014729.3(TOX):c.5A>C (p.Asp2Ala) | not specified [RCV004138063] | uncertain significance | 8 | 59118983 | 59118983 | Human | | name |
| 405758583 | CV3347113 | single nucleotide variant | NM_014729.3(TOX):c.7G>A (p.Val3Ile) | not specified [RCV004468213] | uncertain significance | 8 | 59118981 | 59118981 | Human | | name |
| 405758587 | CV3347114 | single nucleotide variant | NM_014729.3(TOX):c.7G>C (p.Val3Leu) | not specified [RCV004468214] | uncertain significance | 8 | 59118981 | 59118981 | Human | | name |
| 402495954 | CV2883710 | single nucleotide variant | NM_014729.3(TOX):c.678C>T (p.Gly226=) | not provided [RCV003573416] | likely benign | 8 | 58851539 | 58851539 | Human | | name |
| 405758578 | CV3347112 | single nucleotide variant | NM_014729.3(TOX):c.73C>G (p.Pro25Ala) | not specified [RCV004468212] | uncertain significance | 8 | 59118915 | 59118915 | Human | | name |
| 597787236 | CV3611072 | single nucleotide variant | NM_014729.3(TOX):c.55C>A (p.Pro19Thr) | not specified [RCV004875550] | uncertain significance | 8 | 59118933 | 59118933 | Human | | name |
| 597787240 | CV3611073 | single nucleotide variant | NM_014729.3(TOX):c.56C>T (p.Pro19Leu) | not specified [RCV004875551] | uncertain significance | 8 | 59118932 | 59118932 | Human | | name |
| 329373198 | CV2439316 | single nucleotide variant | NM_014729.3(TOX):c.152A>G (p.Tyr51Cys) | not specified [RCV004249625] | uncertain significance | 8 | 58959959 | 58959959 | Human | | name |
| 329377249 | CV2442678 | single nucleotide variant | NM_014729.3(TOX):c.125T>C (p.Met42Thr) | not specified [RCV004265027] | uncertain significance | 8 | 58959986 | 58959986 | Human | | name |
| 405758559 | CV3347108 | single nucleotide variant | NM_014729.3(TOX):c.230C>T (p.Ser77Phe) | not specified [RCV004468208] | uncertain significance | 8 | 58939483 | 58939483 | Human | | name |
| 405758565 | CV3347109 | single nucleotide variant | NM_014729.3(TOX):c.271T>C (p.Ser91Pro) | not specified [RCV004468209] | likely benign | 8 | 58939442 | 58939442 | Human | | name |
| 598188562 | CV3928181 | single nucleotide variant | NM_014729.3(TOX):c.265G>A (p.Val89Ile) | not specified [RCV005287955] | uncertain significance | 8 | 58939448 | 58939448 | Human | | name |
| 156110480 | CV2261620 | single nucleotide variant | NM_014729.3(TOX):c.522G>A (p.Met174Ile) | not specified [RCV004125946] | uncertain significance | 8 | 58851695 | 58851695 | Human | | name |
| 405758568 | CV3347110 | single nucleotide variant | NM_014729.3(TOX):c.311G>A (p.Gly104Asp) | not specified [RCV004468210] | uncertain significance | 8 | 58939402 | 58939402 | Human | | name |
| 405758573 | CV3347111 | single nucleotide variant | NM_014729.3(TOX):c.527A>G (p.His176Arg) | not specified [RCV004468211] | uncertain significance | 8 | 58851690 | 58851690 | Human | | name |
| 407521080 | CV3486845 | single nucleotide variant | NM_014729.3(TOX):c.715C>T (p.Pro239Ser) | not specified [RCV004677169] | uncertain significance | 8 | 58838290 | 58838290 | Human | | name |
| 597787224 | CV3611069 | single nucleotide variant | NM_014729.3(TOX):c.727A>C (p.Met243Leu) | not specified [RCV004875547] | uncertain significance | 8 | 58838278 | 58838278 | Human | | name |
| 597787251 | CV3611076 | single nucleotide variant | NM_014729.3(TOX):c.609C>A (p.Asn203Lys) | not specified [RCV004875554] | uncertain significance | 8 | 58851608 | 58851608 | Human | | name |
| 597787259 | CV3611078 | single nucleotide variant | NM_014729.3(TOX):c.817C>T (p.Arg273Cys) | not specified [RCV004875556] | uncertain significance | 8 | 58838188 | 58838188 | Human | | name |
| 597787263 | CV3611079 | single nucleotide variant | NM_014729.3(TOX):c.713G>A (p.Arg238Gln) | not specified [RCV004875557] | uncertain significance | 8 | 58838292 | 58838292 | Human | | name |
| 598254705 | CV3928183 | single nucleotide variant | NM_014729.3(TOX):c.557A>G (p.Gln186Arg) | not specified [RCV005278486] | uncertain significance | 8 | 58851660 | 58851660 | Human | | name |
| 598188590 | CV3928185 | single nucleotide variant | NM_014729.3(TOX):c.574G>T (p.Gly192Cys) | not specified [RCV005287958] | uncertain significance | 8 | 58851643 | 58851643 | Human | | name |
| 156200198 | CV2237676 | single nucleotide variant | NM_014729.3(TOX):c.1553A>G (p.Gln518Arg) | not specified [RCV004106601] | uncertain significance | 8 | 58807775 | 58807775 | Human | | name |
| 156107366 | CV2254291 | single nucleotide variant | NM_014729.3(TOX):c.1027G>A (p.Val343Met) | not specified [RCV004129958] | uncertain significance | 8 | 58815703 | 58815703 | Human | | name |
| 156215967 | CV2257621 | single nucleotide variant | NM_014729.3(TOX):c.1505C>A (p.Pro502Gln) | not specified [RCV004127446] | uncertain significance | 8 | 58808157 | 58808157 | Human | | name |
| 156013248 | CV2300413 | single nucleotide variant | NM_014729.3(TOX):c.1289A>T (p.His430Leu) | not specified [RCV004153615] | uncertain significance | 8 | 58815441 | 58815441 | Human | | name |
| 155968403 | CV2337839 | single nucleotide variant | NM_014729.3(TOX):c.1100C>T (p.Ser367Leu) | not specified [RCV004183850] | uncertain significance | 8 | 58815630 | 58815630 | Human | | name |
| 156336338 | CV2360720 | single nucleotide variant | NM_014729.3(TOX):c.1207C>A (p.Gln403Lys) | not specified [RCV004213508] | uncertain significance | 8 | 58815523 | 58815523 | Human | | name |
| 156040462 | CV2384359 | single nucleotide variant | NM_014729.3(TOX):c.1284C>A (p.His428Gln) | not specified [RCV004227736] | uncertain significance | 8 | 58815446 | 58815446 | Human | | name |
| 155996869 | CV2393244 | single nucleotide variant | NM_014729.3(TOX):c.1142T>C (p.Met381Thr) | not specified [RCV004226713] | uncertain significance | 8 | 58815588 | 58815588 | Human | | name |
| 329384377 | CV2435044 | single nucleotide variant | NM_014729.3(TOX):c.1199C>T (p.Pro400Leu) | not specified [RCV004252695] | uncertain significance | 8 | 58815531 | 58815531 | Human | | name |
| 405758531 | CV3347103 | single nucleotide variant | NM_014729.3(TOX):c.1136C>T (p.Pro379Leu) | not specified [RCV004468203] | uncertain significance | 8 | 58815594 | 58815594 | Human | | name |
| 405758539 | CV3347104 | single nucleotide variant | NM_014729.3(TOX):c.1166A>G (p.His389Arg) | not specified [RCV004468204] | uncertain significance | 8 | 58815564 | 58815564 | Human | | name |
| 405758542 | CV3347105 | single nucleotide variant | NM_014729.3(TOX):c.1460C>G (p.Thr487Ser) | not specified [RCV004468205] | uncertain significance | 8 | 58808202 | 58808202 | Human | | name |
| 405758549 | CV3347106 | single nucleotide variant | NM_014729.3(TOX):c.1502C>T (p.Pro501Leu) | not specified [RCV004468206] | uncertain significance | 8 | 58808160 | 58808160 | Human | | name |
| 405758555 | CV3347107 | single nucleotide variant | NM_014729.3(TOX):c.1505C>G (p.Pro502Arg) | not specified [RCV004468207] | uncertain significance | 8 | 58808157 | 58808157 | Human | | name |
| 407521077 | CV3486843 | single nucleotide variant | NM_014729.3(TOX):c.1067C>T (p.Pro356Leu) | not specified [RCV004677168] | uncertain significance | 8 | 58815663 | 58815663 | Human | | name |
| 407461143 | CV3486844 | single nucleotide variant | NM_014729.3(TOX):c.1127A>G (p.His376Arg) | not specified [RCV004687578] | uncertain significance | 8 | 58815603 | 58815603 | Human | | name |
| 597787228 | CV3611070 | single nucleotide variant | NM_014729.3(TOX):c.1079A>G (p.His360Arg) | not specified [RCV004875548] | uncertain significance | 8 | 58815651 | 58815651 | Human | | name |
| 597787231 | CV3611071 | single nucleotide variant | NM_014729.3(TOX):c.1138G>A (p.Gly380Arg) | not specified [RCV004875549] | uncertain significance | 8 | 58815592 | 58815592 | Human | | name |
| 597787243 | CV3611074 | single nucleotide variant | NM_014729.3(TOX):c.1453G>A (p.Val485Ile) | not specified [RCV004875552] | uncertain significance | 8 | 58808209 | 58808209 | Human | | name |
| 597787255 | CV3611077 | single nucleotide variant | NM_014729.3(TOX):c.1475A>G (p.Tyr492Cys) | not specified [RCV004875555] | uncertain significance | 8 | 58808187 | 58808187 | Human | | name |
| 598188581 | CV3928184 | single nucleotide variant | NM_014729.3(TOX):c.1400C>G (p.Thr467Ser) | not specified [RCV005287957] | uncertain significance | 8 | 58808262 | 58808262 | Human | | name |
| 407424927 | CV3410867 | indel | NM_014729.3(TOX):c.904_905delinsGG (p.Leu302Gly) | Iron-refractory iron deficiency anemia [RCV004586511] | uncertain significance | 8 | 58838100 | 58838101 | Human | | name |
| 11087714 | CV227797 | single nucleotide variant | NC_000018.9:g.57882787C>A | amisulpride response - Toxicity/ADR [RCV000211314]|aripiprazole response - Toxicity/ADR [RCV000211401]|clozapine response - Toxicity/ADR [RCV000211221]|haloperidol response - Tox ='font-weight:700;'>Toxicity/ADR [RCV000211305]|olanzapine response - Toxicity/ADR [RCV000211428]|paliperidone response - Toxicity/ADR [RCV000211214]|quetiapine response - Toxicity/ADR [RCV000211337]|risperidone response - Toxicity/ADR [RCV000211159]|ziprasidone response - Toxicity/ADR [RCV000211203] | drug response | 18 | 60215554 | 60215554 | Human | 2 | trait |
| 8688957 | CV136743 | single nucleotide variant | NM_000540.3(RYR1):c.103T>C (p.Cys35Arg) | Malignant hyperthermia, susceptibility to, 1 [RCV001588932]|RYR1-related disorder [RCV003591679]|desflurane response - Toxicity [RCV001787930]|enflurane response - Toxicity [RCV001787931]|halothane response - Tox nt-weight:700;'>Toxicity [RCV001787932]|isoflurane response - Toxicity [RCV001787933]|methoxyflurane response - Toxicity [RCV001787934]|not provided [RCV000119411]|sevoflurane response - Toxicity [RCV001787935]|succinylcholine response - Toxicity [RCV001787936] | pathogenic|drug response|not provided | 19 | 38440802 | 38440802 | Human | 2 | trait |
| 8688989 | CV136775 | single nucleotide variant | NM_000540.3(RYR1):c.11969G>T (p.Gly3990Val) | Malignant hyperthermia of anesthesia [RCV004017405]|Malignant hyperthermia, susceptibility to, 1 [RCV002281939]|desflurane response - Toxicity [RCV001787937]|enflurane response - Toxicity [RCV001787938]|halothane response - Toxicity [RCV001787939]|isoflurane response - Toxicity [RCV001787940]|methoxyflurane response - Toxicity [RCV001787941]|not provided [RCV000119447]|sevoflurane response - Toxicity [RCV001787942]|succinylcholine response - Toxicity [RCV001787943] | pathogenic|drug response|not provided | 19 | 38543832 | 38543832 | Human | 3 | trait |
| 8688991 | CV136777 | single nucleotide variant | NM_000540.3(RYR1):c.1201C>T (p.Arg401Cys) | Inborn genetic diseases [RCV001266973]|Malignant hyperthermia of anesthesia [RCV000610923]|Malignant hyperthermia, susceptibility to, 1 [RCV001822999]|RYR1-related disorder [RCV000802489]|desflurane response - Toxicity [RCV003227642]|enflurane response - Tox tyle='font-weight:700;'>Toxicity [RCV003227643]|halothane response - Toxicity [RCV003227644]|isoflurane response - Toxicity [RCV003227645]|methoxyflurane response - Toxicity [RCV003227646]|not provided [RCV000119449]|sevoflurane response - Toxicity [RCV003227647]|succinylcholine response - Toxicity [RCV003227648] | pathogenic|likely pathogenic|drug response|uncertain significance|not provided | 19 | 38451842 | 38451842 | Human | 4 | trait |
| 8689007 | CV136793 | single nucleotide variant | NM_000540.3(RYR1):c.130C>T (p.Arg44Cys) | Central core myopathy [RCV003338417]|Central core myopathy [RCV005025189]|Malignant hyperthermia of anesthesia [RCV004689616]|Malignant hyperthermia, susceptibility to, 1 [RCV001588936]|RYR1-related disorder [RCV001238887]|desflurane response - Toxicity [RCV0017 87944]|enflurane response - Toxicity [RCV001787945]|halothane response - Toxicity [RCV001787946]|isoflurane response - Toxicity [RCV001787947]|methoxyflurane response - Toxicity [RCV001787948]|not provided [RCV000119473]|sevoflurane response - Toxicity [RCV001787949]|succinylcholine response - Toxicity [RCV001787950] | pathogenic|likely pathogenic|conflicting interpretations of pathogenicity|drug response|uncertain significance|not provided | 19 | 38440829 | 38440829 | Human | 7 | trait |
| 8689034 | CV136820 | single nucleotide variant | NM_000540.3(RYR1):c.14497C>T (p.His4833Tyr) | Malignant hyperthermia, susceptibility to, 1 [RCV002225084]|desflurane response - Toxicity [RCV001787951]|enflurane response - Toxicity [RCV001787952]|halothane response - Toxicity [RCV0 01787953]|isoflurane response - Toxicity [RCV001787954]|methoxyflurane response - Toxicity [RCV001787955]|not provided [RCV000119521]|sevoflurane response - Toxicity [RCV001787956]|succinylcholine response - Toxicity [RCV001787957] | pathogenic|likely pathogenic|drug response|not provided | 19 | 38580114 | 38580114 | Human | 2 | trait |
| 8689036 | CV136822 | single nucleotide variant | NM_000540.3(RYR1):c.14512C>G (p.Leu4838Val) | Malignant hyperthermia, susceptibility to, 1 [RCV002281941]|desflurane response - Toxicity [RCV001787958]|enflurane response - Toxicity [RCV001787959]|halothane response - Toxicity [RCV0 01787960]|isoflurane response - Toxicity [RCV001787961]|methoxyflurane response - Toxicity [RCV001787962]|not provided [RCV000119523]|sevoflurane response - Toxicity [RCV001787963]|succinylcholine response - Toxicity [RCV001787964] | likely pathogenic|drug response|not provided | 19 | 38580370 | 38580370 | Human | 2 | trait |
| 8689064 | CV136849 | single nucleotide variant | NM_000540.3(RYR1):c.1597C>T (p.Arg533Cys) | Central core myopathy [RCV005016408]|Malignant hyperthermia of anesthesia [RCV004700425]|Malignant hyperthermia, susceptibility to, 1 [RCV001588943]|RYR1-related disorder [RCV000802081]|desflurane response - Toxicity [RCV003227649]|enflurane response - Tox le='font-weight:700;'>Toxicity [RCV003227650]|halothane response - Toxicity [RCV003227651]|isoflurane response - Toxicity [RCV003227652]|methoxyflurane response - Toxicity [RCV003227653]|not provided [RCV000119577]|sevoflurane response - Toxicity [RCV003227654]|succinylcholine response - Toxicity [RCV003227655] | pathogenic|likely pathogenic|drug response|not provided | 19 | 38455471 | 38455471 | Human | 7 | trait |
| 8689068 | CV136853 | single nucleotide variant | NM_000540.3(RYR1):c.1654C>T (p.Arg552Trp) | Central core myopathy [RCV003325460]|Malignant hyperthermia, susceptibility to, 1 [RCV002281942]|RYR1-related disorder [RCV000536735]|desflurane response - Toxicity [RCV001787965]|enflurane response - Toxicity [RCV001787966] |halothane response - Toxicity [RCV001787967]|isoflurane response - Toxicity [RCV001787968]|methoxyflurane response - Toxicity [RCV001787969]|not provided [RCV000119581]|sevoflurane response - Toxicity [RCV001787970]|succinylcholine response - Toxicity [RCV001787971] | pathogenic|likely pathogenic|drug response|not provided | 19 | 38455528 | 38455528 | Human | 3 | trait |
| 8689070 | CV136855 | single nucleotide variant | NM_000540.3(RYR1):c.1841G>T (p.Arg614Leu) | Central core myopathy [RCV002477305]|Malignant hyperthermia, susceptibility to, 1 [RCV001705880]|RYR1-related disorder [RCV001068141]|desflurane response - Toxicity [RCV002222020]|enflurane response - Toxicity [RCV002222021] |halothane response - Toxicity [RCV002222022]|isoflurane response - Toxicity [RCV002222023]|methoxyflurane response - Toxicity [RCV002222024]|not provided [RCV000119587]|sevoflurane response - Toxicity [RCV002222025]|succinylcholine response - Toxicity [RCV002222026] | pathogenic|drug response|not provided | 19 | 38457546 | 38457546 | Human | 8 | trait |
| 8689099 | CV136884 | single nucleotide variant | NM_000540.3(RYR1):c.488G>T (p.Arg163Leu) | Malignant hyperthermia, susceptibility to, 1 [RCV001588949]|desflurane response - Toxicity [RCV003227656]|enflurane response - Toxicity [RCV003227657]|halothane response - Toxicity [RCV0 03227658]|isoflurane response - Toxicity [RCV003227659]|methoxyflurane response - Toxicity [RCV003227660]|not provided [RCV000119626]|sevoflurane response - Toxicity [RCV003227661]|succinylcholine response - Toxicity [RCV003227662] | pathogenic|likely pathogenic|drug response|not provided | 19 | 38444212 | 38444212 | Human | 2 | trait |
| 8689136 | CV136921 | single nucleotide variant | NM_000540.3(RYR1):c.7007G>A (p.Arg2336His) | Central core myopathy [RCV004698826]|Central core myopathy [RCV005409618]|Malignant hyperthermia of anesthesia [RCV001824615]|Malignant hyperthermia, susceptibility to, 1 [RCV002281943]|RYR1-related disorder [RCV000554523]|desflurane response - Toxicity [RCV0017 87972]|enflurane response - Toxicity [RCV001787973]|halothane response - Toxicity [RCV001787974]|isoflurane response - Toxicity [RCV001787975]|methoxyflurane response - Toxicity [RCV001787976]|not provided [RCV000119673]|sevoflurane response - Toxicity [RCV001787977]|succinylcholine response - Toxicity [RCV001787978] | pathogenic|likely pathogenic|drug response|not provided | 19 | 38499223 | 38499223 | Human | 4 | trait |
| 8689142 | CV136927 | microsatellite | NM_000540.3(RYR1):c.7039GAG[1] (p.Glu2348del) | Congenital multicore myopathy with external ophthalmoplegia [RCV000171131]|Malignant hyperthermia, susceptibility to, 1 [RCV000013850]|RYR1-related disorder [RCV001384027]|desflurane response - Toxicity [RCV001787979]|enflurane response - Tox t:700;'>Toxicity [RCV001787980]|halothane response - Toxicity [RCV001787981]|isoflurane response - Toxicity [RCV001787982]|methoxyflurane response - Toxicity [RCV001787983]|not provided [RCV000119679]|sevoflurane response - Toxicity [RCV001787984]|succinylcholine response - Toxicity [RCV001787985] | pathogenic|likely pathogenic|risk factor|drug response|not provided | 19 | 38499645 | 38499647 | Human | | trait |
| 8689144 | CV136929 | single nucleotide variant | NM_000540.3(RYR1):c.7048G>A (p.Ala2350Thr) | Malignant hyperthermia, susceptibility to, 1 [RCV000148806]|RYR1-related disorder [RCV001383434]|desflurane response - Toxicity [RCV001787986]|enflurane response - Toxicity [RCV001787987]|halothane response - Tox nt-weight:700;'>Toxicity [RCV001787988]|isoflurane response - Toxicity [RCV001787989]|methoxyflurane response - Toxicity [RCV001787990]|not provided [RCV000119681]|sevoflurane response - Toxicity [RCV001787991]|succinylcholine response - Toxicity [RCV001787992] | pathogenic|drug response|not provided | 19 | 38499655 | 38499655 | Human | 2 | trait |
| 8689145 | CV136930 | single nucleotide variant | NM_000540.3(RYR1):c.7063C>T (p.Arg2355Trp) | Central core myopathy [RCV000763425]|Central core myopathy [RCV004813060]|Congenital multicore myopathy with external ophthalmoplegia [RCV000578408]|Malignant hyperthermia of anesthesia [RCV004017408]|Malignant hyperthermia, susceptibility to, 1 [RCV002281944]|RYR1-related disorder [RCV000803469]|de sflurane response - Toxicity [RCV001787993]|enflurane response - Toxicity [RCV001787994]|halothane response - Toxicity [RCV001787995]|isoflurane response - Toxicity [RCV001787996]|methoxyflurane response - Toxicity [RCV001787997]|not provided [RCV000119682]|sevoflurane response - Toxicity [RCV001787998]|succinylcholine response - Toxicity [RCV001787999] | pathogenic|drug response|not provided | 19 | 38499670 | 38499670 | Human | 8 | trait |
| 8689151 | CV136936 | single nucleotide variant | NM_000540.3(RYR1):c.7124G>C (p.Gly2375Ala) | Malignant hyperthermia, susceptibility to, 1 [RCV002281945]|desflurane response - Toxicity [RCV001788000]|enflurane response - Toxicity [RCV001788001]|halothane response - Toxicity [RCV0 01788002]|isoflurane response - Toxicity [RCV001788003]|methoxyflurane response - Toxicity [RCV001788004]|not provided [RCV000119690]|sevoflurane response - Toxicity [RCV001788005]|succinylcholine response - Toxicity [RCV001788006] | pathogenic|drug response|not provided | 19 | 38499731 | 38499731 | Human | 2 | trait |
| 8689155 | CV136940 | single nucleotide variant | NM_000540.3(RYR1):c.7282G>A (p.Ala2428Thr) | Central core myopathy [RCV001127651]|Central core myopathy [RCV002492410]|Congenital multicore myopathy with external ophthalmoplegia [RCV001127649]|Inborn genetic diseases [RCV004019662]|Malignant hyperthermia, susceptibility to [RCV004556734]|Malignant hyperthermia, susceptibility to, 1 [RCV001127 650]|RYR1-related disorder [RCV001236218]|desflurane response - Toxicity [RCV001788007]|enflurane response - Toxicity [RCV001788008]|halothane response - Toxicity [RCV001788009]|isoflurane response - Toxicity [RCV001788010]|methoxyflurane response - Toxicity [RCV001788011]|not provided [RCV000119695]|sevoflurane response - Toxicity [RCV001788012]|succinylcholine response - Toxicity [RCV001788013] | pathogenic|likely pathogenic|drug response|uncertain significance|not provided | 19 | 38499975 | 38499975 | Human | 9 | trait |
| 8689164 | CV136949 | single nucleotide variant | NM_000540.3(RYR1):c.7360C>T (p.Arg2454Cys) | Congenital multicore myopathy with external ophthalmoplegia [RCV005406833]|Malignant hyperthermia of anesthesia [RCV000601471]|Malignant hyperthermia, susceptibility to, 1 [RCV001257496]|RYR1-related disorder [RCV000655594]|RYR1-related myopathy [RCV004786377]|desflurane response - Tox -weight:700;'>Toxicity [RCV001788014]|enflurane response - Toxicity [RCV001788015]|halothane response - Toxicity [RCV001788016]|isoflurane response - Toxicity [RCV001788017]|methoxyflurane response - Toxicity [RCV001788018]|not provided [RCV000119709]|sevoflurane response - Toxicity [RCV001788019]|succinylcholine response - Toxicity [RCV001788020] | pathogenic|likely pathogenic|drug response|not provided | 19 | 38500642 | 38500642 | Human | 5 | trait |
| 8689169 | CV136954 | single nucleotide variant | NM_000540.3(RYR1):c.7523G>A (p.Arg2508His) | Malignant hyperthermia, susceptibility to, 1 [RCV001588961]|RYR1-related disorder [RCV000528193]|desflurane response - Toxicity [RCV001788021]|enflurane response - Toxicity [RCV001788022]|halothane response - Tox nt-weight:700;'>Toxicity [RCV001788023]|isoflurane response - Toxicity [RCV001788024]|methoxyflurane response - Toxicity [RCV001788025]|not provided [RCV000119719]|sevoflurane response - Toxicity [RCV001788026]|succinylcholine response - Toxicity [RCV001788027] | pathogenic|likely pathogenic|drug response|not provided | 19 | 38500899 | 38500899 | Human | 2 | trait |
| 8689202 | CV136985 | single nucleotide variant | NM_000540.3(RYR1):c.9310G>A (p.Glu3104Lys) | Malignant hyperthermia, susceptibility to, 1 [RCV002281947]|RYR1-related disorder [RCV000691233]|desflurane response - Toxicity [RCV001788028]|enflurane response - Toxicity [RCV001788029]|halothane response - Tox nt-weight:700;'>Toxicity [RCV001788030]|isoflurane response - Toxicity [RCV001788031]|methoxyflurane response - Toxicity [RCV001788032]|not provided [RCV000119768]|sevoflurane response - Toxicity [RCV001788033]|succinylcholine response - Toxicity [RCV001788034] | pathogenic|likely pathogenic|drug response|not provided | 19 | 38512321 | 38512321 | Human | 2 | trait |
| 8689207 | CV136990 | single nucleotide variant | NM_000540.3(RYR1):c.982C>T (p.Arg328Trp) | Malignant hyperthermia, susceptibility to, 1 [RCV001588963]|RYR1-related disorder [RCV001854587]|desflurane response - Toxicity [RCV003227663]|enflurane response - Toxicity [RCV003227664]|halothane response - Tox nt-weight:700;'>Toxicity [RCV003227665]|isoflurane response - Toxicity [RCV003227666]|methoxyflurane response - Toxicity [RCV003227667]|not provided [RCV000119775]|sevoflurane response - Toxicity [RCV003227668]|succinylcholine response - Toxicity [RCV003227669] | pathogenic|likely pathogenic|conflicting interpretations of pathogenicity|drug response|uncertain significance|not provided | 19 | 38448673 | 38448673 | Human | 2 | trait |
| 8563405 | CV28003 | single nucleotide variant | NM_000540.3(RYR1):c.1840C>T (p.Arg614Cys) | Central core myopathy [RCV002496349]|Inborn genetic diseases [RCV000624176]|Malignant hyperthermia of anesthesia [RCV000608635]|Malignant hyperthermia, susceptibility to, 1 [RCV000013830]|RYR1-related disorder [RCV000538121]|desflurane response - Toxicity [RCV00 1787388]|enflurane response - Toxicity [RCV001787389]|halothane response - Toxicity [RCV001787390]|isoflurane response - Toxicity [RCV001787391]|methoxyflurane response - Toxicity [RCV001787392]|not provided [RCV000119586]|sevoflurane response - Toxicity [RCV001787393]|succinylcholine response - Toxicity [RCV001787394] | pathogenic|likely pathogenic|risk factor|drug response|conflicting data from submitters|not provided | 19 | 38457545 | 38457545 | Human | 10 | trait |
| 8563407 | CV28005 | single nucleotide variant | NM_000540.3(RYR1):c.7304G>A (p.Arg2435His) | Central core myopathy [RCV000013832]|Central core myopathy [RCV005409599]|Malignant hyperthermia of anesthesia [RCV004017238]|Malignant hyperthermia, susceptibility to, 1 [RCV002281705]|RYR1-related disorder [RCV000707405]|desflurane response - Toxicity [RCV0017 87395]|enflurane response - Toxicity [RCV001787396]|halothane response - Toxicity [RCV001787397]|isoflurane response - Toxicity [RCV001787398]|methoxyflurane response - Toxicity [RCV001787399]|not provided [RCV000119699]|sevoflurane response - Toxicity [RCV001787400]|succinylcholine response - Toxicity [RCV001787401] | pathogenic|drug response|not provided | 19 | 38499997 | 38499997 | Human | 4 | trait |
| 8563408 | CV28006 | single nucleotide variant | NM_000540.3(RYR1):c.487C>T (p.Arg163Cys) | Central core myopathy [RCV000013834]|Malignant hyperthermia of anesthesia [RCV004017239]|Malignant hyperthermia, susceptibility to, 1 [RCV000013833]|RYR1-related disorder [RCV000806352]|desflurane response - Toxicity [RCV001787402]|enflurane response - Tox le='font-weight:700;'>Toxicity [RCV001787706]|halothane response - Toxicity [RCV001787707]|isoflurane response - Toxicity [RCV001787708]|methoxyflurane response - Toxicity [RCV001787709]|not provided [RCV000119625]|sevoflurane response - Toxicity [RCV001787710]|succinylcholine response - Toxicity [RCV001787711] | pathogenic|risk factor|drug response|not provided | 19 | 38444211 | 38444211 | Human | 4 | trait |
| 8563409 | CV28007 | single nucleotide variant | NM_000540.3(RYR1):c.1209C>G (p.Ile403Met) | Central core myopathy [RCV000013835]|Malignant hyperthermia, susceptibility to, 1 [RCV003231102]|RYR1-related disorder [RCV003591629]|desflurane response - Toxicity [RCV001787712]|enflurane response - Toxicity [RCV001787713] |halothane response - Toxicity [RCV001787714]|isoflurane response - Toxicity [RCV001787715]|methoxyflurane response - Toxicity [RCV001787716]|not provided [RCV000119453]|not specified [RCV004782014]|sevoflurane response - Toxicity [RCV001787717]|succinylcholine response - Toxicity [RCV001787718] | pathogenic|likely pathogenic|drug response|uncertain significance|not provided | 19 | 38451850 | 38451850 | Human | 3 | trait |
| 8563411 | CV28009 | single nucleotide variant | NM_000540.3(RYR1):c.7300G>A (p.Gly2434Arg) | Central core myopathy [RCV002288488]|Central core myopathy [RCV005025050]|Inborn genetic diseases [RCV002513026]|Malignant hyperthermia of anesthesia [RCV000612258]|Malignant hyperthermia, susceptibility to, 1 [RCV000013837]|RYR1-related disorder [RCV000551243]|desflurane response - Tox t-weight:700;'>Toxicity [RCV001787719]|enflurane response - Toxicity [RCV001787720]|halothane response - Toxicity [RCV001787721]|isoflurane response - Toxicity [RCV001787722]|methoxyflurane response - Toxicity [RCV001787723]|not provided [RCV000119698]|sevoflurane response - Toxicity [RCV001787724]|succinylcholine response - Toxicity [RCV001787725] | pathogenic|risk factor|drug response|not provided | 19 | 38499993 | 38499993 | Human | 8 | trait |
| 8563412 | CV28010 | single nucleotide variant | NM_000540.3(RYR1):c.7372C>T (p.Arg2458Cys) | Central core myopathy [RCV002490361]|Malignant hyperthermia of anesthesia [RCV000614410]|Malignant hyperthermia, susceptibility to, 1 [RCV000013838]|RYR1-related disorder [RCV000796565]|desflurane response - Toxicity [RCV001787726]|enflurane response - Tox le='font-weight:700;'>Toxicity [RCV001787727]|halothane response - Toxicity [RCV001787728]|isoflurane response - Toxicity [RCV001787729]|methoxyflurane response - Toxicity [RCV001787730]|not provided [RCV000119711]|sevoflurane response - Toxicity [RCV001787731]|succinylcholine response - Toxicity [RCV001787732] | pathogenic|likely pathogenic|risk factor|drug response|not provided | 19 | 38500654 | 38500654 | Human | 9 | trait |
| 8563413 | CV28011 | single nucleotide variant | NM_000540.3(RYR1):c.7373G>A (p.Arg2458His) | Malignant hyperthermia of anesthesia [RCV004017240]|Malignant hyperthermia, susceptibility to, 1 [RCV000013839]|RYR1-related disorder [RCV000793289]|desflurane response - Toxicity [RCV001787733]|enflurane response - Toxicity [RCV001787734]|halothane response - Toxicity [RCV001787735]|isoflurane response - Toxicity [RCV001787736]|methoxyflurane response - Toxicity [RCV001787737]|not provided [RCV000079164]|sevoflurane response - Toxicity [RCV001787738]|succinylcholine response - Toxicity [RCV001787739] | pathogenic|likely pathogenic|risk factor|drug response|not provided | 19 | 38500655 | 38500655 | Human | 3 | trait |
| 8563414 | CV28012 | single nucleotide variant | NM_000540.3(RYR1):c.6487C>T (p.Arg2163Cys) | Central core myopathy [RCV000056223]|Malignant hyperthermia, susceptibility to, 1 [RCV000013840]|RYR1-related disorder [RCV001385701]|desflurane response - Toxicity [RCV001787740]|enflurane response - Toxicity [RCV001787741] |halothane response - Toxicity [RCV001787742]|isoflurane response - Toxicity [RCV001787743]|methoxyflurane response - Toxicity [RCV001787744]|not provided [RCV000119653]|sevoflurane response - Toxicity [RCV001787745]|succinylcholine response - Toxicity [RCV001787746] | pathogenic|risk factor|drug response|not provided | 19 | 38494564 | 38494564 | Human | 3 | trait |
| 8563415 | CV28013 | single nucleotide variant | NM_000540.3(RYR1):c.6488G>A (p.Arg2163His) | Central core myopathy [RCV000013842]|Malignant hyperthermia, susceptibility to, 1 [RCV000013841]|RYR1-related disorder [RCV001204982]|desflurane response - Toxicity [RCV001787747]|enflurane response - Toxicity [RCV001787748] |halothane response - Toxicity [RCV001787749]|isoflurane response - Toxicity [RCV001787750]|methoxyflurane response - Toxicity [RCV001787751]|not provided [RCV000119654]|sevoflurane response - Toxicity [RCV001787752]|succinylcholine response - Toxicity [RCV001787753] | pathogenic|likely pathogenic|risk factor|drug response|not provided | 19 | 38494565 | 38494565 | Human | 3 | trait |
| 8563416 | CV28014 | single nucleotide variant | NM_000540.3(RYR1):c.14693T>C (p.Ile4898Thr) | Central core myopathy [RCV000013843]|Central core myopathy [RCV000763430]|Congenital myopathy [RCV004586003]|Malignant hyperthermia, susceptibility to, 1 [RCV000013844]|RYR1-related disorder [RCV000535754]|RYR1-related myopathy [RCV004737150]|desflurane response - Tox /span>icity [RCV001787754]|enflurane response - Toxicity [RCV001787755]|halothane response - Toxicity [RCV001787756]|isoflurane response - Toxicity [RCV001787757]|methoxyflurane response - Toxicity [RCV001787758]|not provided [RCV000119552]|sevoflurane response - Toxicity [RCV001787759]|succinylcholine response - Toxicity [RCV001787760] | pathogenic|likely pathogenic|risk factor|drug response|uncertain significance|not provided | 19 | 38584989 | 38584989 | Human | 8 | trait |
| 8563417 | CV28015 | single nucleotide variant | NM_000540.3(RYR1):c.6502G>A (p.Val2168Met) | Central core myopathy [RCV001729347]|Congenital multicore myopathy with external ophthalmoplegia [RCV000578323]|Malignant hyperthermia of anesthesia [RCV003398498]|Malignant hyperthermia, susceptibility to, 1 [RCV000013845]|RYR1-related disorder [RCV000557804]|desflurane response - Tox -weight:700;'>Toxicity [RCV001787761]|enflurane response - Toxicity [RCV001787762]|halothane response - Toxicity [RCV001787763]|isoflurane response - Toxicity [RCV001787764]|methoxyflurane response - Toxicity [RCV001787765]|not provided [RCV000119656]|sevoflurane response - Toxicity [RCV001787766]|succinylcholine response - Toxicity [RCV001787767] | pathogenic|risk factor|drug response|not provided | 19 | 38494579 | 38494579 | Human | 6 | trait |
| 8563419 | CV28017 | single nucleotide variant | NM_000540.3(RYR1):c.14477C>T (p.Thr4826Ile) | Malignant hyperthermia, susceptibility to, 1 [RCV000013847]|RYR1-related disorder [RCV003591630]|desflurane response - Toxicity [RCV001787768]|enflurane response - Toxicity [RCV001787769]|halothane response - Tox nt-weight:700;'>Toxicity [RCV001787770]|isoflurane response - Toxicity [RCV001787771]|methoxyflurane response - Toxicity [RCV001787772]|not provided [RCV000119520]|sevoflurane response - Toxicity [RCV001787773]|succinylcholine response - Toxicity [RCV001787774] | pathogenic|risk factor|drug response|not provided | 19 | 38580094 | 38580094 | Human | 2 | trait |
| 8563420 | CV28018 | single nucleotide variant | NM_000540.3(RYR1):c.14387A>G (p.Tyr4796Cys) | Central core myopathy [RCV000013848]|Malignant hyperthermia, susceptibility to, 1 [RCV000013849]|RYR1-related disorder [RCV001060960]|desflurane response - Toxicity [RCV001787775]|enflurane response - Toxicity [RCV001787776] |halothane response - Toxicity [RCV001787777]|isoflurane response - Toxicity [RCV001787778]|methoxyflurane response - Toxicity [RCV001787779]|not provided [RCV000119509]|sevoflurane response - Toxicity [RCV001787780]|succinylcholine response - Toxicity [RCV001787781] | pathogenic|risk factor|drug response|uncertain significance|not provided | 19 | 38580004 | 38580004 | Human | 3 | trait |
| 8563423 | CV28021 | single nucleotide variant | NM_000540.3(RYR1):c.14582G>A (p.Arg4861His) | Central core myopathy [RCV000013852]|Malignant hyperthermia of anesthesia [RCV004017241]|Malignant hyperthermia, susceptibility to, 1 [RCV000851296]|RYR1-related disorder [RCV000534187]|RYR1-related myopathy [RCV004991972]|desflurane response - Toxicity [RCV0017 87782]|enflurane response - Toxicity [RCV001787783]|halothane response - Toxicity [RCV001787784]|isoflurane response - Toxicity [RCV001787785]|methoxyflurane response - Toxicity [RCV001787786]|not provided [RCV000119533]|sevoflurane response - Toxicity [RCV001787787]|succinylcholine response - Toxicity [RCV001787788] | pathogenic|drug response|uncertain significance|not provided | 19 | 38580440 | 38580440 | Human | 4 | trait |
| 8563425 | CV28023 | single nucleotide variant | NM_000540.3(RYR1):c.14545G>A (p.Val4849Ile) | Centronuclear myopathy [RCV004586004]|Congenital multicore myopathy with external ophthalmoplegia [RCV000013856]|Inborn genetic diseases [RCV004658962]|Malignant hyperthermia of anesthesia [RCV004017242]|Malignant hyperthermia, susceptibility to, 1 [RCV000990211]|RYR1-related disorder [RCV001060435] |RYR1-related myopathy [RCV004786258]|desflurane response - Toxicity [RCV001787789]|enflurane response - Toxicity [RCV001787790]|halothane response - Toxicity [RCV001787791]|isoflurane response - Toxicity [RCV001787792]|methoxyflurane response - Toxicity [RCV001787793]|not provided [RCV000119527]|sevoflurane response - Toxicity [RCV001787794]|succinylcholine response - Toxicity [RCV001787795] | pathogenic|likely pathogenic|drug response|not provided | 19 | 38580403 | 38580403 | Human | 8 | trait |
| 8563433 | CV28032 | single nucleotide variant | NM_000540.3(RYR1):c.1565A>C (p.Tyr522Ser) | Malignant hyperthermia, susceptibility to, 1 [RCV000013865]|desflurane response - Toxicity [RCV001787796]|enflurane response - Toxicity [RCV001787797]|halothane response - Toxicity [RCV0 01787798]|isoflurane response - Toxicity [RCV001787799]|methoxyflurane response - Toxicity [RCV001787800]|not provided [RCV000119574]|sevoflurane response - Toxicity [RCV001787801]|succinylcholine response - Toxicity [RCV001787802] | pathogenic|risk factor|drug response|not provided | 19 | 38455359 | 38455359 | Human | 2 | trait |
| 8566324 | CV32665 | single nucleotide variant | NM_000069.3(CACNA1S):c.3257G>A (p.Arg1086His) | Hypokalemic periodic paralysis, type 1 [RCV001851936]|Malignant hyperthermia, susceptibility to, 5 [RCV000019193]|desflurane response - Toxicity [RCV003227606]|enflurane response - Toxicity [RCV001787808]|halothane response - Toxicity [RCV001787809]|isoflurane response - Toxicity [RCV001787810]|methoxyflurane response - Toxicity [RCV001787811]|not provided [RCV001753422]|sevoflurane response - Toxicity [RCV001787812]|succinylcholine response - Toxicity [RCV001787813] | pathogenic|risk factor|drug response | 1 | 201060815 | 201060815 | Human | 3 | trait |
| 9688413 | CV40587 | single nucleotide variant | NM_006446.5(SLCO1B1):c.521T>C (p.Val174Ala) | Gilbert syndrome [RCV000999565]|Rotor syndrome [RCV000311457]|SLCO1B1-related disorder [RCV003982852]|atorvastatin response - Metabolism/PK [RCV001787819]|atorvastatin response - Toxicity [RCV001787820]|fluvastatin response - Metabolism/PK [RCV003227613]|fluvast atin response - Toxicity [RCV003227614]|hmg coa reductase inhibitors response - Toxicity [RCV001787333]|lovastatin acid response - Metabolism/PK [RCV003227615]|lovastatin response - Metabolism/PK [RCV003227616]|lovastatin response - Toxicity [RCV003227617]|not provided [RCV000325818]|not specified [RCV001705611]|pitavastatin response - Metabolism/PK [RCV003227618]|pravastatin response - Toxicity [RCV003227619]|rosuvastatin response - Metabolism/PK [RCV001787324]|rosuvastatin response - Toxicity [RCV003227620]|simvastatin acid response - Metabolism/PK [RCV000660832]|simvastatin response - Metabolism/PK [RCV003227621]|simvastatin response - Toxicity [RCV001787325] | pathogenic|benign|likely benign|drug response|other|not provided | 12 | 21178615 | 21178615 | Human | 156 | trait |
| 13801887 | CV557106 | single nucleotide variant | NM_000069.3(CACNA1S):c.520C>T (p.Arg174Trp) | Hypokalemic periodic paralysis, type 1 [RCV000698038]|Hypokalemic periodic paralysis, type 1 [RCV005010706]|Malignant hyperthermia of anesthesia [RCV004017719]|Malignant hyperthermia, susceptibility to, 5 [RCV002468602]|desflurane response - Toxicity [RCV0017883 30]|enflurane response - Toxicity [RCV001788331]|halothane response - Toxicity [RCV001788332]|isoflurane response - Toxicity [RCV001788333]|methoxyflurane response - Toxicity [RCV001788334]|not provided [RCV001093102]|not specified [RCV002249414]|sevoflurane response - Toxicity [RCV001788335]|succinylcholine response - Toxicity [RCV001788336] | pathogenic|likely pathogenic|drug response|uncertain significance | 1 | 201091993 | 201091993 | Human | 6 | trait , alternate_id |
| 8573509 | CV76887 | single nucleotide variant | NM_000540.3(RYR1):c.7354C>T (p.Arg2452Trp) | Central core myopathy [RCV000056226]|King Denborough syndrome [RCV001729374]|Malignant hyperthermia, susceptibility to, 1 [RCV002281899]|RYR1-related disorder [RCV000527240]|RYR1-related myopathy [RCV002221195]|desflurane response - Toxicity [RCV001787847]|enflu rane response - Toxicity [RCV001787848]|halothane response - Toxicity [RCV001787849]|isoflurane response - Toxicity [RCV001787850]|methoxyflurane response - Toxicity [RCV001787851]|not provided [RCV000119706]|sevoflurane response - Toxicity [RCV001787852]|succinylcholine response - Toxicity [RCV001787853] | pathogenic|likely pathogenic|drug response|not provided | 19 | 38500636 | 38500636 | Human | 4 | trait |
| 8573510 | CV76888 | single nucleotide variant | NM_000540.3(RYR1):c.7361G>A (p.Arg2454His) | Central core myopathy [RCV000056227]|Central core myopathy [RCV005016355]|Malignant hyperthermia of anesthesia [RCV004700357]|Malignant hyperthermia, susceptibility to, 1 [RCV000709760]|RYR1-related disorder [RCV000699835]|desflurane response - Toxicity [RCV0017 87854]|enflurane response - Toxicity [RCV001787855]|halothane response - Toxicity [RCV001787856]|isoflurane response - Toxicity [RCV001787857]|methoxyflurane response - Toxicity [RCV001787858]|not provided [RCV000119710]|sevoflurane response - Toxicity [RCV001787859]|succinylcholine response - Toxicity [RCV001787860] | pathogenic|drug response|not provided | 19 | 38500643 | 38500643 | Human | 7 | trait |
| 8554992 | CV24667 | single nucleotide variant | NC_012920.1(MT-ND1):m.1555A>G | Aminoglycoside induced ototoxicity [RCV004554597]|Aminoglycoside-induced deafness [RCV000010254]|Aminoglycoside-induced deafness [RCV000505667]|Gentamicin response [RCV000722074]|Hearing loss, sensorineural, autosomal-mitochondrial type [RCV003445067]|Mitochondr ial disease [RCV003153300]|Mitochondrial non-syndromic sensorineural hearing loss [RCV000010255]|Rare genetic deafness [RCV000844677]|Restrictive cardiomyopathy [RCV000010256]|amikacin response - Toxicity [RCV001787375]|aminoglycoside antibacterials response - Toxicity [RCV001787321]|gentamicin response - Toxicity [RCV001787374]|kanamycin response - Toxicity [RCV001787376]|not provided [RCV000224935]|streptomycin response - Toxicity [RCV001787377]|tobramycin response - Toxicity [RCV001787378] | pathogenic|likely pathogenic|drug response | MT | 1555 | 1555 | Human | 6 | trait , alternate_id |
| 8554995 | CV24671 | single nucleotide variant | NC_012920.1(MT-ND1):m.1494C>T | Aminoglycoside Ototoxicity [RCV004554598]|Aminoglycoside-induced deafness [RCV000010262]|Gentamicin response [RCV000722075]|Mitochondrial disease [RCV002291211]|Mitochondrial non-syndromic sensorineural hearing loss [RCV000010263]|Rare genetic deafness [RCV00144 9811]|aminoglycoside antibacterials response - Toxicity [RCV001787322]|gentamicin response - Toxicity [RCV001787383]|kanamycin response - Toxicity [RCV001787384]|streptomycin response - Toxicity [RCV001787385]|tobramycin response - Toxicity [RCV001787386] | pathogenic|likely pathogenic|risk factor|drug response | MT | 1494 | 1494 | Human | 3 | trait , alternate_id |
| 8554994 | CV24670 | single nucleotide variant | NC_012920.1(MT-CYB):m.1095T>C | Aminoglycoside-induced deafness [RCV000010259]|Auditory neuropathy [RCV000010261]|Mitochondrial non-syndromic sensorineural hearing loss [RCV000010260]|aminoglycoside antibacterials response - Toxicity [RCV001787380]|gentamicin response - Tox t:700;'>Toxicity [RCV001787379]|kanamycin response - Toxicity [RCV001787381]|not provided [RCV004696633]|not specified [RCV000035031]|streptomycin response - Toxicity [RCV001787382] | pathogenic|likely pathogenic|drug response|uncertain significance | MT | 1095 | 1095 | Human | 3 | trait , alternate_id |
| 8555629 | CV15471 | single nucleotide variant | NM_000110.4(DPYD):c.1905+1G>A | DPYD-related disorder [RCV005222656]|Dihydropyrimidine dehydrogenase deficiency [RCV000000460]|Fluorouracil response [RCV000030868]|Hirschsprung disease, susceptibility to, 1 [RCV000201291]|Inborn genetic diseases [RCV004018525]|capecitabine response - Toxicity [RCV001787360]|fluorouracil response - Other [RCV001787359]|fluorouracil response - Toxicity [RCV001787337]|not provided [RCV000086468]|tegafur response - Toxicity [RCV001787361] | pathogenic|likely pathogenic|conflicting interpretations of pathogenicity|drug response|uncertain significance|not provided | 1 | 97450058 | 97450058 | Human | 5 | trait , alternate_id |
| 8646473 | CV94529 | single nucleotide variant | NM_000110.4(DPYD):c.2846A>T (p.Asp949Val) | DPYD-related disorder [RCV005222738]|Dihydropyrimidine dehydrogenase deficiency [RCV000410600]|Fluorouracil response [RCV000500980]|Inborn genetic diseases [RCV000623094]|capecitabine response - Toxicity [RCV001787864]|fluorouracil response - Other [RCV001787863 ]|fluorouracil response - Toxicity [RCV001787336]|not provided [RCV000086452]|tegafur response - Toxicity [RCV001787865] | pathogenic|likely pathogenic|likely benign|conflicting interpretations of pathogenicity|drug response|uncertain significance|no classifications from unflagged records|other|not provided | 1 | 97082391 | 97082391 | Human | 3 | trait , alternate_id |
| 8646495 | CV94530 | single nucleotide variant | NM_000110.4(DPYD):c.1679T>G (p.Ile560Ser) | Dihydropyrimidine dehydrogenase deficiency [RCV000410952]|Inborn genetic diseases [RCV004619197]|capecitabine response - Toxicity [RCV001787867]|fluorouracil response - Other [RCV001787866]|fluorouracil response - Toxicity [ RCV001787326]|not provided [RCV000086474]|tegafur response - Toxicity [RCV001787868] | pathogenic|likely pathogenic|drug response|not provided | 1 | 97515787 | 97515787 | Human | 3 | trait |
| 8583480 | CV118042 | single nucleotide variant | NM_001303523.1(TOX4):c.6+4451A>G | Lung cancer [RCV000098562] | uncertain significance | 14 | 21481735 | 21481735 | Human | | name |
| 8584893 | CV119470 | single nucleotide variant | NM_001146188.1(TOX3):c.75+5866A>T | Lung cancer [RCV000099990] | uncertain significance | 16 | 52513540 | 52513540 | Human | | name |
| 8584892 | CV119469 | single nucleotide variant | NM_001146188.1(TOX3):c.76-20579A>T | Lung cancer [RCV000099989] | uncertain significance | 16 | 52489153 | 52489153 | Human | | name |
| 8586478 | CV121081 | single nucleotide variant | NM_001098796.1(TOX2):c.-28+4685C>T | Lung cancer [RCV000101601] | uncertain significance | 20 | 43920893 | 43920893 | Human | | name |
| 8584894 | CV119471 | single nucleotide variant | NM_001146188.1(TOX3):c.-100+11611A>T | Lung cancer [RCV000099991] | uncertain significance | 16 | 52536103 | 52536103 | Human | | name |
| 8646483 | CV105957 | single nucleotide variant | NM_000110.4(DPYD):c.2194G>A (p.Val732Ile) | DPYD-related disorder [RCV003891585]|Dihydropyrimidine dehydrogenase deficiency [RCV000407597]|capecitabine response - Toxicity [RCV001787903]|fluorouracil response - Other [RCV001787902]|fluorouracil response - Toxicity [RC V001787904]|not provided [RCV000086462]|not specified [RCV000249656] | benign|likely benign|drug response|not provided | 1 | 97305364 | 97305364 | Human | 2 | trait |
| 8646491 | CV105965 | single nucleotide variant | NM_000110.4(DPYD):c.1896T>C (p.Phe632=) | Dihydropyrimidine dehydrogenase deficiency [RCV000270743]|capecitabine response - Toxicity [RCV001787905]|fluorouracil response - Toxicity [RCV001787906]|not provided [RCV000086470]|not specified [RCV000244711] | benign|likely benign|drug response|not provided | 1 | 97450068 | 97450068 | Human | 2 | trait |
| 8646496 | CV105969 | single nucleotide variant | NM_000110.4(DPYD):c.1627A>G (p.Ile543Val) | DPYD-related disorder [RCV003891586]|Dihydropyrimidine dehydrogenase deficiency [RCV000389596]|capecitabine response - Toxicity [RCV001787907]|fluorouracil response - Toxicity [RCV001787908]|not provided [RCV000086475]|not s pecified [RCV000174446] | benign|likely benign|conflicting interpretations of pathogenicity|drug response|not provided | 1 | 97515839 | 97515839 | Human | 2 | trait |
| 8646498 | CV105971 | single nucleotide variant | NM_000110.4(DPYD):c.1601G>A (p.Ser534Asn) | DPYD-related disorder [RCV003891587]|Dihydropyrimidine dehydrogenase deficiency [RCV000603277]|capecitabine response - Toxicity [RCV001787909]|fluorouracil response - Toxicity [RCV001787910]|not provided [RCV000086477]|not s pecified [RCV000249334] | benign|likely benign|conflicting interpretations of pathogenicity|drug response|uncertain significance|not provided | 1 | 97515865 | 97515865 | Human | 2 | trait |
| 8646504 | CV105977 | single nucleotide variant | NM_000110.4(DPYD):c.1236G>A (p.Glu412=) | Dihydropyrimidine dehydrogenase deficiency [RCV001102326]|capecitabine response - Toxicity [RCV001787911]|fluorouracil response - Toxicity [RCV001787912]|not provided [RCV000086483]|not specified [RCV000252397] | benign|likely benign|drug response|not provided | 1 | 97573863 | 97573863 | Human | 2 | trait |
| 8646520 | CV105993 | single nucleotide variant | NM_000110.4(DPYD):c.496A>G (p.Met166Val) | DPYD-related disorder [RCV003891588]|Dihydropyrimidine dehydrogenase deficiency [RCV000276917]|capecitabine response - Toxicity [RCV001787915]|fluorouracil response - Toxicity [RCV001787916]|not provided [RCV000086499]|not s pecified [RCV000245015] | benign|likely benign|conflicting interpretations of pathogenicity|drug response|not provided | 1 | 97699535 | 97699535 | Human | 2 | trait |
| 8594982 | CV15474 | single nucleotide variant | NM_000110.4(DPYD):c.85T>C (p.Cys29Arg) | Dihydropyrimidine dehydrogenase deficiency [RCV000000464]|capecitabine response - Toxicity [RCV001787362]|fluorouracil response - Toxicity [RCV001787363]|not provided [RCV000711510]|not specified [RCV002247229] | pathogenic|benign|drug response | 1 | 97883329 | 97883329 | Human | 5 | trait |
| 8594982 | CV15474 | single nucleotide variant | NM_000110.4(DPYD):c.85T>C (p.Cys29Arg) | Dihydropyrimidine dehydrogenase deficiency [RCV000000464]|capecitabine response - Toxicity [RCV001787362]|fluorouracil response - Toxicity [RCV001787363]|not provided [RCV000711510]|not specified [RCV002247229] | pathogenic|benign|drug response | 1 | 97883329 | 97883330 | Human | 5 | trait |
| 8556698 | CV17250 | single nucleotide variant | NM_024006.4(VKORC1):c.-1639G>A | See cases [RCV003993732]|Thrombus [RCV003996074]|VKORC1-related disorder [RCV003952337]|Venous thromboembolism [RCV003150805]|Warfarin response [RCV000002295]|acenocoumarol response - Dosage [RCV003227594]|not provided [RCV000377657]|not specified [RCV000603173]|phenprocoumon response - Dosage [RCV0 01787364]|phenprocoumon response - Toxicity [RCV001787365]|warfarin response - Dosage [RCV003227593]|warfarin response - Efficacy [RCV003227595]|warfarin response - Toxicity [RCV001787366] | pathogenic|benign|likely benign|drug response|protective|uncertain significance|other | 16 | 31096368 | 31096368 | Human | 11 | trait |
| 11087690 | CV227779 | single nucleotide variant | NC_000015.9:g.45620985C>T | hmg coa reductase inhibitors response - Toxicity/ADR [RCV000211134]|simvastatin response - Toxicity/ADR [RCV000211259] | drug response | 15 | 45328787 | 45328787 | Human | 1 | trait |
| 11087690 | CV227779 | single nucleotide variant | NC_000015.9:g.45620985C>T | hmg coa reductase inhibitors response - Toxicity/ADR [RCV000211134]|simvastatin response - Toxicity/ADR [RCV000211259] | drug response | 15 | 45328787 | 45328788 | Human | 1 | trait |
| 11087735 | CV227780 | single nucleotide variant | NM_001321015.2(GATM):c.-394-272A>G | hmg coa reductase inhibitors response - Toxicity/ADR [RCV000211394]|simvastatin response - Toxicity/ADR [RCV000211216] | drug response | 15 | 45380831 | 45380831 | Human | | trait |
| 11087736 | CV227832 | single nucleotide variant | NC_000011.9:g.103418158A>G | Platinum compounds response - Toxicity/ADR [RCV000211343]|etoposide response - Toxicity/ADR [RCV000211218] | drug response | 11 | 103547430 | 103547430 | Human | 5 | trait |
| 11087736 | CV227832 | single nucleotide variant | NC_000011.9:g.103418158A>G | Platinum compounds response - Toxicity/ADR [RCV000211343]|etoposide response - Toxicity/ADR [RCV000211218] | drug response | 11 | 103547430 | 103547431 | Human | 5 | trait |
| 11087697 | CV227835 | microsatellite | NC_000002.11:g.234668881_234668882TA[5][6][7][8] | SN-38 response - Other [RCV000211306]|atazanavir and ritonavir response - Toxicity/ADR [RCV000211183]|irinotecan response - Toxicity/ADR [RCV000211397] | drug response | 2 | 233760235 | 233760236 | Human | | trait |
| 14696472 | CV623100 | single nucleotide variant | NM_000110.4(DPYD):c.1129-5923C>G | DPYD-related disorder [RCV003975320]|capecitabine response - Toxicity [RCV001788348]|fluorouracil response - Other [RCV001788347]|fluorouracil response - Toxicity [RCV001788349]|not provided [RCV003411727] | pathogenic|benign|likely benign|drug response | 1 | 97579893 | 97579893 | Human | 1 | trait |
| 8596140 | CV18559 | single nucleotide variant | NM_005957.5(MTHFR):c.665C>T (p.Ala222Val) | Gastrointestinal stromal tumor [RCV000144921]|Homocystinuria due to methylene tetrahydrofolate reductase deficiency [RCV001030751]|MTHFR THERMOLABILE POLYMORPHISM [RCV000003697]|Neural tube defects, folate-sensitive [RCV000259890]|See cases [RCV004584309]|Thrombophilia due to thrombin defect [RCV005 419857]|methotrexate response - Toxicity [RCV001847567]|not provided [RCV000153516]|not specified [RCV000428048] | pathogenic|risk factor|association|benign|likely benign|conflicting interpretations of pathogenicity|drug response|uncertain significance|other|not provided | 1 | 11796321 | 11796321 | Human | 36 | trait , alternate_id |
| 8603164 | CV15472 | single nucleotide variant | NM_000110.4(DPYD):c.2921A>T (p.Asp974Val) | Fluorouracil response [RCV000030869] | pathogenic | 1 | 97079133 | 97079133 | Human | 1 | alternate_id |
| 126729053 | CV1015940 | single nucleotide variant | NM_014362.4(HIBCH):c.529G>C (p.Asp177His) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV001333044] | uncertain significance | 2 | 190252296 | 190252296 | Human | 2 | alternate_id |
| 126739025 | CV1019517 | single nucleotide variant | NM_014362.4(HIBCH):c.856C>T (p.Gln286Ter) | Beta-hydroxyisobutyryl-CoA deacylase deficiency [RCV001335656] | pathogenic | 2 | 190244922 | 190244922 | Human | 1 | alternate_id |
| 126739020 | CV1019518 | single nucleotide variant | NM_014362.4(HIBCH):c.763C>G (p.Arg255Gly) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV001335655] | uncertain significance | 2 | 190246200 | 190246200 | Human | 2 | alternate_id |
| 127251295 | CV1055171 | single nucleotide variant | NM_014362.4(HIBCH):c.439-2A>G | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV001378527] | likely pathogenic|conflicting interpretations of pathogenicity | 2 | 190261236 | 190261236 | Human | 2 | alternate_id |
| 150535904 | CV1312093 | single nucleotide variant | NM_014362.4(HIBCH):c.1036G>A (p.Val346Ile) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV001868830]|Inborn genetic diseases [RCV003163921]|not provided [RCV001779905] | uncertain significance | 2 | 190208889 | 190208889 | Human | 3 | alternate_id |
| 150544441 | CV1313344 | single nucleotide variant | NM_014362.4(HIBCH):c.937C>T (p.Gln313Ter) | Beta-hydroxyisobutyryl-CoA deacylase deficiency [RCV001783421] | pathogenic | 2 | 190213030 | 190213030 | Human | 1 | alternate_id |
| 150542460 | CV1314801 | single nucleotide variant | NM_014362.4(HIBCH):c.439-1G>A | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV001782252] | likely pathogenic | 2 | 190261235 | 190261235 | Human | 2 | alternate_id |
| 151351389 | CV1323538 | single nucleotide variant | NM_014362.4(HIBCH):c.777T>A (p.Phe259Leu) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV001806394] | likely pathogenic | 2 | 190246186 | 190246186 | Human | 2 | alternate_id |
| 151350511 | CV1324744 | single nucleotide variant | NM_014362.4(HIBCH):c.386-1G>C | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV001809189] | pathogenic|likely pathogenic | 2 | 190287639 | 190287639 | Human | 2 | alternate_id |
| 151813054 | CV1341081 | deletion | NC_000002.12:g.190246209_190246214del | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV001946420] | uncertain significance | 2 | 190246207 | 190246212 | Human | 2 | alternate_id |
| 151786601 | CV1367825 | single nucleotide variant | NM_014362.4(HIBCH):c.196C>A (p.Arg66=) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV001894096] | likely benign|uncertain significance | 2 | 190296836 | 190296836 | Human | 2 | alternate_id |
| 151720286 | CV1369554 | single nucleotide variant | NM_014362.4(HIBCH):c.385+2T>A | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV002036141] | likely pathogenic | 2 | 190290403 | 190290403 | Human | 2 | alternate_id |
| 151718942 | CV1382911 | single nucleotide variant | NM_014362.4(HIBCH):c.1103C>T (p.Thr368Ile) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV002031650] | uncertain significance | 2 | 190205175 | 190205175 | Human | 2 | alternate_id |
| 151793559 | CV1399375 | single nucleotide variant | NM_014362.4(HIBCH):c.974T>G (p.Val325Gly) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV001908616] | uncertain significance | 2 | 190212993 | 190212993 | Human | 2 | alternate_id |
| 151722459 | CV1401795 | single nucleotide variant | NM_014362.4(HIBCH):c.284G>C (p.Cys95Ser) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV002042720] | uncertain significance | 2 | 190294566 | 190294566 | Human | 2 | alternate_id |
| 151811783 | CV1403421 | single nucleotide variant | NM_014362.4(HIBCH):c.4G>A (p.Gly2Arg) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV001943646] | uncertain significance | 2 | 190319747 | 190319747 | Human | 2 | alternate_id |
| 151814639 | CV1406203 | single nucleotide variant | NM_014362.4(HIBCH):c.153A>G (p.Leu51=) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV001949656] | likely benign | 2 | 190296879 | 190296879 | Human | 2 | alternate_id |
| 151785344 | CV1425107 | single nucleotide variant | NM_014362.4(HIBCH):c.11G>T (p.Arg4Leu) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV001891450] | uncertain significance | 2 | 190319740 | 190319740 | Human | 2 | alternate_id |
| 151829337 | CV1446497 | single nucleotide variant | NM_014362.4(HIBCH):c.891+1G>A | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV001980827] | likely pathogenic | 2 | 190244886 | 190244886 | Human | 2 | alternate_id |
| 151824025 | CV1462187 | deletion | NM_014362.4(HIBCH):c.1128del (p.Phe376fs) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV001970494] | uncertain significance | 2 | 190205150 | 190205150 | Human | 2 | alternate_id |
| 151797023 | CV1482931 | single nucleotide variant | NM_014362.4(HIBCH):c.1012A>T (p.Arg338Ter) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV001914882]|See cases [RCV003156142] | pathogenic|likely pathogenic | 2 | 190208913 | 190208913 | Human | 2 | alternate_id |
| 151800280 | CV1496343 | single nucleotide variant | NM_014362.4(HIBCH):c.145A>G (p.Ile49Val) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV001921938] | uncertain significance | 2 | 190296887 | 190296887 | Human | 2 | alternate_id |
| 151713102 | CV1508560 | single nucleotide variant | NM_014362.4(HIBCH):c.1034G>T (p.Gly345Val) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV002010036] | uncertain significance | 2 | 190208891 | 190208891 | Human | 2 | alternate_id |
| 152159217 | CV1522015 | single nucleotide variant | NM_014362.4(HIBCH):c.798C>T (p.Asp266=) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV002180626] | likely benign | 2 | 190246165 | 190246165 | Human | 2 | alternate_id |
| 152042543 | CV1522195 | single nucleotide variant | NM_014362.4(HIBCH):c.809+19C>T | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV002088152] | likely benign | 2 | 190246135 | 190246135 | Human | 2 | alternate_id |
| 152050771 | CV1533292 | single nucleotide variant | NM_014362.4(HIBCH):c.219+16A>G | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV002166850] | likely benign | 2 | 190296797 | 190296797 | Human | 2 | alternate_id |
| 152072309 | CV1551621 | single nucleotide variant | NM_014362.4(HIBCH):c.892-18A>C | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV002075271] | likely benign | 2 | 190213093 | 190213093 | Human | 2 | alternate_id |
| 152076779 | CV1564568 | single nucleotide variant | NM_014362.4(HIBCH):c.897T>C (p.Ile299=) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV002192514] | likely benign | 2 | 190213070 | 190213070 | Human | 2 | alternate_id |
| 152129515 | CV1607786 | deletion | NM_014362.4(HIBCH):c.1011+20del | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV002176612] | benign | 2 | 190212936 | 190212936 | Human | 2 | alternate_id |
| 8555999 | CV16183 | single nucleotide variant | NM_014362.4(HIBCH):c.220-9T>G | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV000001203] | pathogenic | 2 | 190294639 | 190294639 | Human | 2 | alternate_id |
| 8556000 | CV16184 | single nucleotide variant | NM_014362.4(HIBCH):c.365A>G (p.Tyr122Cys) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV000001204]|Inborn genetic diseases [RCV000623332]|not provided [RCV000224374] | pathogenic|likely pathogenic|conflicting interpretations of pathogenicity | 2 | 190290425 | 190290425 | Human | 3 | alternate_id |
| 8556001 | CV16185 | single nucleotide variant | NM_014362.4(HIBCH):c.79-3C>G | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV000001205] | pathogenic | 2 | 190296956 | 190296956 | Human | 2 | alternate_id |
| 152043415 | CV1621868 | single nucleotide variant | NM_014362.4(HIBCH):c.550T>C (p.Leu184=) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV002108046] | likely benign | 2 | 190252275 | 190252275 | Human | 2 | alternate_id |
| 152139659 | CV1625011 | single nucleotide variant | NM_014362.4(HIBCH):c.891+18T>C | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV002219205] | likely benign | 2 | 190244869 | 190244869 | Human | 2 | alternate_id |
| 152164737 | CV1625548 | single nucleotide variant | NM_014362.4(HIBCH):c.312G>A (p.Ser104=) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV002160308] | likely benign | 2 | 190290478 | 190290478 | Human | 2 | alternate_id |
| 152048721 | CV1656022 | single nucleotide variant | NM_014362.4(HIBCH):c.783T>G (p.Leu261=) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV002207242] | likely benign | 2 | 190246180 | 190246180 | Human | 2 | alternate_id |
| 155715442 | CV1774115 | single nucleotide variant | NM_014362.4(HIBCH):c.716A>G (p.Asn239Ser) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV002296396] | uncertain significance | 2 | 190249674 | 190249674 | Human | 2 | alternate_id |
| 10041634 | CV185756 | single nucleotide variant | NM_014362.4(HIBCH):c.950G>A (p.Gly317Glu) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV000167584] | pathogenic|likely pathogenic|not provided | 2 | 190213017 | 190213017 | Human | 2 | alternate_id |
| 156163916 | CV1860014 | single nucleotide variant | NM_014362.4(HIBCH):c.810-4A>G | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV002573583]|See cases [RCV003233005] | likely benign|uncertain significance | 2 | 190244972 | 190244972 | Human | 2 | alternate_id |
| 329954582 | CV1860017 | single nucleotide variant | NM_004208.4(AIFM1):c.1084A>C (p.Lys362Gln) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV003233008] | uncertain significance | X | 130136723 | 130136723 | Human | 2 | alternate_id |
| 329954675 | CV1860018 | single nucleotide variant | NM_014362.4(HIBCH):c.958A>G (p.Lys320Glu) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV003233009] | uncertain significance | 2 | 190213009 | 190213009 | Human | 2 | alternate_id |
| 155798174 | CV1861894 | single nucleotide variant | NM_014362.4(HIBCH):c.860A>G (p.Asp287Gly) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV002471297] | likely pathogenic | 2 | 190244918 | 190244918 | Human | 2 | alternate_id |
| 156213745 | CV1869141 | deletion | NM_014362.4(HIBCH):c.1010_1011+3del | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV003058633]|not provided [RCV003329457] | pathogenic|likely pathogenic | 2 | 190212953 | 190212957 | Human | 2 | alternate_id |
| 155946765 | CV1872217 | single nucleotide variant | NM_014362.4(HIBCH):c.945G>A (p.Met315Ile) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV003073896]|Inborn genetic diseases [RCV004070242] | uncertain significance | 2 | 190213022 | 190213022 | Human | 3 | alternate_id |
| 156160412 | CV1872266 | single nucleotide variant | NM_014362.4(HIBCH):c.832G>A (p.Glu278Lys) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV003056878] | uncertain significance | 2 | 190244946 | 190244946 | Human | 2 | alternate_id |
| 10044818 | CV188107 | single nucleotide variant | NM_014362.4(HIBCH):c.196C>T (p.Arg66Trp) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV000170481] | pathogenic|likely pathogenic|uncertain significance | 2 | 190296836 | 190296836 | Human | 2 | alternate_id |
| 156026421 | CV1883328 | single nucleotide variant | NM_014362.4(HIBCH):c.1035C>T (p.Gly345=) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV003077894]|not provided [RCV004695299] | likely benign|uncertain significance | 2 | 190208890 | 190208890 | Human | 2 | alternate_id |
| 156254216 | CV1884155 | single nucleotide variant | NM_014362.4(HIBCH):c.1028A>T (p.His343Leu) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV003086217] | uncertain significance | 2 | 190208897 | 190208897 | Human | 2 | alternate_id |
| 156369414 | CV1887880 | single nucleotide variant | NM_014362.4(HIBCH):c.35G>A (p.Arg12Lys) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV003092300] | uncertain significance | 2 | 190319716 | 190319716 | Human | 2 | alternate_id |
| 156127329 | CV1889142 | single nucleotide variant | NM_014362.4(HIBCH):c.125A>G (p.Lys42Arg) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV003081690]|Inborn genetic diseases [RCV004985162] | likely benign|uncertain significance | 2 | 190296907 | 190296907 | Human | 3 | alternate_id |
| 156354686 | CV1894684 | single nucleotide variant | NM_014362.4(HIBCH):c.1012-16C>G | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV003091252] | likely benign | 2 | 190208929 | 190208929 | Human | 2 | alternate_id |
| 156416734 | CV1898054 | single nucleotide variant | NM_014362.4(HIBCH):c.925A>G (p.Ile309Val) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV002610334] | uncertain significance | 2 | 190213042 | 190213042 | Human | 2 | alternate_id |
| 156365802 | CV1906264 | single nucleotide variant | NM_014362.4(HIBCH):c.751-4A>G | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV003092045] | uncertain significance | 2 | 190246216 | 190246216 | Human | 2 | alternate_id |
| 156161784 | CV1906960 | single nucleotide variant | NM_014362.4(HIBCH):c.863G>C (p.Gly288Ala) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV003082922]|Inborn genetic diseases [RCV004985193] | uncertain significance | 2 | 190244915 | 190244915 | Human | 3 | alternate_id |
| 156101890 | CV1907158 | single nucleotide variant | NM_014362.4(HIBCH):c.324G>T (p.Lys108Asn) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV003080632] | uncertain significance | 2 | 190290466 | 190290466 | Human | 2 | alternate_id |
| 156418501 | CV1922245 | single nucleotide variant | NM_014362.4(HIBCH):c.1004C>T (p.Ala335Val) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV002611698] | uncertain significance | 2 | 190212963 | 190212963 | Human | 2 | alternate_id |
| 156298727 | CV1924275 | single nucleotide variant | NM_014362.4(HIBCH):c.175G>T (p.Ala59Ser) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV002629138] | uncertain significance | 2 | 190296857 | 190296857 | Human | 2 | alternate_id |
| 156305408 | CV1931303 | single nucleotide variant | NM_014362.4(HIBCH):c.518-12A>G | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV002647861] | likely benign | 2 | 190252319 | 190252319 | Human | 2 | alternate_id |
| 156162047 | CV1933259 | single nucleotide variant | NM_014362.4(HIBCH):c.288C>T (p.Ala96=) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV002624407] | uncertain significance | 2 | 190294562 | 190294562 | Human | 2 | alternate_id |
| 156444159 | CV1937683 | single nucleotide variant | NM_014362.4(HIBCH):c.951G>T (p.Gly317=) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV003115080] | likely benign | 2 | 190213016 | 190213016 | Human | 2 | alternate_id |
| 156336343 | CV1963958 | deletion | NM_014362.4(HIBCH):c.751-5_751-2del | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV002580267] | uncertain significance | 2 | 190246214 | 190246217 | Human | 2 | alternate_id |
| 156139930 | CV1973554 | single nucleotide variant | NM_014362.4(HIBCH):c.1084G>A (p.Ala362Thr) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV002593795] | uncertain significance | 2 | 190205194 | 190205194 | Human | 2 | alternate_id |
| 156265316 | CV1993893 | single nucleotide variant | NM_014362.4(HIBCH):c.469C>T (p.Arg157Ter) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV002646354]|not provided [RCV003108126] | pathogenic | 2 | 190261204 | 190261204 | Human | 2 | alternate_id |
| 155947675 | CV1996455 | single nucleotide variant | NM_014362.4(HIBCH):c.305-5C>T | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV002685838] | likely benign | 2 | 190290490 | 190290490 | Human | 2 | alternate_id |
| 156101431 | CV2009797 | single nucleotide variant | NM_014362.4(HIBCH):c.222G>A (p.Lys74=) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV002706683] | uncertain significance | 2 | 190294628 | 190294628 | Human | 2 | alternate_id |
| 156009409 | CV2011367 | single nucleotide variant | NM_014362.4(HIBCH):c.79-4A>T | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV002690433] | likely benign | 2 | 190296957 | 190296957 | Human | 2 | alternate_id |
| 156396122 | CV2012311 | single nucleotide variant | NM_014362.4(HIBCH):c.712G>A (p.Glu238Lys) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV002725562] | uncertain significance | 2 | 190249678 | 190249678 | Human | 2 | alternate_id |
| 156359489 | CV2016522 | single nucleotide variant | NM_014362.4(HIBCH):c.891+16T>C | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV002720762] | likely benign | 2 | 190244871 | 190244871 | Human | 2 | alternate_id |
| 155935907 | CV2024033 | single nucleotide variant | NM_014362.4(HIBCH):c.517+16T>C | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV002774865] | likely benign | 2 | 190261140 | 190261140 | Human | 2 | alternate_id |
| 156224956 | CV2037887 | single nucleotide variant | NM_014362.4(HIBCH):c.692C>T (p.Ala231Val) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV002790776]|Inborn genetic diseases [RCV002790777] | uncertain significance | 2 | 190249698 | 190249698 | Human | 3 | alternate_id |
| 155941588 | CV2038302 | single nucleotide variant | NM_014362.4(HIBCH):c.594A>T (p.Thr198=) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV002775229] | uncertain significance | 2 | 190252231 | 190252231 | Human | 2 | alternate_id |
| 156111531 | CV2046998 | single nucleotide variant | NM_014362.4(HIBCH):c.932T>G (p.Leu311Arg) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV002761714]|Inborn genetic diseases [RCV004632072] | uncertain significance | 2 | 190213035 | 190213035 | Human | 3 | alternate_id |
| 10401362 | CV205049 | duplication | NM_014362.4(HIBCH):c.129dup (p.Gly44fs) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV000190537]|not provided [RCV001657966] | pathogenic|likely pathogenic | 2 | 190296902 | 190296903 | Human | 2 | alternate_id |
| 10401363 | CV205050 | single nucleotide variant | NM_014362.4(HIBCH):c.1033G>A (p.Gly345Ser) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV000190538] | pathogenic | 2 | 190208892 | 190208892 | Human | 2 | alternate_id |
| 156378999 | CV2050743 | single nucleotide variant | NM_014362.4(HIBCH):c.616G>A (p.Asp206Asn) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV002814938] | uncertain significance | 2 | 190252209 | 190252209 | Human | 2 | alternate_id |
| 155997684 | CV2057243 | single nucleotide variant | NM_014362.4(HIBCH):c.438+4A>G | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV002819500] | uncertain significance | 2 | 190287582 | 190287582 | Human | 2 | alternate_id |
| 155932307 | CV2067382 | single nucleotide variant | NM_014362.4(HIBCH):c.79-9T>C | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV002838833] | likely benign | 2 | 190296962 | 190296962 | Human | 2 | alternate_id |
| 155911207 | CV2069489 | single nucleotide variant | NM_014362.4(HIBCH):c.304+9T>G | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV002837730] | likely benign | 2 | 190294537 | 190294537 | Human | 2 | alternate_id |
| 155999480 | CV2074532 | single nucleotide variant | NM_014362.4(HIBCH):c.1045G>C (p.Val349Leu) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV002843338] | uncertain significance | 2 | 190208880 | 190208880 | Human | 2 | alternate_id |
| 156226843 | CV2081144 | single nucleotide variant | NM_014362.4(HIBCH):c.663+14T>G | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV002853421] | likely benign | 2 | 190252148 | 190252148 | Human | 2 | alternate_id |
| 156009550 | CV2083278 | single nucleotide variant | NM_014362.4(HIBCH):c.1012-19A>T | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV002866029] | likely benign | 2 | 190208932 | 190208932 | Human | 2 | alternate_id |
| 155935607 | CV2114123 | single nucleotide variant | NM_014362.4(HIBCH):c.1024T>C (p.Phe342Leu) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV002904110] | uncertain significance | 2 | 190208901 | 190208901 | Human | 2 | alternate_id |
| 156351543 | CV2122426 | duplication | NM_014362.4(HIBCH):c.1011+10dup | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV002966335] | likely benign | 2 | 190212945 | 190212946 | Human | 2 | alternate_id |
| 10408131 | CV213970 | duplication | NM_014362.4(HIBCH):c.1128dup (p.Lys377Ter) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV000201262]|not provided [RCV002510816] | pathogenic|likely pathogenic | 2 | 190205149 | 190205150 | Human | 2 | alternate_id |
| 155999731 | CV2149259 | single nucleotide variant | NM_014362.4(HIBCH):c.253A>T (p.Ile85Phe) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV002996960] | uncertain significance | 2 | 190294597 | 190294597 | Human | 2 | alternate_id |
| 155990045 | CV2151217 | single nucleotide variant | NM_014362.4(HIBCH):c.1139G>A (p.Gly380Glu) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV003016784] | uncertain significance | 2 | 190205139 | 190205139 | Human | 2 | alternate_id |
| 155969000 | CV2152407 | single nucleotide variant | NM_014362.4(HIBCH):c.219G>A (p.Lys73=) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV003015841] | uncertain significance | 2 | 190296813 | 190296813 | Human | 2 | alternate_id |
| 156060918 | CV2155095 | single nucleotide variant | NM_014362.4(HIBCH):c.664-2A>G | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV003000200] | likely pathogenic | 2 | 190249728 | 190249728 | Human | 2 | alternate_id |
| 155997133 | CV2168769 | single nucleotide variant | NM_014362.4(HIBCH):c.56C>G (p.Thr19Ser) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV003017104] | uncertain significance | 2 | 190310776 | 190310776 | Human | 2 | alternate_id |
| 156284487 | CV2172138 | single nucleotide variant | NM_014362.4(HIBCH):c.831G>A (p.Val277=) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV003027435] | likely benign | 2 | 190244947 | 190244947 | Human | 2 | alternate_id |
| 156356867 | CV2188947 | single nucleotide variant | NM_014362.4(HIBCH):c.60T>C (p.Asn20=) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV003048748] | likely benign | 2 | 190310772 | 190310772 | Human | 2 | alternate_id |
| 156376815 | CV2189053 | single nucleotide variant | NM_014362.4(HIBCH):c.68T>A (p.Leu23Gln) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV003050171] | uncertain significance | 2 | 190310764 | 190310764 | Human | 2 | alternate_id |
| 11350849 | CV237274 | single nucleotide variant | NM_014362.4(HIBCH):c.796G>A (p.Asp266Asn) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV001079577]|HIBCH-related disorder [RCV004755816]|not provided [RCV000224515] | likely benign|conflicting interpretations of pathogenicity|uncertain significance | 2 | 190246167 | 190246167 | Human | 2 | alternate_id |
| 243052929 | CV2407704 | single nucleotide variant | NM_014362.4(HIBCH):c.311C>T (p.Ser104Leu) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV003131129] | uncertain significance | 2 | 190290479 | 190290479 | Human | 2 | alternate_id |
| 243057344 | CV2415080 | single nucleotide variant | NM_014362.4(HIBCH):c.556C>T (p.Arg186Ter) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV003146022] | likely pathogenic | 2 | 190252269 | 190252269 | Human | 2 | alternate_id |
| 12912407 | CV243978 | single nucleotide variant | NM_014362.4(HIBCH):c.410C>T (p.Ala137Val) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV000491605] | pathogenic|conflicting interpretations of pathogenicity|uncertain significance | 2 | 190287614 | 190287614 | Human | 2 | alternate_id |
| 404977846 | CV2851654 | indel | NM_014362.4(HIBCH):c.760_761delinsAT (p.Asp254Ile) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV003486321] | likely pathogenic | 2 | 190246202 | 190246203 | Human | | alternate_id |
| 402510023 | CV2854880 | single nucleotide variant | NM_014362.4(HIBCH):c.664-18T>C | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV003495540] | likely benign | 2 | 190249744 | 190249744 | Human | 2 | alternate_id |
| 402515260 | CV2911558 | single nucleotide variant | NM_014362.4(HIBCH):c.78+17G>A | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV003496015] | likely benign | 2 | 190310737 | 190310737 | Human | 2 | alternate_id |
| 402511881 | CV2919442 | single nucleotide variant | NM_014362.4(HIBCH):c.963C>G (p.Thr321=) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV003495707] | likely benign | 2 | 190213004 | 190213004 | Human | 2 | alternate_id |
| 405035275 | CV2995292 | single nucleotide variant | NM_014362.4(HIBCH):c.1149T>C (p.Asp383=) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV003602137] | likely benign | 2 | 190205129 | 190205129 | Human | 2 | alternate_id |
| 405037450 | CV3011892 | deletion | NM_014362.4(HIBCH):c.664-16del | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV003602335] | benign | 2 | 190249742 | 190249742 | Human | 2 | alternate_id |
| 405048667 | CV3137910 | single nucleotide variant | NM_014362.4(HIBCH):c.1000C>T (p.Gln334Ter) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV003831948] | pathogenic | 2 | 190212967 | 190212967 | Human | 2 | alternate_id |
| 405208349 | CV3145608 | single nucleotide variant | NM_014362.4(HIBCH):c.663+13A>G | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV003845338] | likely benign | 2 | 190252149 | 190252149 | Human | 2 | alternate_id |
| 405200448 | CV3147210 | single nucleotide variant | NM_014362.4(HIBCH):c.150A>G (p.Thr50=) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV003844370] | likely benign | 2 | 190296882 | 190296882 | Human | 2 | alternate_id |
| 405002821 | CV3184705 | variation | HIBCH, CYS163PHE | Beta-hydroxyisobutyryl-CoA deacylase deficiency [RCV003882763] | pathogenic | | | | Human | | alternate_id |
| 405003227 | CV3184706 | deletion | HIBCH, 1-BP DEL, 852A | Beta-hydroxyisobutyryl-CoA deacylase deficiency [RCV003882764] | pathogenic | | | | Human | 1 | alternate_id |
| 405866699 | CV3401105 | single nucleotide variant | NM_014362.4(HIBCH):c.644A>G (p.His215Arg) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV004577221] | uncertain significance | 2 | 190252181 | 190252181 | Human | 2 | alternate_id |
| 12835008 | CV366235 | single nucleotide variant | NM_014362.4(HIBCH):c.488G>C (p.Cys163Ser) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV000956017]|HIBCH-related disorder [RCV003912679]|not provided [RCV004708855]|not specified [RCV000420934] | pathogenic|benign | 2 | 190261185 | 190261185 | Human | 2 | alternate_id |
| 12838337 | CV366237 | single nucleotide variant | NM_014362.4(HIBCH):c.36-13A>T | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV002062749]|not specified [RCV000426774] | likely benign | 2 | 190310809 | 190310809 | Human | 2 | alternate_id |
| 12846342 | CV366274 | single nucleotide variant | NM_014362.4(HIBCH):c.1038T>A (p.Val346=) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV000966838]|HIBCH-related disorder [RCV003902530]|not provided [RCV004711064]|not specified [RCV000441458] | benign|likely benign | 2 | 190208887 | 190208887 | Human | 2 | alternate_id |
| 12846036 | CV366276 | single nucleotide variant | NM_014362.4(HIBCH):c.438+9A>T | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV000970431]|HIBCH-related disorder [RCV004755913]|not provided [RCV001720266] | benign|likely benign | 2 | 190287577 | 190287577 | Human | 2 | alternate_id |
| 12834805 | CV366277 | single nucleotide variant | NM_014362.4(HIBCH):c.214C>T (p.Leu72=) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV000953184]|not provided [RCV001200441] | benign|likely benign | 2 | 190296818 | 190296818 | Human | 2 | alternate_id |
| 12836210 | CV366282 | single nucleotide variant | NM_014362.4(HIBCH):c.136A>G (p.Thr46Ala) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV001517776]|not provided [RCV000676751]|not specified [RCV000423009] | benign | 2 | 190296896 | 190296896 | Human | 2 | alternate_id |
| 12837880 | CV366800 | single nucleotide variant | NM_014362.4(HIBCH):c.735A>C (p.Glu245Asp) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV000946654]|not provided [RCV004708851]|not specified [RCV000425938] | benign | 2 | 190249655 | 190249655 | Human | 2 | alternate_id |
| 12842046 | CV366801 | single nucleotide variant | NM_014362.4(HIBCH):c.663+19G>T | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV002064922]|not specified [RCV000433697] | benign|likely benign | 2 | 190252143 | 190252143 | Human | 2 | alternate_id |
| 12836606 | CV366803 | single nucleotide variant | NM_014362.4(HIBCH):c.517+15T>A | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV001512151]|not provided [RCV004708820]|not specified [RCV000423700] | benign | 2 | 190261141 | 190261141 | Human | 2 | alternate_id |
| 12845667 | CV366807 | single nucleotide variant | NM_014362.4(HIBCH):c.2T>C (p.Met1Thr) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV001509616]|not provided [RCV000676752]|not specified [RCV000440239] | benign | 2 | 190319749 | 190319749 | Human | 3 | alternate_id |
| 12845667 | CV366807 | single nucleotide variant | NM_014362.4(HIBCH):c.2T>C (p.Met1Thr) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV001509616]|not provided [RCV000676752]|not specified [RCV000440239] | benign | 2 | 190319749 | 190319750 | Human | 3 | alternate_id |
| 597888277 | CV3739239 | single nucleotide variant | NM_014362.4(HIBCH):c.850T>C (p.Leu284=) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV005070786] | likely benign | 2 | 190244928 | 190244928 | Human | 2 | alternate_id |
| 597901313 | CV3741342 | single nucleotide variant | NM_014362.4(HIBCH):c.517+12G>T | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV005072313] | likely benign | 2 | 190261144 | 190261144 | Human | 2 | alternate_id |
| 597841060 | CV3752737 | single nucleotide variant | NM_014362.4(HIBCH):c.1090C>T (p.Leu364=) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV005086466] | likely benign | 2 | 190205188 | 190205188 | Human | 2 | alternate_id |
| 597958074 | CV3755245 | single nucleotide variant | NM_014362.4(HIBCH):c.138G>A (p.Thr46=) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV005080915] | likely benign | 2 | 190296894 | 190296894 | Human | 2 | alternate_id |
| 597961726 | CV3756692 | single nucleotide variant | NM_014362.4(HIBCH):c.312G>C (p.Ser104=) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV005081814] | likely benign | 2 | 190290478 | 190290478 | Human | 2 | alternate_id |
| 597920281 | CV3765097 | single nucleotide variant | NM_014362.4(HIBCH):c.420T>A (p.His140Gln) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV005115114] | uncertain significance | 2 | 190287604 | 190287604 | Human | 2 | alternate_id |
| 597876557 | CV3766657 | single nucleotide variant | NM_014362.4(HIBCH):c.664-7C>T | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV005108597] | likely benign | 2 | 190249733 | 190249733 | Human | 2 | alternate_id |
| 597959348 | CV3797543 | single nucleotide variant | NM_014362.4(HIBCH):c.809+12G>C | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV005138230] | likely benign | 2 | 190246142 | 190246142 | Human | 2 | alternate_id |
| 597970562 | CV3802001 | single nucleotide variant | NM_014362.4(HIBCH):c.405T>C (p.Tyr135=) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV005141793] | likely benign | 2 | 190287619 | 190287619 | Human | 2 | alternate_id |
| 597869992 | CV3803559 | single nucleotide variant | NM_014362.4(HIBCH):c.921A>G (p.Leu307=) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV005148157] | likely benign | 2 | 190213046 | 190213046 | Human | 2 | alternate_id |
| 597953545 | CV3808874 | single nucleotide variant | NM_014362.4(HIBCH):c.1070C>A (p.Pro357Gln) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV005161792] | uncertain significance | 2 | 190205208 | 190205208 | Human | 2 | alternate_id |
| 597920800 | CV3842798 | single nucleotide variant | NM_014362.4(HIBCH):c.1046-15A>G | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV005184283] | likely benign | 2 | 190205247 | 190205247 | Human | 2 | alternate_id |
| 597938690 | CV3852886 | single nucleotide variant | NM_014362.4(HIBCH):c.891+9G>A | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV005187287] | likely benign | 2 | 190244878 | 190244878 | Human | 2 | alternate_id |
| 598202138 | CV3892922 | deletion | NM_014362.4(HIBCH):c.12_35del (p.Glu5_Arg12del) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV005255248] | likely pathogenic | 2 | 190319716 | 190319739 | Human | 2 | alternate_id |
| 598202132 | CV3892923 | single nucleotide variant | NM_014362.4(HIBCH):c.536G>A (p.Gly179Asp) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV005255249] | likely pathogenic | 2 | 190252289 | 190252289 | Human | 2 | alternate_id |
| 598202000 | CV3892943 | single nucleotide variant | NM_014362.4(HIBCH):c.488G>A (p.Cys163Tyr) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV005255269] | likely pathogenic | 2 | 190261185 | 190261185 | Human | 2 | alternate_id |
| 598198719 | CV4007217 | single nucleotide variant | NM_014362.4(HIBCH):c.10C>T (p.Arg4Cys) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV005398045] | likely benign | 2 | 190319741 | 190319741 | Human | 2 | alternate_id |
| 598198726 | CV4007218 | deletion | NM_014362.4(HIBCH):c.494_495del (p.Phe165fs) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV005398046] | likely pathogenic | 2 | 190261178 | 190261179 | Human | 2 | alternate_id |
| 12893945 | CV405524 | single nucleotide variant | NM_014362.4(HIBCH):c.809+1G>A | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV000607054]|not provided [RCV000480908] | pathogenic|likely pathogenic | 2 | 190246153 | 190246153 | Human | 2 | alternate_id |
| 12900664 | CV405525 | microsatellite | NM_014362.4(HIBCH):c.35+8AG[2] | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV003495135]|not specified [RCV000482897] | benign|likely benign | 2 | 190319703 | 190319704 | Human | | alternate_id |
| 12913300 | CV421351 | deletion | NM_014362.4(HIBCH):c.852del (p.Leu284fs) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV001195536]|not provided [RCV000493651] | pathogenic|likely pathogenic | 2 | 190244926 | 190244926 | Human | 2 | alternate_id |
| 12912901 | CV421352 | single nucleotide variant | NM_014362.4(HIBCH):c.488G>T (p.Cys163Phe) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV003114621]|not provided [RCV000493154] | pathogenic|likely pathogenic | 2 | 190261185 | 190261185 | Human | 2 | alternate_id |
| 13508756 | CV481398 | single nucleotide variant | NM_014362.4(HIBCH):c.830T>A (p.Val277Glu) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV000578248]|Inborn genetic diseases [RCV002530365] | likely pathogenic|uncertain significance | 2 | 190244948 | 190244948 | Human | 3 | alternate_id |
| 13508778 | CV481399 | single nucleotide variant | NM_014362.4(HIBCH):c.212A>C (p.Gln71Pro) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV000578336] | likely pathogenic | 2 | 190296820 | 190296820 | Human | 2 | alternate_id |
| 13526190 | CV499462 | deletion | NM_014362.4(HIBCH):c.385+11del | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV001519360]|not specified [RCV000603794] | benign | 2 | 190290394 | 190290394 | Human | 2 | alternate_id |
| 13529601 | CV499680 | single nucleotide variant | NM_014362.4(HIBCH):c.957A>G (p.Ser319=) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV000884219]|not specified [RCV000600369] | benign|likely benign | 2 | 190213010 | 190213010 | Human | 2 | alternate_id |
| 13541502 | CV499689 | single nucleotide variant | NM_014362.4(HIBCH):c.438+19C>G | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV002529671]|not specified [RCV000616245] | likely benign | 2 | 190287567 | 190287567 | Human | 2 | alternate_id |
| 13533796 | CV499696 | single nucleotide variant | NM_014362.4(HIBCH):c.243T>G (p.Thr81=) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV000969163]|not provided [RCV003432651]|not specified [RCV000601765] | benign|likely benign | 2 | 190294607 | 190294607 | Human | 2 | alternate_id |
| 13529606 | CV499852 | single nucleotide variant | NM_014362.4(HIBCH):c.1012-10T>G | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV002528803]|not specified [RCV000605801] | likely benign|uncertain significance | 2 | 190208923 | 190208923 | Human | 2 | alternate_id |
| 13537711 | CV499864 | single nucleotide variant | NM_014362.4(HIBCH):c.438+11T>G | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV002532804]|not specified [RCV000610780] | likely benign | 2 | 190287575 | 190287575 | Human | 2 | alternate_id |
| 14741599 | CV629237 | single nucleotide variant | NM_014362.4(HIBCH):c.1053T>G (p.Ile351Met) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV000822310] | uncertain significance | 2 | 190205225 | 190205225 | Human | 2 | alternate_id |
| 14718793 | CV629238 | single nucleotide variant | NM_014362.4(HIBCH):c.794T>C (p.Met265Thr) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV000795907]|Inborn genetic diseases [RCV002537013] | uncertain significance | 2 | 190246169 | 190246169 | Human | 3 | alternate_id |
| 14709007 | CV629239 | deletion | NM_014362.4(HIBCH):c.609del (p.Gly204fs) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV000810904]|HIBCH-related disorder [RCV003413630] | pathogenic|likely pathogenic | 2 | 190252216 | 190252216 | Human | 2 | alternate_id |
| 14716872 | CV629240 | single nucleotide variant | NM_014362.4(HIBCH):c.238G>C (p.Glu80Gln) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV000795254]|Inborn genetic diseases [RCV004629328] | uncertain significance | 2 | 190294612 | 190294612 | Human | 3 | alternate_id |
| 14709267 | CV658745 | single nucleotide variant | NM_014362.4(HIBCH):c.1011+11A>T | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV002062211]|not provided [RCV000827387] | benign|likely benign | 2 | 190212945 | 190212945 | Human | 2 | alternate_id |
| 14978474 | CV677411 | single nucleotide variant | NM_014362.4(HIBCH):c.517+1G>A | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV000850559] | pathogenic | 2 | 190261155 | 190261155 | Human | 2 | alternate_id |
| 15148598 | CV730094 | single nucleotide variant | NM_014362.4(HIBCH):c.79-7T>C | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV000878992]|not provided [RCV003438549] | likely benign | 2 | 190296960 | 190296960 | Human | 2 | alternate_id |
| 15135112 | CV733029 | single nucleotide variant | NM_014362.4(HIBCH):c.885A>G (p.Gln295=) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV002065654]|HIBCH-related disorder [RCV003950512] | likely benign | 2 | 190244893 | 190244893 | Human | 2 | alternate_id |
| 15116521 | CV743857 | single nucleotide variant | NM_014362.4(HIBCH):c.35+10A>C | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV000895216] | likely benign | 2 | 190319706 | 190319706 | Human | 2 | alternate_id |
| 15120331 | CV781100 | single nucleotide variant | NM_014362.4(HIBCH):c.1048T>C (p.Leu350=) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV001479198] | likely benign | 2 | 190205230 | 190205230 | Human | 2 | alternate_id |
| 15173923 | CV789112 | single nucleotide variant | NM_014362.4(HIBCH):c.182C>T (p.Thr61Ile) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV000984514] | uncertain significance | 2 | 190296850 | 190296850 | Human | 2 | alternate_id |
| 38494046 | CV952868 | single nucleotide variant | NM_014362.4(HIBCH):c.226G>A (p.Glu76Lys) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV001241076] | conflicting interpretations of pathogenicity|uncertain significance | 2 | 190294624 | 190294624 | Human | 2 | alternate_id |
| 38463610 | CV961231 | single nucleotide variant | NM_014362.4(HIBCH):c.835G>T (p.Glu279Ter) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV001249211] | pathogenic | 2 | 190244943 | 190244943 | Human | 2 | alternate_id |
| 38463605 | CV961232 | single nucleotide variant | NM_014362.4(HIBCH):c.457C>T (p.His153Tyr) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV001249210]|not provided [RCV004727047] | likely pathogenic | 2 | 190261216 | 190261216 | Human | 2 | alternate_id |
| 38465608 | CV961752 | single nucleotide variant | NM_014362.4(HIBCH):c.790C>T (p.His264Tyr) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV001250100] | uncertain significance | 2 | 190246173 | 190246173 | Human | 2 | alternate_id |
| 38465326 | CV961753 | single nucleotide variant | NM_014362.4(HIBCH):c.763C>T (p.Arg255Ter) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV001250109] | pathogenic | 2 | 190246200 | 190246200 | Human | 2 | alternate_id |
| 38465333 | CV961754 | single nucleotide variant | NM_014362.4(HIBCH):c.632G>T (p.Gly211Val) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV001250111] | likely benign | 2 | 190252193 | 190252193 | Human | 2 | alternate_id |
| 38465331 | CV961755 | single nucleotide variant | NM_014362.4(HIBCH):c.428C>A (p.Thr143Lys) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV001250110] | likely benign | 2 | 190287596 | 190287596 | Human | 2 | alternate_id |
| 38465287 | CV961756 | single nucleotide variant | NM_014362.4(HIBCH):c.353T>C (p.Phe118Ser) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV001250091] | conflicting interpretations of pathogenicity|uncertain significance | 2 | 190290437 | 190290437 | Human | 2 | alternate_id |
| 40889812 | CV975017 | single nucleotide variant | NM_014362.4(HIBCH):c.913A>G (p.Thr305Ala) | 3-hydroxyisobutyryl-CoA hydrolase deficiency [RCV005094281]|not provided [RCV001268287] | pathogenic|likely pathogenic | 2 | 190213054 | 190213054 | Human | 2 | alternate_id |
| 598254752 | CV3928203 | single nucleotide variant | NM_014828.4(TOX4):c.8T>G (p.Phe3Cys) | not specified [RCV005278492] | uncertain significance | 14 | 21477497 | 21477497 | Human | | name |
| 401886293 | CV2771722 | single nucleotide variant | NM_014828.4(TOX4):c.55C>G (p.Pro19Ala) | not specified [RCV004350507] | uncertain significance | 14 | 21477544 | 21477544 | Human | | name |
| 155923776 | CV2280378 | single nucleotide variant | NM_014828.4(TOX4):c.122C>A (p.Pro41His) | not specified [RCV004140564] | uncertain significance | 14 | 21487497 | 21487497 | Human | | name |
| 156395820 | CV2325943 | single nucleotide variant | NM_014828.4(TOX4):c.214A>C (p.Ser72Arg) | not specified [RCV004174114] | uncertain significance | 14 | 21487589 | 21487589 | Human | | name |
| 597787331 | CV3611097 | single nucleotide variant | NM_014828.4(TOX4):c.109T>C (p.Phe37Leu) | not specified [RCV004875575] | uncertain significance | 14 | 21487484 | 21487484 | Human | | name |
| 155956286 | CV2281904 | single nucleotide variant | NM_014828.4(TOX4):c.865G>A (p.Ala289Thr) | not specified [RCV004138682] | uncertain significance | 14 | 21492350 | 21492350 | Human | | name |
| 156273991 | CV2293731 | single nucleotide variant | NM_014828.4(TOX4):c.601G>A (p.Val201Ile) | not specified [RCV004155018] | uncertain significance | 14 | 21489194 | 21489194 | Human | | name |
| 156267456 | CV2305045 | single nucleotide variant | NM_014828.4(TOX4):c.655G>A (p.Asp219Asn) | not specified [RCV004168931] | uncertain significance | 14 | 21489248 | 21489248 | Human | | name |
| 156068674 | CV2341062 | single nucleotide variant | NM_014828.4(TOX4):c.994A>G (p.Ile332Val) | not specified [RCV004181545] | uncertain significance | 14 | 21492610 | 21492610 | Human | | name |
| 156079364 | CV2341250 | single nucleotide variant | NM_001098797.2(TOX2):c.19C>T (p.Pro7Ser) | not specified [RCV004186663] | uncertain significance | 20 | 43914910 | 43914910 | Human | | name |
| 401768599 | CV2675477 | single nucleotide variant | NM_014828.4(TOX4):c.515G>C (p.Arg172Pro) | not specified [RCV004292269] | uncertain significance | 14 | 21488786 | 21488786 | Human | | name |
| 401768136 | CV2727393 | single nucleotide variant | NM_014828.4(TOX4):c.524C>A (p.Thr175Asn) | not specified [RCV004327490] | uncertain significance | 14 | 21488795 | 21488795 | Human | | name |
| 401872617 | CV2779825 | single nucleotide variant | NM_001080430.4(TOX3):c.17A>G (p.Tyr6Cys) | not specified [RCV004353451] | uncertain significance | 16 | 52546707 | 52546707 | Human | | name |
| 401891759 | CV2780735 | single nucleotide variant | NM_014828.4(TOX4):c.334A>G (p.Ile112Val) | not specified [RCV004352068] | uncertain significance | 14 | 21488605 | 21488605 | Human | | name |
| 401888303 | CV2788286 | single nucleotide variant | NM_014828.4(TOX4):c.946C>T (p.Pro316Ser) | not specified [RCV004352875] | uncertain significance | 14 | 21492562 | 21492562 | Human | | name |
| 405758608 | CV3347118 | single nucleotide variant | NM_001098797.2(TOX2):c.25G>T (p.Ala9Ser) | not specified [RCV004468218] | uncertain significance | 20 | 43914916 | 43914916 | Human | | name |
| 405758644 | CV3347124 | single nucleotide variant | NM_001080430.4(TOX3):c.12G>C (p.Arg4Ser) | not specified [RCV004468224] | uncertain significance | 16 | 52546712 | 52546712 | Human | | name |
| 405758726 | CV3347137 | single nucleotide variant | NM_014828.4(TOX4):c.335T>C (p.Ile112Thr) | not specified [RCV004468237] | uncertain significance | 14 | 21488606 | 21488606 | Human | | name |
| 405758732 | CV3347138 | single nucleotide variant | NM_014828.4(TOX4):c.476G>C (p.Gly159Ala) | not specified [RCV004468238] | uncertain significance | 14 | 21488747 | 21488747 | Human | | name |
| 407521114 | CV3486858 | single nucleotide variant | NM_014828.4(TOX4):c.575G>T (p.Arg192Leu) | not specified [RCV004677181] | uncertain significance | 14 | 21488846 | 21488846 | Human | | name |
| 407521118 | CV3486860 | single nucleotide variant | NM_014828.4(TOX4):c.595A>C (p.Lys199Gln) | not specified [RCV004677183] | uncertain significance | 14 | 21489188 | 21489188 | Human | | name |
| 597787323 | CV3611095 | single nucleotide variant | NM_014828.4(TOX4):c.368C>A (p.Thr123Lys) | not specified [RCV004875573] | uncertain significance | 14 | 21488639 | 21488639 | Human | | name |
| 597787329 | CV3611096 | single nucleotide variant | NM_014828.4(TOX4):c.370A>G (p.Ile124Val) | not specified [RCV004875574] | uncertain significance | 14 | 21488641 | 21488641 | Human | | name |
| 598188668 | CV3928199 | single nucleotide variant | NM_014828.4(TOX4):c.515G>A (p.Arg172His) | not specified [RCV005287969] | uncertain significance | 14 | 21488786 | 21488786 | Human | | name |
| 155979708 | CV2222911 | single nucleotide variant | NM_014828.4(TOX4):c.1633G>A (p.Val545Ile) | not specified [RCV004101725] | uncertain significance | 14 | 21493249 | 21493249 | Human | | name |
| 155984318 | CV2273175 | single nucleotide variant | NM_014828.4(TOX4):c.1781A>G (p.Asn594Ser) | not specified [RCV004137806] | uncertain significance | 14 | 21495368 | 21495368 | Human | | name |
| 156254979 | CV2280936 | single nucleotide variant | NM_001080430.4(TOX3):c.44G>T (p.Ser15Ile) | not specified [RCV004145176] | uncertain significance | 16 | 52546680 | 52546680 | Human | | name |
| 155997992 | CV2287096 | single nucleotide variant | NM_014828.4(TOX4):c.1325G>A (p.Arg442Gln) | not specified [RCV004144970] | uncertain significance | 14 | 21492941 | 21492941 | Human | | name |
| 156004384 | CV2290157 | single nucleotide variant | NM_014828.4(TOX4):c.1424C>T (p.Pro475Leu) | not specified [RCV004152820] | uncertain significance | 14 | 21493040 | 21493040 | Human | | name |
| 155955035 | CV2302329 | single nucleotide variant | NM_014828.4(TOX4):c.1286C>T (p.Ala429Val) | not specified [RCV004161088] | uncertain significance | 14 | 21492902 | 21492902 | Human | | name |
| 156303281 | CV2331815 | single nucleotide variant | NM_014828.4(TOX4):c.1141A>G (p.Met381Val) | not specified [RCV004184430] | uncertain significance | 14 | 21492757 | 21492757 | Human | | name |
| 156171477 | CV2337515 | single nucleotide variant | NM_014828.4(TOX4):c.1541G>A (p.Ser514Asn) | not specified [RCV004187945] | uncertain significance | 14 | 21493157 | 21493157 | Human | | name |
| 155984234 | CV2344394 | single nucleotide variant | NM_014828.4(TOX4):c.1051G>A (p.Val351Met) | not specified [RCV004195145] | uncertain significance | 14 | 21492667 | 21492667 | Human | | name |
| 155910756 | CV2366628 | single nucleotide variant | NM_014828.4(TOX4):c.1315C>G (p.Pro439Ala) | not specified [RCV004210641] | uncertain significance | 14 | 21492931 | 21492931 | Human | | name |
| 155999363 | CV2378577 | single nucleotide variant | NM_014828.4(TOX4):c.1553G>A (p.Arg518Gln) | not specified [RCV004229012] | likely benign | 14 | 21493169 | 21493169 | Human | | name |
| 156041078 | CV2384410 | single nucleotide variant | NM_014828.4(TOX4):c.1547C>G (p.Pro516Arg) | not specified [RCV004229828] | uncertain significance | 14 | 21493163 | 21493163 | Human | | name |
| 329374486 | CV2443681 | single nucleotide variant | NM_014828.4(TOX4):c.1558A>G (p.Met520Val) | not specified [RCV004255983] | likely benign | 14 | 21493174 | 21493174 | Human | | name |
| 401734720 | CV2688600 | single nucleotide variant | NM_014828.4(TOX4):c.1610T>C (p.Ile537Thr) | not specified [RCV004301556] | uncertain significance | 14 | 21493226 | 21493226 | Human | | name |
| 401756908 | CV2696645 | single nucleotide variant | NM_001080430.4(TOX3):c.43A>G (p.Ser15Gly) | not specified [RCV004312662] | likely benign | 16 | 52546681 | 52546681 | Human | | name |
| 401780527 | CV2716818 | single nucleotide variant | NM_014828.4(TOX4):c.1091A>G (p.Asn364Ser) | not specified [RCV004329634] | uncertain significance | 14 | 21492707 | 21492707 | Human | | name |
| 405758685 | CV3347130 | single nucleotide variant | NM_014828.4(TOX4):c.1242A>C (p.Gln414His) | not specified [RCV004468230] | uncertain significance | 14 | 21492858 | 21492858 | Human | | name |
| 405758697 | CV3347132 | single nucleotide variant | NM_014828.4(TOX4):c.1552C>G (p.Arg518Gly) | not specified [RCV004468232] | uncertain significance | 14 | 21493168 | 21493168 | Human | | name |
| 405758704 | CV3347133 | single nucleotide variant | NM_014828.4(TOX4):c.1580A>G (p.His527Arg) | not specified [RCV004468233] | uncertain significance | 14 | 21493196 | 21493196 | Human | | name |
| 405758710 | CV3347134 | single nucleotide variant | NM_014828.4(TOX4):c.1655C>T (p.Ser552Phe) | not specified [RCV004468234] | uncertain significance | 14 | 21495242 | 21495242 | Human | | name |
| 405758721 | CV3347136 | single nucleotide variant | NM_014828.4(TOX4):c.1712G>A (p.Arg571Gln) | not specified [RCV004468236] | uncertain significance | 14 | 21495299 | 21495299 | Human | | name |
| 407521108 | CV3486856 | single nucleotide variant | NM_014828.4(TOX4):c.1442G>T (p.Arg481Leu) | not specified [RCV004677179] | uncertain significance | 14 | 21493058 | 21493058 | Human | | name |
| 407521111 | CV3486857 | single nucleotide variant | NM_014828.4(TOX4):c.1449T>G (p.Asn483Lys) | not specified [RCV004677180] | uncertain significance | 14 | 21493065 | 21493065 | Human | | name |
| 407521117 | CV3486859 | single nucleotide variant | NM_014828.4(TOX4):c.1315C>T (p.Pro439Ser) | not specified [RCV004677182] | uncertain significance | 14 | 21492931 | 21492931 | Human | | name |
| 597787267 | CV3611080 | single nucleotide variant | NM_001098797.2(TOX2):c.94G>A (p.Gly32Ser) | not specified [RCV004875558] | uncertain significance | 20 | 43914985 | 43914985 | Human | | name |
| 597787321 | CV3611094 | single nucleotide variant | NM_014828.4(TOX4):c.1262G>A (p.Arg421Gln) | not specified [RCV004875572] | uncertain significance | 14 | 21492878 | 21492878 | Human | | name |
| 597787335 | CV3611098 | single nucleotide variant | NM_014828.4(TOX4):c.1514C>G (p.Thr505Ser) | not specified [RCV004875576] | uncertain significance | 14 | 21493130 | 21493130 | Human | | name |
| 597787340 | CV3611099 | single nucleotide variant | NM_014828.4(TOX4):c.1825G>A (p.Val609Ile) | not specified [RCV004875577] | uncertain significance | 14 | 21496565 | 21496565 | Human | | name |
| 598188661 | CV3928197 | single nucleotide variant | NM_014828.4(TOX4):c.1637C>A (p.Pro546His) | not specified [RCV005287968] | uncertain significance | 14 | 21493253 | 21493253 | Human | | name |
| 598254730 | CV3928198 | single nucleotide variant | NM_014828.4(TOX4):c.1382C>G (p.Thr461Ser) | not specified [RCV005278489] | uncertain significance | 14 | 21492998 | 21492998 | Human | | name |
| 598254736 | CV3928200 | single nucleotide variant | NM_014828.4(TOX4):c.1145C>A (p.Ser382Tyr) | not specified [RCV005278490] | uncertain significance | 14 | 21492761 | 21492761 | Human | | name |
| 598254744 | CV3928202 | single nucleotide variant | NM_014828.4(TOX4):c.1739C>T (p.Pro580Leu) | not specified [RCV005278491] | uncertain significance | 14 | 21495326 | 21495326 | Human | | name |
| 8637319 | CV92545 | single nucleotide variant | NM_001098798.1(TOX2):c.43C>T (p.Arg15Cys) | Malignant melanoma [RCV000072643] | not provided | 20 | 43945955 | 43945955 | Human | | name |
| 156135887 | CV2213520 | single nucleotide variant | NM_001080430.4(TOX3):c.229C>T (p.Pro77Ser) | not specified [RCV004087484] | uncertain significance | 16 | 52464113 | 52464113 | Human | | name |
| 155923545 | CV2217664 | single nucleotide variant | NM_001098797.2(TOX2):c.233C>T (p.Pro78Leu) | not specified [RCV004090173] | uncertain significance | 20 | 44006614 | 44006614 | Human | | name |
| 156028015 | CV2238189 | single nucleotide variant | NM_001098797.2(TOX2):c.101T>C (p.Phe34Ser) | not specified [RCV004111494] | uncertain significance | 20 | 43973368 | 43973368 | Human | | name |
| 156287674 | CV2370544 | single nucleotide variant | NM_001098797.2(TOX2):c.112A>G (p.Ser38Gly) | not specified [RCV004215878] | uncertain significance | 20 | 43973379 | 43973379 | Human | | name |
| 329359953 | CV2462202 | single nucleotide variant | NM_001080430.4(TOX3):c.293A>G (p.Gln98Arg) | not specified [RCV004266210] | uncertain significance | 16 | 52464049 | 52464049 | Human | | name |
| 405758603 | CV3347117 | single nucleotide variant | NM_001098797.2(TOX2):c.157A>G (p.Thr53Ala) | not specified [RCV004468217] | uncertain significance | 20 | 43973424 | 43973424 | Human | | name |
| 407521093 | CV3486851 | single nucleotide variant | NM_001080430.4(TOX3):c.249T>A (p.Asp83Glu) | not specified [RCV004677174] | uncertain significance | 16 | 52464093 | 52464093 | Human | | name |
| 597787275 | CV3611082 | single nucleotide variant | NM_001098797.2(TOX2):c.143C>T (p.Pro48Leu) | not specified [RCV004875560] | uncertain significance | 20 | 43973410 | 43973410 | Human | | name |
| 597787290 | CV3611086 | single nucleotide variant | NM_001080430.4(TOX3):c.125C>T (p.Ala42Val) | not specified [RCV004875564] | uncertain significance | 16 | 52468537 | 52468537 | Human | | name |
| 598127170 | CV3888051 | single nucleotide variant | NM_001098797.2(TOX2):c.1107C>G (p.Ser369=) | not provided [RCV005242737] | likely benign | 20 | 44065858 | 44065858 | Human | | name |
| 598127172 | CV3888052 | single nucleotide variant | NM_001098797.2(TOX2):c.1125G>C (p.Arg375=) | not provided [RCV005242738] | likely benign | 20 | 44065876 | 44065876 | Human | | name |
| 598188602 | CV3928187 | single nucleotide variant | NM_001098797.2(TOX2):c.212C>T (p.Pro71Leu) | not specified [RCV005287960] | uncertain significance | 20 | 44006593 | 44006593 | Human | | name |
| 15200730 | CV703734 | single nucleotide variant | NM_001080430.4(TOX3):c.1149C>T (p.Ile383=) | not provided [RCV000957414] | benign | 16 | 52439807 | 52439807 | Human | | name |
| 156401614 | CV2207470 | single nucleotide variant | NM_001098797.2(TOX2):c.409A>G (p.Thr137Ala) | not specified [RCV004089952] | uncertain significance | 20 | 44006790 | 44006790 | Human | | name |
| 156262193 | CV2216537 | single nucleotide variant | NM_001098797.2(TOX2):c.540G>A (p.Met180Ile) | not specified [RCV004097325] | uncertain significance | 20 | 44051434 | 44051434 | Human | | name |
| 155926166 | CV2258702 | single nucleotide variant | NM_001080430.4(TOX3):c.697G>C (p.Ala233Pro) | not specified [RCV004117943] | uncertain significance | 16 | 52446203 | 52446203 | Human | | name |
| 156146005 | CV2265091 | single nucleotide variant | NM_001098797.2(TOX2):c.544A>G (p.Ile182Val) | not specified [RCV004126236] | uncertain significance | 20 | 44051438 | 44051438 | Human | | name |
| 156154999 | CV2266113 | single nucleotide variant | NM_001098797.2(TOX2):c.386A>G (p.His129Arg) | not specified [RCV004128706] | uncertain significance | 20 | 44006767 | 44006767 | Human | | name |
| 156059890 | CV2284367 | single nucleotide variant | NM_001098797.2(TOX2):c.710A>G (p.Lys237Arg) | not specified [RCV004146709] | uncertain significance | 20 | 44054357 | 44054357 | Human | | name |
| 156053050 | CV2329064 | single nucleotide variant | NM_001080430.4(TOX3):c.919A>G (p.Lys307Glu) | not specified [RCV004180338] | uncertain significance | 16 | 52444344 | 52444344 | Human | | name |
| 156083629 | CV2330711 | single nucleotide variant | NM_001080430.4(TOX3):c.464G>A (p.Arg155Gln) | not specified [RCV004185780] | uncertain significance | 16 | 52450491 | 52450491 | Human | | name |
| 156043375 | CV2381544 | single nucleotide variant | NM_001098797.2(TOX2):c.670C>T (p.Pro224Ser) | not specified [RCV004230016] | uncertain significance | 20 | 44054317 | 44054317 | Human | | name |
| 329391403 | CV2452310 | single nucleotide variant | NM_001098797.2(TOX2):c.547C>T (p.Arg183Trp) | not specified [RCV004278987] | uncertain significance | 20 | 44051441 | 44051441 | Human | | name |
| 329368132 | CV2457074 | single nucleotide variant | NM_001098797.2(TOX2):c.826G>A (p.Val276Met) | not specified [RCV004264858] | uncertain significance | 20 | 44054473 | 44054473 | Human | | name |
| 401757521 | CV2675352 | single nucleotide variant | NM_001098797.2(TOX2):c.307G>A (p.Gly103Ser) | not specified [RCV004292160] | uncertain significance | 20 | 44006688 | 44006688 | Human | | name |
| 401755658 | CV2682545 | single nucleotide variant | NM_001080430.4(TOX3):c.836A>T (p.Asn279Ile) | not specified [RCV004290557] | uncertain significance | 16 | 52446064 | 52446064 | Human | | name |
| 401772512 | CV2687717 | single nucleotide variant | NM_001080430.4(TOX3):c.443A>G (p.Gln148Arg) | not specified [RCV004302706] | uncertain significance | 16 | 52450512 | 52450512 | Human | | name |
| 405758613 | CV3347119 | single nucleotide variant | NM_001098797.2(TOX2):c.529A>T (p.Ile177Phe) | not specified [RCV004468219] | uncertain significance | 20 | 44051423 | 44051423 | Human | | name |
| 405758619 | CV3347120 | single nucleotide variant | NM_001098797.2(TOX2):c.548G>A (p.Arg183Gln) | not specified [RCV004468220] | uncertain significance | 20 | 44051442 | 44051442 | Human | | name |
| 405758624 | CV3347121 | single nucleotide variant | NM_001098797.2(TOX2):c.656C>T (p.Ser219Leu) | not specified [RCV004468221] | uncertain significance | 20 | 44054303 | 44054303 | Human | | name |
| 405758668 | CV3347128 | single nucleotide variant | NM_001080430.4(TOX3):c.494G>A (p.Arg165His) | not specified [RCV004468228] | uncertain significance | 16 | 52450461 | 52450461 | Human | | name |
| 407521083 | CV3486847 | single nucleotide variant | NM_001098797.2(TOX2):c.635C>T (p.Ser212Leu) | not specified [RCV004677170] | uncertain significance | 20 | 44051529 | 44051529 | Human | | name |
| 407521089 | CV3486849 | single nucleotide variant | NM_001080430.4(TOX3):c.874A>G (p.Met292Val) | not specified [RCV004677172] | uncertain significance | 16 | 52446026 | 52446026 | Human | | name |
| 407521102 | CV3486854 | single nucleotide variant | NM_001080430.4(TOX3):c.584T>C (p.Met195Thr) | not specified [RCV004677177] | uncertain significance | 16 | 52450371 | 52450371 | Human | | name |
| 597787271 | CV3611081 | single nucleotide variant | NM_001098797.2(TOX2):c.463G>A (p.Gly155Arg) | not specified [RCV004875559] | uncertain significance | 20 | 44051357 | 44051357 | Human | | name |
| 597787282 | CV3611084 | single nucleotide variant | NM_001098797.2(TOX2):c.568T>C (p.Ser190Pro) | not specified [RCV004875562] | uncertain significance | 20 | 44051462 | 44051462 | Human | | name |
| 597787286 | CV3611085 | single nucleotide variant | NM_001098797.2(TOX2):c.665A>C (p.Lys222Thr) | not specified [RCV004875563] | uncertain significance | 20 | 44054312 | 44054312 | Human | | name |
| 597787302 | CV3611089 | single nucleotide variant | NM_001080430.4(TOX3):c.404A>G (p.His135Arg) | not specified [RCV004875567] | uncertain significance | 16 | 52463938 | 52463938 | Human | | name |
| 597787306 | CV3611090 | single nucleotide variant | NM_001080430.4(TOX3):c.905A>G (p.Gln302Arg) | not specified [RCV004875568] | uncertain significance | 16 | 52445995 | 52445995 | Human | | name |
| 597787312 | CV3611092 | single nucleotide variant | NM_001080430.4(TOX3):c.836A>G (p.Asn279Ser) | not specified [RCV004875570] | uncertain significance | 16 | 52446064 | 52446064 | Human | | name |
| 597787316 | CV3611093 | single nucleotide variant | NM_001080430.4(TOX3):c.664G>T (p.Asp222Tyr) | not specified [RCV004875571] | uncertain significance | 16 | 52450291 | 52450291 | Human | | name |
| 598188609 | CV3928188 | single nucleotide variant | NM_001098797.2(TOX2):c.446A>G (p.Tyr149Cys) | not specified [RCV005287961] | uncertain significance | 20 | 44051340 | 44051340 | Human | | name |
| 598188616 | CV3928189 | single nucleotide variant | NM_001098797.2(TOX2):c.665A>G (p.Lys222Arg) | not specified [RCV005287962] | uncertain significance | 20 | 44054312 | 44054312 | Human | | name |
| 598254715 | CV3928190 | single nucleotide variant | NM_001098797.2(TOX2):c.596C>A (p.Ala199Glu) | not specified [RCV005278487] | uncertain significance | 20 | 44051490 | 44051490 | Human | | name |
| 598188647 | CV3928195 | single nucleotide variant | NM_001080430.4(TOX3):c.308C>T (p.Thr103Ile) | not specified [RCV005287966] | uncertain significance | 16 | 52464034 | 52464034 | Human | | name |
| 13798473 | CV551335 | single nucleotide variant | NM_001098797.2(TOX2):c.666G>T (p.Lys222Asn) | not provided [RCV000678388] | uncertain significance | 20 | 44054313 | 44054313 | Human | | name |
| 15165052 | CV705498 | single nucleotide variant | NM_001098797.2(TOX2):c.421A>G (p.Met141Val) | not provided [RCV000948496] | likely benign | 20 | 44051315 | 44051315 | Human | | name |
| 15197941 | CV726676 | single nucleotide variant | NM_001080430.4(TOX3):c.550G>A (p.Ala184Thr) | not provided [RCV000890211] | benign | 16 | 52450405 | 52450405 | Human | | name |
| 8635837 | CV91060 | single nucleotide variant | NM_001146188.1(TOX3):c.344G>A (p.Arg115Lys) | Malignant melanoma [RCV000071158] | not provided | 16 | 52463983 | 52463983 | Human | | name |
| 156313778 | CV2196551 | single nucleotide variant | NM_001080430.4(TOX3):c.1286C>T (p.Ser429Phe) | not specified [RCV004073836] | uncertain significance | 16 | 52439670 | 52439670 | Human | | name |
| 156072906 | CV2201370 | single nucleotide variant | NM_001098797.2(TOX2):c.1175C>T (p.Pro392Leu) | not specified [RCV004077493] | uncertain significance | 20 | 44065926 | 44065926 | Human | | name |
| 156069040 | CV2237095 | single nucleotide variant | NM_001098797.2(TOX2):c.1429A>C (p.Ser477Arg) | not specified [RCV004114852] | uncertain significance | 20 | 44066802 | 44066802 | Human | | name |
| 155989172 | CV2259665 | single nucleotide variant | NM_001080430.4(TOX3):c.1710A>T (p.Leu570Phe) | not specified [RCV004116698] | uncertain significance | 16 | 52439246 | 52439246 | Human | | name |
| 156100651 | CV2260273 | single nucleotide variant | NM_001098797.2(TOX2):c.1255C>A (p.Pro419Thr) | not specified [RCV004129376] | uncertain significance | 20 | 44066006 | 44066006 | Human | | name |
| 155905740 | CV2303171 | single nucleotide variant | NM_001080430.4(TOX3):c.1058C>T (p.Thr353Ile) | not specified [RCV004156936] | uncertain significance | 16 | 52439898 | 52439898 | Human | | name |
| 156359668 | CV2328264 | single nucleotide variant | NM_001098797.2(TOX2):c.1046T>C (p.Met349Thr) | not specified [RCV004173348] | uncertain significance | 20 | 44065797 | 44065797 | Human | | name |
| 156003538 | CV2357468 | single nucleotide variant | NM_001098797.2(TOX2):c.1228C>T (p.Pro410Ser) | not specified [RCV004202756] | uncertain significance | 20 | 44065979 | 44065979 | Human | | name |
| 156307149 | CV2369607 | single nucleotide variant | NM_001080430.4(TOX3):c.1213G>A (p.Ala405Thr) | not specified [RCV004215019] | uncertain significance | 16 | 52439743 | 52439743 | Human | | name |
| 155927361 | CV2396124 | single nucleotide variant | NM_001098797.2(TOX2):c.1427G>T (p.Ser476Ile) | not specified [RCV004237655] | uncertain significance | 20 | 44066800 | 44066800 | Human | | name |
| 329400284 | CV2437571 | single nucleotide variant | NM_001080430.4(TOX3):c.1622C>G (p.Thr541Arg) | not specified [RCV004258854] | uncertain significance | 16 | 52439334 | 52439334 | Human | | name |
| 329377738 | CV2450010 | single nucleotide variant | NM_001080430.4(TOX3):c.1452C>A (p.His484Gln) | not specified [RCV004269068] | uncertain significance | 16 | 52439504 | 52439504 | Human | | name |
| 401721074 | CV2673591 | single nucleotide variant | NM_001080430.4(TOX3):c.1624T>A (p.Ser542Thr) | not specified [RCV004282329] | uncertain significance | 16 | 52439332 | 52439332 | Human | | name |
| 401745967 | CV2678741 | single nucleotide variant | NM_001098797.2(TOX2):c.1045A>C (p.Met349Leu) | not specified [RCV004292737] | uncertain significance | 20 | 44065796 | 44065796 | Human | | name |
| 401754887 | CV2682326 | single nucleotide variant | NM_001080430.4(TOX3):c.1217A>G (p.Asn406Ser) | not specified [RCV004290364] | uncertain significance | 16 | 52439739 | 52439739 | Human | | name |
| 401743202 | CV2684041 | single nucleotide variant | NM_001080430.4(TOX3):c.1526A>T (p.Gln509Leu) | not specified [RCV004295645] | uncertain significance | 16 | 52439430 | 52439430 | Human | | name |
| 401771003 | CV2686136 | single nucleotide variant | NM_001080430.4(TOX3):c.1676C>T (p.Ser559Leu) | not specified [RCV004297142] | uncertain significance | 16 | 52439280 | 52439280 | Human | | name |
| 401770457 | CV2707223 | single nucleotide variant | NM_001098797.2(TOX2):c.1190C>T (p.Pro397Leu) | not specified [RCV004310852] | uncertain significance | 20 | 44065941 | 44065941 | Human | | name |
| 401768669 | CV2716691 | single nucleotide variant | NM_001080430.4(TOX3):c.1523A>T (p.Gln508Leu) | not specified [RCV004327742] | uncertain significance | 16 | 52439433 | 52439433 | Human | | name |
| 401867864 | CV2767099 | single nucleotide variant | NM_001098797.2(TOX2):c.1123C>T (p.Arg375Trp) | not specified [RCV004347500] | uncertain significance | 20 | 44065874 | 44065874 | Human | | name |
| 401891828 | CV2779483 | single nucleotide variant | NM_001080430.4(TOX3):c.1226C>T (p.Ser409Leu) | not specified [RCV004351112] | uncertain significance | 16 | 52439730 | 52439730 | Human | | name |
| 405758592 | CV3347115 | single nucleotide variant | NM_001098797.2(TOX2):c.1073C>T (p.Pro358Leu) | not specified [RCV004468215] | uncertain significance | 20 | 44065824 | 44065824 | Human | | name |
| 405758597 | CV3347116 | single nucleotide variant | NM_001098797.2(TOX2):c.1139A>T (p.Lys380Met) | not specified [RCV004468216] | uncertain significance | 20 | 44065890 | 44065890 | Human | | name |
| 405758633 | CV3347122 | single nucleotide variant | NM_001080430.4(TOX3):c.1185C>A (p.Asn395Lys) | not specified [RCV004468222] | uncertain significance | 16 | 52439771 | 52439771 | Human | | name |
| 405758638 | CV3347123 | single nucleotide variant | NM_001080430.4(TOX3):c.1238C>A (p.Ala413Asp) | not specified [RCV004468223] | uncertain significance | 16 | 52439718 | 52439718 | Human | | name |
| 405758651 | CV3347125 | single nucleotide variant | NM_001080430.4(TOX3):c.1368G>C (p.Met456Ile) | not specified [RCV004468225] | uncertain significance | 16 | 52439588 | 52439588 | Human | | name |
| 405758654 | CV3347126 | single nucleotide variant | NM_001080430.4(TOX3):c.1538G>A (p.Arg513His) | not specified [RCV004468226] | likely benign | 16 | 52439418 | 52439418 | Human | | name |
| 405758662 | CV3347127 | single nucleotide variant | NM_001080430.4(TOX3):c.1658C>T (p.Ala553Val) | not specified [RCV004468227] | uncertain significance | 16 | 52439298 | 52439298 | Human | | name |
| 407461147 | CV3486846 | single nucleotide variant | NM_001098797.2(TOX2):c.1465T>C (p.Cys489Arg) | not specified [RCV004687579] | uncertain significance | 20 | 44066838 | 44066838 | Human | | name |
| 407521086 | CV3486848 | single nucleotide variant | NM_001098797.2(TOX2):c.1336C>T (p.Pro446Ser) | not specified [RCV004677171] | uncertain significance | 20 | 44066087 | 44066087 | Human | | name |
| 407521092 | CV3486850 | single nucleotide variant | NM_001080430.4(TOX3):c.1499A>G (p.Gln500Arg) | not specified [RCV004677173] | uncertain significance | 16 | 52439457 | 52439457 | Human | | name |
| 407521096 | CV3486852 | single nucleotide variant | NM_001080430.4(TOX3):c.1661C>G (p.Ser554Cys) | not specified [RCV004677175] | uncertain significance | 16 | 52439295 | 52439295 | Human | | name |
| 407521105 | CV3486855 | single nucleotide variant | NM_001080430.4(TOX3):c.1094A>G (p.His365Arg) | not specified [RCV004677178] | uncertain significance | 16 | 52439862 | 52439862 | Human | | name |
| 597787294 | CV3611087 | single nucleotide variant | NM_001080430.4(TOX3):c.1022G>A (p.Arg341His) | not specified [RCV004875565] | uncertain significance | 16 | 52439934 | 52439934 | Human | | name |
| 597787298 | CV3611088 | single nucleotide variant | NM_001080430.4(TOX3):c.1642G>A (p.Gly548Arg) | not specified [RCV004875566] | uncertain significance | 16 | 52439314 | 52439314 | Human | | name |
| 597787309 | CV3611091 | single nucleotide variant | NM_001080430.4(TOX3):c.1093C>T (p.His365Tyr) | not specified [RCV004875569] | uncertain significance | 16 | 52439863 | 52439863 | Human | | name |
| 598188594 | CV3928186 | single nucleotide variant | NM_001098797.2(TOX2):c.1163C>T (p.Ala388Val) | not specified [RCV005287959] | uncertain significance | 20 | 44065914 | 44065914 | Human | | name |
| 598254720 | CV3928191 | single nucleotide variant | NM_001080430.4(TOX3):c.1052A>G (p.Asn351Ser) | not specified [RCV005278488] | uncertain significance | 16 | 52439904 | 52439904 | Human | | name |
| 598188630 | CV3928193 | single nucleotide variant | NM_001080430.4(TOX3):c.1262C>T (p.Thr421Met) | not specified [RCV005287964] | uncertain significance | 16 | 52439694 | 52439694 | Human | | name |
| 598188639 | CV3928194 | single nucleotide variant | NM_001080430.4(TOX3):c.1237G>C (p.Ala413Pro) | not specified [RCV005287965] | uncertain significance | 16 | 52439719 | 52439719 | Human | | name |
| 598188653 | CV3928196 | single nucleotide variant | NM_001080430.4(TOX3):c.1237G>A (p.Ala413Thr) | not specified [RCV005287967] | uncertain significance | 16 | 52439719 | 52439719 | Human | | name |
| 15182246 | CV714965 | single nucleotide variant | NM_001080430.4(TOX3):c.1537C>T (p.Arg513Cys) | not provided [RCV000974585] | benign | 16 | 52439419 | 52439419 | Human | | name |
| 150422000 | CV1194884 | deletion | NM_000369.5(TSHR):c.1963_1964del (p.Thr655fs) | Familial gestational hyperthyroidism [RCV002476874]|Hypothyroidism due to TSH receptor mutations [RCV002274197]|not provided [RCV001570778] | pathogenic|likely pathogenic | 14 | 81144020 | 81144021 | Human | 4 | alternate_id |
| 150446252 | CV1274345 | single nucleotide variant | NM_000369.5(TSHR):c.692+163A>G | Familial gestational hyperthyroidism [RCV001840831]|Familial hyperthyroidism due to mutations in TSH receptor [RCV001840829]|Hypothyroidism due to TSH receptor mutations [RCV001840830]|not provided [RCV001713681]|not specified [RCV001698749] | benign | 14 | 81108615 | 81108615 | Human | 4 | alternate_id |
| 150545488 | CV1293825 | single nucleotide variant | NM_000369.5(TSHR):c.170T>C (p.Leu57Pro) | Familial gestational hyperthyroidism [RCV002496076]|not provided [RCV001763006] | uncertain significance | 14 | 80955850 | 80955850 | Human | 1 | alternate_id |
| 151750475 | CV1334493 | single nucleotide variant | NM_000369.5(TSHR):c.692+48T>A | Familial gestational hyperthyroidism [RCV001840959]|Familial hyperthyroidism due to mutations in TSH receptor [RCV001840957]|Hypothyroidism due to TSH receptor mutations [RCV001840958]|not provided [RCV004706258] | benign|likely benign | 14 | 81108500 | 81108500 | Human | 4 | alternate_id |
| 8688587 | CV139131 | single nucleotide variant | NM_000369.5(TSHR):c.154C>A (p.Pro52Thr) | Familial gestational hyperthyroidism [RCV001839916]|Familial hyperthyroidism due to mutations in TSH receptor [RCV001118138]|Hypothyroidism due to TSH receptor mutations [RCV000319857]|not provided [RCV001657769]|not specified [RCV000122244] | benign|likely benign|not provided | 14 | 80955834 | 80955834 | Human | 4 | alternate_id |
| 8688589 | CV139133 | single nucleotide variant | NM_000369.5(TSHR):c.1600C>T (p.Arg534Cys) | Familial hyperthyroidism due to mutations in TSH receptor [RCV001119885]|Hypothyroidism due to TSH receptor mutations [RCV001119886]|TSHR-related disorder [RCV004530041]|not provided [RCV000864226]|not specified [RCV000122247] | benign|likely benign|uncertain significance|not provided | 14 | 81143658 | 81143658 | Human | 3 | alternate_id |
| 8688591 | CV139135 | single nucleotide variant | NM_000369.5(TSHR):c.2232C>G (p.Asn744Lys) | Familial hyperthyroidism due to mutations in TSH receptor [RCV000359860]|Hypothyroidism due to TSH receptor mutations [RCV000267968]|TSHR-related disorder [RCV004530042]|not provided [RCV000870818]|not specified [RCV000122249] | benign|likely benign|not provided | 14 | 81144290 | 81144290 | Human | 3 | alternate_id |
| 8688593 | CV139137 | single nucleotide variant | NM_000369.5(TSHR):c.1270G>A (p.Val424Ile) | Familial hyperthyroidism due to mutations in TSH receptor [RCV001115203]|Hypothyroidism due to TSH receptor mutations [RCV001115204]|not specified [RCV000122252] | uncertain significance|not provided | 14 | 81143328 | 81143328 | Human | 3 | alternate_id |
| 8688594 | CV139138 | single nucleotide variant | NM_000369.5(TSHR):c.2161G>T (p.Val721Phe) | Familial hyperthyroidism due to mutations in TSH receptor [RCV000299331]|Hypothyroidism due to TSH receptor mutations [RCV000356472]|not provided [RCV000873340]|not specified [RCV000122253] | benign|uncertain significance|not provided | 14 | 81144219 | 81144219 | Human | 3 | alternate_id |
| 8688595 | CV139139 | single nucleotide variant | NM_000369.5(TSHR):c.2181G>C (p.Glu727Asp) | Familial gestational hyperthyroidism [RCV001839917]|Familial hyperthyroidism due to mutations in TSH receptor [RCV000392451]|Hypothyroidism due to TSH receptor mutations [RCV000302729]|not provided [RCV001541679]|not specified [RCV000122254] | benign|likely benign|not provided | 14 | 81144239 | 81144239 | Human | 4 | alternate_id |
| 8688596 | CV139140 | single nucleotide variant | NM_000369.5(TSHR):c.929G>A (p.Arg310His) | Familial hyperthyroidism due to mutations in TSH receptor [RCV001121767]|Hypothyroidism due to TSH receptor mutations [RCV001121768]|TSHR-related disorder [RCV004530043]|not provided [RCV000954542]|not specified [RCV000122255] | benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance|not provided | 14 | 81142987 | 81142987 | Human | 3 | alternate_id |
| 8688598 | CV139142 | single nucleotide variant | NM_000369.5(TSHR):c.692+209C>A | Familial gestational hyperthyroidism [RCV001839920]|Familial hyperthyroidism due to mutations in TSH receptor [RCV001839918]|Hypothyroidism due to TSH receptor mutations [RCV001839919]|not provided [RCV001610431]|not specified [RCV000122257] | benign|not provided | 14 | 81108661 | 81108661 | Human | 4 | alternate_id |
| 156048650 | CV1867602 | single nucleotide variant | NM_000369.5(TSHR):c.1225G>T (p.Glu409Ter) | Familial gestational hyperthyroidism [RCV005008602]|not provided [RCV002510074] | likely pathogenic|conflicting interpretations of pathogenicity|uncertain significance | 14 | 81143283 | 81143283 | Human | 1 | alternate_id |
| 8597116 | CV21469 | single nucleotide variant | NM_000369.5(TSHR):c.106G>C (p.Asp36His) | Familial hyperthyroidism due to mutations in TSH receptor [RCV000259846]|Graves disease, susceptibility to, 1 [RCV004991966]|Hypothyroidism due to TSH receptor mutations [RCV000373195]|not provided [RCV000870612]|not specified [RCV000122245] | benign|likely benign|not provided | 14 | 80955786 | 80955786 | Human | 4 | alternate_id |
| 8597119 | CV21472 | single nucleotide variant | NM_000369.5(TSHR):c.1891T>C (p.Phe631Leu) | Familial hyperthyroidism due to mutations in TSH receptor [RCV000006802]|Thyroid adenoma, hyperfunctioning, somatic [RCV000006803] | pathogenic|other | 14 | 81143949 | 81143949 | Human | 2 | alternate_id |
| 8597121 | CV21474 | single nucleotide variant | NM_000369.5(TSHR):c.484C>G (p.Pro162Ala) | Familial gestational hyperthyroidism [RCV002490329]|Familial gestational hyperthyroidism [RCV003466821]|Hypothyroidism due to TSH receptor mutations [RCV000006805]|not provided [RCV001815162] | pathogenic|likely pathogenic | 14 | 81092547 | 81092547 | Human | 4 | alternate_id |
| 8597122 | CV21475 | single nucleotide variant | NM_000369.5(TSHR):c.1358T>C (p.Met453Thr) | Familial hyperthyroidism due to mutations in TSH receptor [RCV000006806] | pathogenic|likely pathogenic | 14 | 81143416 | 81143416 | Human | 1 | alternate_id |
| 8597124 | CV21477 | single nucleotide variant | NM_000369.5(TSHR):c.326G>A (p.Arg109Gln) | Familial gestational hyperthyroidism [RCV005007829]|Hypothyroidism due to TSH receptor mutations [RCV000006808]|not provided [RCV003555948] | pathogenic|likely pathogenic | 14 | 81087962 | 81087962 | Human | 4 | alternate_id |
| 8597125 | CV21478 | single nucleotide variant | NM_000369.5(TSHR):c.1637G>A (p.Trp546Ter) | Familial gestational hyperthyroidism [RCV005007830]|Hypothyroidism due to TSH receptor mutations [RCV000006809]|Inborn genetic diseases [RCV002512852]|TSHR-related disorder [RCV004528087]|not provided [RCV000333686] | pathogenic|likely pathogenic|benign | 14 | 81143695 | 81143695 | Human | 5 | alternate_id |
| 8597128 | CV21481 | single nucleotide variant | NM_000369.5(TSHR):c.122G>C (p.Cys41Ser) | Epilepsy [RCV000415318]|Familial hyperthyroidism due to mutations in TSH receptor [RCV001197388]|Hypothyroidism due to TSH receptor mutations [RCV000006812]|not provided [RCV005003341]|not specified [RCV004700195] | pathogenic|likely pathogenic|uncertain significance | 14 | 80955802 | 80955802 | Human | 7 | alternate_id |
| 8597130 | CV21483 | single nucleotide variant | NM_000369.5(TSHR):c.1170T>G (p.Cys390Trp) | Familial gestational hyperthyroidism [RCV002490330]|Hypothyroidism due to TSH receptor mutations [RCV000006814] | pathogenic|likely pathogenic | 14 | 81143228 | 81143228 | Human | 4 | alternate_id |
| 8597131 | CV21484 | single nucleotide variant | NM_000369.5(TSHR):c.1657G>A (p.Ala553Thr) | Familial gestational hyperthyroidism [RCV004566686]|Familial gestational hyperthyroidism [RCV005007831]|Hypothyroidism due to TSH receptor mutations [RCV000006815]|Inborn genetic diseases [RCV002512853]|TSHR-related disorder [RCV004532302]|not provided [RCV003764533] | pathogenic|likely pathogenic|likely benign|conflicting interpretations of pathogenicity | 14 | 81143715 | 81143715 | Human | 6 | alternate_id |
| 8597131 | CV21484 | single nucleotide variant | NM_000369.5(TSHR):c.1657G>A (p.Ala553Thr) | Familial gestational hyperthyroidism [RCV004566686]|Familial gestational hyperthyroidism [RCV005007831]|Hypothyroidism due to TSH receptor mutations [RCV000006815]|Inborn genetic diseases [RCV002512853]|TSHR-related disorder [RCV004532302]|not provided [RCV003764533] | pathogenic|likely pathogenic|likely benign|conflicting interpretations of pathogenicity | 14 | 81143715 | 81143716 | Human | 6 | alternate_id |
| 8597133 | CV21487 | single nucleotide variant | NM_000369.5(TSHR):c.1526T>C (p.Val509Ala) | Familial hyperthyroidism due to mutations in TSH receptor [RCV000006818] | pathogenic | 14 | 81143584 | 81143584 | Human | 1 | alternate_id |
| 8597134 | CV21488 | single nucleotide variant | NM_000369.5(TSHR):c.2015G>A (p.Cys672Tyr) | Familial hyperthyroidism due to mutations in TSH receptor [RCV000006819] | pathogenic | 14 | 81144073 | 81144073 | Human | 1 | alternate_id |
| 8597135 | CV21489 | single nucleotide variant | NM_000369.5(TSHR):c.1514G>A (p.Ser505Asn) | Familial hyperthyroidism due to mutations in TSH receptor [RCV000006820]|not provided [RCV002468962] | pathogenic|likely pathogenic | 14 | 81143572 | 81143572 | Human | 1 | alternate_id |
| 8597136 | CV21490 | single nucleotide variant | NM_000369.5(TSHR):c.1887G>T (p.Leu629Phe) | Familial hyperthyroidism due to mutations in TSH receptor [RCV000006821]|Thyroid adenoma, hyperfunctioning, somatic [RCV000006822] | pathogenic|other | 14 | 81143945 | 81143945 | Human | 2 | alternate_id |
| 8597137 | CV21491 | single nucleotide variant | NM_000369.5(TSHR):c.842G>A (p.Ser281Asn) | Familial hyperthyroidism due to mutations in TSH receptor [RCV000006823] | pathogenic | 14 | 81139828 | 81139828 | Human | 1 | alternate_id |
| 8597139 | CV21493 | single nucleotide variant | NM_000369.5(TSHR):c.1915C>T (p.Pro639Ser) | Familial hyperthyroidism due to mutations in TSH receptor [RCV000006825] | pathogenic | 14 | 81143973 | 81143973 | Human | 1 | alternate_id |
| 8597142 | CV21496 | single nucleotide variant | NM_000369.5(TSHR):c.1291G>A (p.Gly431Ser) | Familial hyperthyroidism due to mutations in TSH receptor [RCV000006828] | pathogenic | 14 | 81143349 | 81143349 | Human | 1 | alternate_id |
| 10449662 | CV215485 | single nucleotide variant | NM_000369.5(TSHR):c.881+3A>G | Familial hyperthyroidism due to mutations in TSH receptor [RCV000321154]|Hypothyroidism due to TSH receptor mutations [RCV000378172]|TSHR-related disorder [RCV004530210]|not provided [RCV000864415]|not specified [RCV000202706] | benign|likely benign|uncertain significance | 14 | 81139870 | 81139870 | Human | 3 | alternate_id |
| 12907333 | CV227361 | single nucleotide variant | NM_000369.5(TSHR):c.733G>A (p.Gly245Ser) | Familial hyperthyroidism due to mutations in TSH receptor [RCV001118245]|Hypothyroidism due to TSH receptor mutations [RCV000490322]|not provided [RCV001753637] | benign|uncertain significance | 14 | 81139719 | 81139719 | Human | 3 | alternate_id |
| 11578089 | CV227362 | single nucleotide variant | NM_000369.5(TSHR):c.1349G>A (p.Arg450His) | Congenital hypothyroidism [RCV000826152]|Familial gestational hyperthyroidism [RCV003225722]|Familial gestational hyperthyroidism [RCV005008151]|Hypothyroidism due to TSH receptor mutations [RCV000490528]|Ovarian cancer [RCV003153491]|not provided [RCV000273881] | pathogenic|likely pathogenic|benign | 14 | 81143407 | 81143407 | Human | 10 | alternate_id |
| 11544331 | CV255092 | single nucleotide variant | NM_000369.5(TSHR):c.545+13A>G | Familial hyperthyroidism due to mutations in TSH receptor [RCV000400761]|Hypothyroidism due to TSH receptor mutations [RCV000347168]|not provided [RCV001658165]|not specified [RCV000243644] | benign|likely benign | 14 | 81092621 | 81092621 | Human | 3 | alternate_id |
| 11547920 | CV255093 | single nucleotide variant | NM_000369.5(TSHR):c.561T>C (p.Asn187=) | Familial hyperthyroidism due to mutations in TSH receptor [RCV000312123]|Hypothyroidism due to TSH receptor mutations [RCV000371329]|not provided [RCV001698502]|not specified [RCV000248392] | benign|likely benign | 14 | 81096654 | 81096654 | Human | 3 | alternate_id |
| 11544591 | CV255095 | single nucleotide variant | NM_000369.5(TSHR):c.1377G>A (p.Ala459=) | Familial hyperthyroidism due to mutations in TSH receptor [RCV000346528]|Hypothyroidism due to TSH receptor mutations [RCV000384951]|not provided [RCV001574623]|not specified [RCV000243995] | benign|likely benign | 14 | 81143435 | 81143435 | Human | 3 | alternate_id |
| 401721358 | CV2737535 | single nucleotide variant | NM_000369.5(TSHR):c.1891T>G (p.Phe631Val) | Familial hyperthyroidism due to mutations in TSH receptor [RCV003314474] | likely pathogenic | 14 | 81143949 | 81143949 | Human | 1 | alternate_id |
| 401901628 | CV2797903 | single nucleotide variant | NM_000369.5(TSHR):c.2234C>G (p.Ser745Cys) | Familial gestational hyperthyroidism [RCV005399378]|TSHR-related disorder [RCV004534360] | uncertain significance | 14 | 81144292 | 81144292 | Human | 4 | alternate_id |
| 401905095 | CV2831384 | single nucleotide variant | NM_000369.5(TSHR):c.1966G>A (p.Val656Ile) | Familial hyperthyroidism due to mutations in TSH receptor [RCV003444185] | likely pathogenic | 14 | 81144024 | 81144024 | Human | 1 | alternate_id |
| 8564520 | CV29948 | variation | HLA-B*15:02 | Stevens-Johnson syndrome, susceptibility to [RCV004576901]|Susceptibility to severe cutaneous adverse reaction [RCV000016039]|Toxic epidermal necrolysis [RCV000016041] | risk factor | | | | Human | | trait , alternate_id |
| 8564522 | CV29950 | variation | HLA–B*58:01 | Allopurinol response [RCV000031851]|Stevens-Johnson syndrome, susceptibility to [RCV004576902]|Susceptibility to severe cutaneous adverse reaction [RCV000016044]|Toxic epidermal necrolysis [RCV000016046] | risk factor|not provided | | | | Human | | trait , alternate_id |
| 405203694 | CV3165161 | single nucleotide variant | NM_000369.5(TSHR):c.881+1G>T | Familial gestational hyperthyroidism [RCV005013256]|not provided [RCV003861022] | pathogenic|likely pathogenic | 14 | 81139868 | 81139868 | Human | 1 | alternate_id |
| 402483549 | CV3171179 | deletion | NM_000369.5(TSHR):c.801_810del (p.Leu267fs) | Familial gestational hyperthyroidism [RCV005013268]|not provided [RCV003876206] | pathogenic|likely pathogenic | 14 | 81139780 | 81139789 | Human | 1 | alternate_id |
| 11602217 | CV321627 | single nucleotide variant | NM_000369.5(TSHR):c.1290G>A (p.Leu430=) | Familial hyperthyroidism due to mutations in TSH receptor [RCV000289210]|Hypothyroidism due to TSH receptor mutations [RCV000381332]|not provided [RCV000909751] | benign|likely benign|uncertain significance | 14 | 81143348 | 81143348 | Human | 3 | alternate_id |
| 11605905 | CV321628 | single nucleotide variant | NM_000369.5(TSHR):c.*18C>A | Familial hyperthyroidism due to mutations in TSH receptor [RCV000363808]|Hypothyroidism due to TSH receptor mutations [RCV000325352] | benign|likely benign | 14 | 81144371 | 81144371 | Human | 3 | alternate_id |
| 11652572 | CV321633 | single nucleotide variant | NM_000369.5(TSHR):c.*319G>A | Familial hyperthyroidism due to mutations in TSH receptor [RCV000362971]|Hypothyroidism due to TSH receptor mutations [RCV000305925] | uncertain significance | 14 | 81144672 | 81144672 | Human | 3 | alternate_id |
| 11657941 | CV321634 | duplication | NM_000369.5(TSHR):c.*1154dup | Congenital hypothyroidism [RCV000400446]|Familial hyperthyroidism due to mutations in TSH receptor [RCV000345465] | likely benign | 14 | 81145506 | 81145507 | Human | 3 | alternate_id |
| 11645879 | CV321635 | single nucleotide variant | NM_000369.5(TSHR):c.*1620C>G | Familial hyperthyroidism due to mutations in TSH receptor [RCV000267613]|Hypothyroidism due to TSH receptor mutations [RCV000378468] | uncertain significance | 14 | 81145973 | 81145973 | Human | 3 | alternate_id |
| 11649924 | CV321636 | single nucleotide variant | NM_000369.5(TSHR):c.*1742G>T | Congenital hypothyroidism [RCV000290258]|Familial hyperthyroidism due to mutations in TSH receptor [RCV000347614] | uncertain significance | 14 | 81146095 | 81146095 | Human | 3 | alternate_id |
| 11614542 | CV330890 | single nucleotide variant | NM_000369.5(TSHR):c.-60G>A | Familial hyperthyroidism due to mutations in TSH receptor [RCV000332604]|Hypothyroidism due to TSH receptor mutations [RCV000277558] | benign|uncertain significance | 14 | 80955621 | 80955621 | Human | 3 | alternate_id |
| 11620665 | CV330891 | single nucleotide variant | NM_000369.5(TSHR):c.171-11T>C | Familial hyperthyroidism due to mutations in TSH receptor [RCV000339754]|Hypothyroidism due to TSH receptor mutations [RCV000380414]|not provided [RCV003736711] | benign|uncertain significance | 14 | 81062137 | 81062137 | Human | 3 | alternate_id |
| 11644501 | CV330894 | single nucleotide variant | NM_000369.5(TSHR):c.615-6C>G | Familial hyperthyroidism due to mutations in TSH receptor [RCV000260249]|Hypothyroidism due to TSH receptor mutations [RCV000299176] | uncertain significance | 14 | 81108369 | 81108369 | Human | 3 | alternate_id |
| 11612922 | CV330904 | single nucleotide variant | NM_000369.5(TSHR):c.692+3G>A | Familial hyperthyroidism due to mutations in TSH receptor [RCV000356284]|Hypothyroidism due to TSH receptor mutations [RCV000263643]|not provided [RCV003105866]|not specified [RCV003488529] | benign|likely benign|uncertain significance | 14 | 81108455 | 81108455 | Human | 3 | alternate_id |
| 11615659 | CV330906 | single nucleotide variant | NM_000369.5(TSHR):c.*1152T>A | Familial hyperthyroidism due to mutations in TSH receptor [RCV000288117]|Hypothyroidism due to TSH receptor mutations [RCV000396098]|not provided [RCV004714877] | benign|likely benign | 14 | 81145505 | 81145505 | Human | 3 | alternate_id |
| 11618065 | CV330908 | single nucleotide variant | NM_000369.5(TSHR):c.*1222G>C | Familial hyperthyroidism due to mutations in TSH receptor [RCV000349021]|Hypothyroidism due to TSH receptor mutations [RCV000310384]|not provided [RCV004714878] | benign|likely benign | 14 | 81145575 | 81145575 | Human | 3 | alternate_id |
| 11618466 | CV330912 | single nucleotide variant | NM_000369.5(TSHR):c.*1289A>G | Familial hyperthyroidism due to mutations in TSH receptor [RCV000399743]|Hypothyroidism due to TSH receptor mutations [RCV000314042]|not provided [RCV004703672] | benign|likely benign | 14 | 81145642 | 81145642 | Human | 3 | alternate_id |
| 11615441 | CV337547 | single nucleotide variant | NM_000369.5(TSHR):c.357T>A (p.Pro119=) | Familial hyperthyroidism due to mutations in TSH receptor [RCV000345712]|Hypothyroidism due to TSH receptor mutations [RCV000286041]|not provided [RCV000871206]|not specified [RCV000500628] | benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance | 14 | 81087993 | 81087993 | Human | 3 | alternate_id |
| 11617870 | CV337553 | single nucleotide variant | NM_000369.5(TSHR):c.394G>C (p.Gly132Arg) | Familial gestational hyperthyroidism [RCV004567857]|Familial gestational hyperthyroidism [RCV005010273]|Ovarian cancer [RCV003153557]|TSHR-related disorder [RCV003335304]|not provided [RCV000489665] | likely pathogenic|benign|uncertain significance|no classifications from unflagged records | 14 | 81091070 | 81091070 | Human | 6 | alternate_id |
| 11620232 | CV337556 | single nucleotide variant | NM_000369.5(TSHR):c.2120G>A (p.Arg707Gln) | Familial hyperthyroidism due to mutations in TSH receptor [RCV000334617]|Hypothyroidism due to TSH receptor mutations [RCV000401092]|Inborn genetic diseases [RCV005286062]|not specified [RCV003401322] | likely benign|uncertain significance | 14 | 81144178 | 81144178 | Human | 4 | alternate_id |
| 11613771 | CV337563 | single nucleotide variant | NM_000369.5(TSHR):c.*116G>A | Familial hyperthyroidism due to mutations in TSH receptor [RCV000328706]|Hypothyroidism due to TSH receptor mutations [RCV000271572] | uncertain significance | 14 | 81144469 | 81144469 | Human | 3 | alternate_id |
| 11614814 | CV337564 | single nucleotide variant | NM_000369.5(TSHR):c.*172C>A | Familial hyperthyroidism due to mutations in TSH receptor [RCV000279898]|Hypothyroidism due to TSH receptor mutations [RCV000337203]|not provided [RCV004715870] | benign|likely benign | 14 | 81144525 | 81144525 | Human | 3 | alternate_id |
| 11615211 | CV337565 | single nucleotide variant | NM_000369.5(TSHR):c.*182G>T | Familial hyperthyroidism due to mutations in TSH receptor [RCV000283517]|Hypothyroidism due to TSH receptor mutations [RCV000398056] | benign|likely benign|uncertain significance | 14 | 81144535 | 81144535 | Human | 3 | alternate_id |
| 11617875 | CV337571 | single nucleotide variant | NM_000369.5(TSHR):c.*400T>C | Familial hyperthyroidism due to mutations in TSH receptor [RCV000308761]|Hypothyroidism due to TSH receptor mutations [RCV000390075] | uncertain significance | 14 | 81144753 | 81144753 | Human | 3 | alternate_id |
| 11619900 | CV337572 | single nucleotide variant | NM_000369.5(TSHR):c.*474G>T | Familial hyperthyroidism due to mutations in TSH receptor [RCV000330876]|Hypothyroidism due to TSH receptor mutations [RCV000369106] | benign|likely benign | 14 | 81144827 | 81144827 | Human | 3 | alternate_id |
| 11614423 | CV337585 | single nucleotide variant | NM_000369.5(TSHR):c.*728A>G | Familial hyperthyroidism due to mutations in TSH receptor [RCV000276943]|Hypothyroidism due to TSH receptor mutations [RCV000316669] | benign|likely benign|uncertain significance | 14 | 81145081 | 81145081 | Human | 3 | alternate_id |
| 11614995 | CV337591 | single nucleotide variant | NM_000369.5(TSHR):c.*909C>T | Familial hyperthyroidism due to mutations in TSH receptor [RCV000281480]|Hypothyroidism due to TSH receptor mutations [RCV000373593]|not provided [RCV004714876] | benign|likely benign | 14 | 81145262 | 81145262 | Human | 6 | alternate_id |
| 11614995 | CV337591 | single nucleotide variant | NM_000369.5(TSHR):c.*909C>T | Familial hyperthyroidism due to mutations in TSH receptor [RCV000281480]|Hypothyroidism due to TSH receptor mutations [RCV000373593]|not provided [RCV004714876] | benign|likely benign | 14 | 81145262 | 81145263 | Human | 6 | alternate_id |
| 11619380 | CV337607 | single nucleotide variant | NM_000369.5(TSHR):c.*1695T>C | Familial hyperthyroidism due to mutations in TSH receptor [RCV000382307]|Hypothyroidism due to TSH receptor mutations [RCV000324982] | benign|uncertain significance | 14 | 81146048 | 81146048 | Human | 3 | alternate_id |
| 11616372 | CV337609 | single nucleotide variant | NM_000369.5(TSHR):c.*1813T>A | Familial hyperthyroidism due to mutations in TSH receptor [RCV000293889]|Hypothyroidism due to TSH receptor mutations [RCV000385843] | benign|likely benign | 14 | 81146166 | 81146166 | Human | 3 | alternate_id |
| 11616758 | CV337613 | single nucleotide variant | NM_000369.5(TSHR):c.*1946C>T | Familial hyperthyroidism due to mutations in TSH receptor [RCV000336110]|Hypothyroidism due to TSH receptor mutations [RCV000297348] | benign|uncertain significance | 14 | 81146299 | 81146299 | Human | 3 | alternate_id |
| 11648946 | CV339633 | single nucleotide variant | NM_000369.5(TSHR):c.157A>C (p.Ser53Arg) | Familial hyperthyroidism due to mutations in TSH receptor [RCV000374577]|Hypothyroidism due to TSH receptor mutations [RCV000284776] | uncertain significance | 14 | 80955837 | 80955837 | Human | 3 | alternate_id |
| 11613305 | CV339636 | single nucleotide variant | NM_000369.5(TSHR):c.1191G>T (p.Val397=) | Familial hyperthyroidism due to mutations in TSH receptor [RCV000267339]|Hypothyroidism due to TSH receptor mutations [RCV000324461] | uncertain significance | 14 | 81143249 | 81143249 | Human | 3 | alternate_id |
| 11650611 | CV339638 | single nucleotide variant | NM_000369.5(TSHR):c.*125A>G | Familial hyperthyroidism due to mutations in TSH receptor [RCV000293788]|Hypothyroidism due to TSH receptor mutations [RCV000385595] | uncertain significance | 14 | 81144478 | 81144478 | Human | 3 | alternate_id |
| 11656285 | CV339642 | deletion | NM_000369.5(TSHR):c.*137del | Congenital hypothyroidism [RCV000332370]|Familial hyperthyroidism due to mutations in TSH receptor [RCV000372124] | uncertain significance | 14 | 81144487 | 81144487 | Human | 3 | alternate_id |
| 11620754 | CV339647 | single nucleotide variant | NM_000369.5(TSHR):c.*245C>T | Familial hyperthyroidism due to mutations in TSH receptor [RCV000340818]|Hypothyroidism due to TSH receptor mutations [RCV000398726]|not provided [RCV001636893] | benign|likely benign | 14 | 81144598 | 81144598 | Human | 3 | alternate_id |
| 11613978 | CV339648 | single nucleotide variant | NM_000369.5(TSHR):c.*431T>C | Familial hyperthyroidism due to mutations in TSH receptor [RCV000273443]|Hypothyroidism due to TSH receptor mutations [RCV000365744]|not provided [RCV004714875] | benign|likely benign | 14 | 81144784 | 81144784 | Human | 3 | alternate_id |
| 11618984 | CV339655 | single nucleotide variant | NM_000369.5(TSHR):c.*960T>C | Familial hyperthyroidism due to mutations in TSH receptor [RCV000320210]|Hypothyroidism due to TSH receptor mutations [RCV000376939] | benign|likely benign|uncertain significance | 14 | 81145313 | 81145313 | Human | 3 | alternate_id |
| 11615384 | CV339657 | single nucleotide variant | NM_000369.5(TSHR):c.*1106G>T | Familial hyperthyroidism due to mutations in TSH receptor [RCV000342322]|Hypothyroidism due to TSH receptor mutations [RCV000285030] | benign|likely benign|uncertain significance | 14 | 81145459 | 81145459 | Human | 3 | alternate_id |
| 11644533 | CV339660 | single nucleotide variant | NM_000369.5(TSHR):c.*1317C>A | Familial hyperthyroidism due to mutations in TSH receptor [RCV000371095]|Hypothyroidism due to TSH receptor mutations [RCV000260629] | uncertain significance | 14 | 81145670 | 81145670 | Human | 3 | alternate_id |
| 11616952 | CV339661 | single nucleotide variant | NM_000369.5(TSHR):c.*1417T>C | Familial hyperthyroidism due to mutations in TSH receptor [RCV000299426]|Hypothyroidism due to TSH receptor mutations [RCV000356567]|not provided [RCV004714879] | benign|likely benign | 14 | 81145770 | 81145770 | Human | 3 | alternate_id |
| 11612945 | CV339664 | single nucleotide variant | NM_000369.5(TSHR):c.*1580A>G | Familial hyperthyroidism due to mutations in TSH receptor [RCV000321498]|Hypothyroidism due to TSH receptor mutations [RCV000264128] | benign|likely benign|uncertain significance | 14 | 81145933 | 81145933 | Human | 3 | alternate_id |
| 11658678 | CV339665 | single nucleotide variant | NM_000369.5(TSHR):c.*1898A>G | Familial hyperthyroidism due to mutations in TSH receptor [RCV000396484]|Hypothyroidism due to TSH receptor mutations [RCV000351094] | uncertain significance | 14 | 81146251 | 81146251 | Human | 3 | alternate_id |
| 405869992 | CV3399649 | single nucleotide variant | NM_000369.5(TSHR):c.1192T>G (p.Cys398Gly) | Familial gestational hyperthyroidism [RCV004573794]|Familial gestational hyperthyroidism [RCV005392822] | likely pathogenic|uncertain significance | 14 | 81143250 | 81143250 | Human | 1 | alternate_id |
| 407475866 | CV3494717 | single nucleotide variant | NM_000369.5(TSHR):c.755T>C (p.Leu252Pro) | Familial hyperthyroidism due to mutations in TSH receptor [RCV004690616] | likely pathogenic | 14 | 81139741 | 81139741 | Human | 1 | alternate_id |
| 597707028 | CV3711055 | single nucleotide variant | NM_000369.5(TSHR):c.485C>T (p.Pro162Leu) | Familial gestational hyperthyroidism [RCV005009337] | likely pathogenic | 14 | 81092548 | 81092548 | Human | 1 | alternate_id |
| 597707037 | CV3711056 | single nucleotide variant | NM_000369.5(TSHR):c.1465C>T (p.Gln489Ter) | Familial gestational hyperthyroidism [RCV005009338]|not provided [RCV005061861] | pathogenic|likely pathogenic | 14 | 81143523 | 81143523 | Human | 1 | alternate_id |
| 597707046 | CV3711057 | single nucleotide variant | NM_000369.5(TSHR):c.1582C>A (p.Arg528Ser) | Familial gestational hyperthyroidism [RCV005009339] | likely pathogenic | 14 | 81143640 | 81143640 | Human | 1 | alternate_id |
| 597707054 | CV3711058 | single nucleotide variant | NM_000369.5(TSHR):c.1918A>G (p.Ile640Val) | Familial gestational hyperthyroidism [RCV005009340] | uncertain significance | 14 | 81143976 | 81143976 | Human | 1 | alternate_id |
| 597707065 | CV3711059 | single nucleotide variant | NM_000369.5(TSHR):c.2066T>G (p.Val689Gly) | Familial gestational hyperthyroidism [RCV005009341] | likely pathogenic | 14 | 81144124 | 81144124 | Human | 1 | alternate_id |
| 12896518 | CV390132 | single nucleotide variant | NM_000369.5(TSHR):c.692+49T>C | Familial gestational hyperthyroidism [RCV001840570]|Familial hyperthyroidism due to mutations in TSH receptor [RCV001840568]|Hypothyroidism due to TSH receptor mutations [RCV001840569]|not provided [RCV004703997]|not specified [RCV000455456] | benign|likely benign | 14 | 81108501 | 81108501 | Human | 4 | alternate_id |
| 598188804 | CV4008631 | single nucleotide variant | NM_000369.5(TSHR):c.2104C>G (p.Gln702Glu) | Familial gestational hyperthyroidism [RCV005396130] | uncertain significance | 14 | 81144162 | 81144162 | Human | 1 | alternate_id |
| 12894599 | CV409157 | indel | NM_000369.5(TSHR):c.267_270delinsTCCT (p.Gln90Pro) | Familial gestational hyperthyroidism [RCV005010391]|TSHR-related disorder [RCV004541520]|not provided [RCV000483426] | likely pathogenic | 14 | 81068278 | 81068281 | Human | | alternate_id |
| 12907009 | CV415406 | deletion | NM_000369.5(TSHR):c.418del (p.Met140fs) | Familial gestational hyperthyroidism [RCV002481552]|not provided [RCV000489917] | pathogenic|likely pathogenic | 14 | 81091091 | 81091091 | Human | 1 | alternate_id |
| 13216774 | CV429594 | single nucleotide variant | NM_000369.5(TSHR):c.202C>T (p.Pro68Ser) | Familial gestational hyperthyroidism [RCV004568640]|Familial gestational hyperthyroidism [RCV005010439]|Familial hyperthyroidism due to mutations in TSH receptor [RCV000989248]|Hypothyroidism due to TSH receptor mutations [RCV000504179]|Inborn genetic diseases [RCV002524319]|Malignant tumor of breas t [RCV001005031]|TSHR-related disorder [RCV004735578]|not provided [RCV001223345] | pathogenic|likely pathogenic|benign|conflicting interpretations of pathogenicity|uncertain significance | 14 | 81062179 | 81062179 | Human | 7 | alternate_id |
| 15138321 | CV693609 | single nucleotide variant | NM_000369.5(TSHR):c.735C>G (p.Gly245=) | Familial hyperthyroidism due to mutations in TSH receptor [RCV001118246]|Hypothyroidism due to TSH receptor mutations [RCV001118247]|not provided [RCV000877140] | benign|likely benign|uncertain significance | 14 | 81139721 | 81139721 | Human | 3 | alternate_id |
| 15149900 | CV739359 | single nucleotide variant | NM_000369.5(TSHR):c.765A>G (p.Arg255=) | Familial hyperthyroidism due to mutations in TSH receptor [RCV001119784]|Hypothyroidism due to TSH receptor mutations [RCV001119785]|not provided [RCV000901034] | likely benign|uncertain significance | 14 | 81139751 | 81139751 | Human | 3 | alternate_id |
| 15139942 | CV754183 | single nucleotide variant | NM_000369.5(TSHR):c.1206C>T (p.Ser402=) | Familial hyperthyroidism due to mutations in TSH receptor [RCV001121770]|Hypothyroidism due to TSH receptor mutations [RCV001121769]|TSHR-related disorder [RCV004543458]|not provided [RCV000921598] | likely benign|uncertain significance | 14 | 81143264 | 81143264 | Human | 3 | alternate_id |
| 21072606 | CV791425 | single nucleotide variant | NM_000369.5(TSHR):c.1429A>C (p.Thr477Pro) | Familial hyperthyroidism due to mutations in TSH receptor [RCV000989249] | benign | 14 | 81143487 | 81143487 | Human | 1 | alternate_id |
| 28877803 | CV872794 | single nucleotide variant | NM_000369.2(TSHR):c.-102C>T | Familial hyperthyroidism due to mutations in TSH receptor [RCV001116691]|Hypothyroidism due to TSH receptor mutations [RCV001116692] | uncertain significance | 14 | 80955579 | 80955579 | Human | 3 | alternate_id |
| 28882451 | CV872795 | single nucleotide variant | NM_000369.5(TSHR):c.100G>A (p.Glu34Lys) | Familial hyperthyroidism due to mutations in TSH receptor [RCV001118137]|Hypothyroidism due to TSH receptor mutations [RCV001118136]|Inborn genetic diseases [RCV002556512]|not provided [RCV001593281]|not specified [RCV002249730] | benign|uncertain significance | 14 | 80955780 | 80955780 | Human | 4 | alternate_id |
| 28887610 | CV872796 | single nucleotide variant | NM_000369.5(TSHR):c.190C>T (p.Leu64=) | Familial hyperthyroidism due to mutations in TSH receptor [RCV001119680]|Hypothyroidism due to TSH receptor mutations [RCV001119679] | uncertain significance | 14 | 81062167 | 81062167 | Human | 3 | alternate_id |
| 28887616 | CV872797 | single nucleotide variant | NM_000369.5(TSHR):c.197C>A (p.Thr66Asn) | Familial hyperthyroidism due to mutations in TSH receptor [RCV001119681]|Hypothyroidism due to TSH receptor mutations [RCV001119682] | uncertain significance | 14 | 81062174 | 81062174 | Human | 3 | alternate_id |
| 28893359 | CV872798 | single nucleotide variant | NM_000369.5(TSHR):c.406A>G (p.Thr136Ala) | Familial hyperthyroidism due to mutations in TSH receptor [RCV001121665]|Hypothyroidism due to TSH receptor mutations [RCV001121666] | uncertain significance | 14 | 81091082 | 81091082 | Human | 3 | alternate_id |
| 28893367 | CV872799 | single nucleotide variant | NM_000369.5(TSHR):c.463A>T (p.Ile155Leu) | Familial hyperthyroidism due to mutations in TSH receptor [RCV001121667]|Hypothyroidism due to TSH receptor mutations [RCV001121668]|not provided [RCV001354991]|not specified [RCV005236619] | likely benign|uncertain significance | 14 | 81091139 | 81091139 | Human | 3 | alternate_id |
| 28878111 | CV872800 | single nucleotide variant | NM_000369.5(TSHR):c.611C>T (p.Ala204Val) | Familial hyperthyroidism due to mutations in TSH receptor [RCV001116791]|Hypothyroidism due to TSH receptor mutations [RCV001116792]|not specified [RCV004689996] | benign|uncertain significance | 14 | 81096704 | 81096704 | Human | 3 | alternate_id |
| 28882809 | CV872801 | single nucleotide variant | NM_000369.5(TSHR):c.756G>C (p.Leu252=) | Familial hyperthyroidism due to mutations in TSH receptor [RCV001118248]|Hypothyroidism due to TSH receptor mutations [RCV001118249] | uncertain significance | 14 | 81139742 | 81139742 | Human | 3 | alternate_id |
| 28882814 | CV872802 | single nucleotide variant | NM_000369.5(TSHR):c.758T>C (p.Ile253Thr) | Familial hyperthyroidism due to mutations in TSH receptor [RCV001119783]|Hypothyroidism due to TSH receptor mutations [RCV001118250] | uncertain significance | 14 | 81139744 | 81139744 | Human | 3 | alternate_id |
| 28887948 | CV872803 | single nucleotide variant | NM_000369.5(TSHR):c.891G>A (p.Glu297=) | Familial hyperthyroidism due to mutations in TSH receptor [RCV001119786]|Hypothyroidism due to TSH receptor mutations [RCV001119787]|TSHR-related disorder [RCV004538346]|not provided [RCV003769174] | benign|likely benign|uncertain significance | 14 | 81142949 | 81142949 | Human | 3 | alternate_id |
| 28887955 | CV872804 | single nucleotide variant | NM_000369.5(TSHR):c.915T>A (p.Ser305Arg) | Familial hyperthyroidism due to mutations in TSH receptor [RCV001119788]|Hypothyroidism due to TSH receptor mutations [RCV001121766]|not provided [RCV002556560] | benign|uncertain significance | 14 | 81142973 | 81142973 | Human | 3 | alternate_id |
| 28873846 | CV872805 | single nucleotide variant | NM_000369.5(TSHR):c.1222T>C (p.Cys408Arg) | Familial hyperthyroidism due to mutations in TSH receptor [RCV001115202]|Hypothyroidism due to TSH receptor mutations [RCV001121771]|not provided [RCV001760082] | uncertain significance | 14 | 81143280 | 81143280 | Human | 3 | alternate_id |
| 28873850 | CV872806 | single nucleotide variant | NM_000369.5(TSHR):c.1341C>T (p.Asn447=) | Familial hyperthyroidism due to mutations in TSH receptor [RCV001115205]|Hypothyroidism due to TSH receptor mutations [RCV001115206]|not provided [RCV003727868] | benign|likely benign|uncertain significance | 14 | 81143399 | 81143399 | Human | 3 | alternate_id |
| 28883125 | CV872807 | single nucleotide variant | NM_000369.5(TSHR):c.1479G>A (p.Gly493=) | Familial hyperthyroidism due to mutations in TSH receptor [RCV001118349]|Hypothyroidism due to TSH receptor mutations [RCV001118348]|not provided [RCV005093532] | likely benign|uncertain significance | 14 | 81143537 | 81143537 | Human | 3 | alternate_id |
| 28883129 | CV872808 | single nucleotide variant | NM_000369.5(TSHR):c.1556G>A (p.Arg519His) | Familial gestational hyperthyroidism [RCV005012572]|Hypothyroidism due to TSH receptor mutations [RCV001118351]|not provided [RCV002245863] | pathogenic|likely pathogenic|conflicting interpretations of pathogenicity|uncertain significance | 14 | 81143614 | 81143614 | Human | 4 | alternate_id |
| 28888253 | CV872809 | single nucleotide variant | NM_000369.5(TSHR):c.1583G>A (p.Arg528His) | Familial hyperthyroidism due to mutations in TSH receptor [RCV001119884]|Hypothyroidism due to TSH receptor mutations [RCV001119883] | uncertain significance | 14 | 81143641 | 81143641 | Human | 3 | alternate_id |
| 28888262 | CV872810 | single nucleotide variant | NM_000369.5(TSHR):c.1621A>G (p.Ile541Val) | Familial gestational hyperthyroidism [RCV005394750]|Familial hyperthyroidism due to mutations in TSH receptor [RCV001119887]|Hypothyroidism due to TSH receptor mutations [RCV001119888] | benign|uncertain significance | 14 | 81143679 | 81143679 | Human | 4 | alternate_id |
| 28888268 | CV872811 | single nucleotide variant | NM_000369.5(TSHR):c.1656C>T (p.Leu552=) | Familial hyperthyroidism due to mutations in TSH receptor [RCV001119889]|Hypothyroidism due to TSH receptor mutations [RCV001121874]|not provided [RCV003769176] | benign|likely benign|uncertain significance | 14 | 81143714 | 81143714 | Human | 3 | alternate_id |
| 28893889 | CV872812 | single nucleotide variant | NM_000369.5(TSHR):c.1971C>T (p.Ser657=) | Familial hyperthyroidism due to mutations in TSH receptor [RCV001121876]|Hypothyroidism due to TSH receptor mutations [RCV001121875]|not provided [RCV003727874] | benign|uncertain significance | 14 | 81144029 | 81144029 | Human | 4 | alternate_id |
| 28893889 | CV872812 | single nucleotide variant | NM_000369.5(TSHR):c.1971C>T (p.Ser657=) | Familial hyperthyroidism due to mutations in TSH receptor [RCV001121876]|Hypothyroidism due to TSH receptor mutations [RCV001121875]|not provided [RCV003727874] | benign|uncertain significance | 14 | 81144029 | 81144030 | Human | 4 | alternate_id |
| 28893894 | CV872813 | single nucleotide variant | NM_000369.5(TSHR):c.2034T>C (p.Tyr678=) | Familial hyperthyroidism due to mutations in TSH receptor [RCV001121877]|Hypothyroidism due to TSH receptor mutations [RCV001121878]|not provided [RCV003736987] | benign|likely benign|uncertain significance | 14 | 81144092 | 81144092 | Human | 3 | alternate_id |
| 28874089 | CV872814 | single nucleotide variant | NM_000369.5(TSHR):c.2154T>C (p.Asp718=) | Familial hyperthyroidism due to mutations in TSH receptor [RCV001115302]|Hypothyroidism due to TSH receptor mutations [RCV001115303]|not provided [RCV003558677] | likely benign|uncertain significance | 14 | 81144212 | 81144212 | Human | 3 | alternate_id |
| 28883493 | CV872815 | single nucleotide variant | NM_000369.5(TSHR):c.2257G>A (p.Gly753Ser) | Familial hyperthyroidism due to mutations in TSH receptor [RCV001118461]|Hypothyroidism due to TSH receptor mutations [RCV001118460] | uncertain significance | 14 | 81144315 | 81144315 | Human | 3 | alternate_id |
| 28888577 | CV872816 | single nucleotide variant | NM_000369.5(TSHR):c.*242C>T | Familial hyperthyroidism due to mutations in TSH receptor [RCV001119978]|Hypothyroidism due to TSH receptor mutations [RCV001119977] | uncertain significance | 14 | 81144595 | 81144595 | Human | 3 | alternate_id |
| 28889494 | CV872817 | single nucleotide variant | NM_000369.5(TSHR):c.*249A>C | Familial hyperthyroidism due to mutations in TSH receptor [RCV001120276]|Hypothyroidism due to TSH receptor mutations [RCV001120277] | benign|uncertain significance | 14 | 81144602 | 81144602 | Human | 3 | alternate_id |
| 28874283 | CV872818 | single nucleotide variant | NM_000369.5(TSHR):c.*458G>T | Familial hyperthyroidism due to mutations in TSH receptor [RCV001115390]|Hypothyroidism due to TSH receptor mutations [RCV001115389] | uncertain significance | 14 | 81144811 | 81144811 | Human | 3 | alternate_id |
| 28883767 | CV872819 | single nucleotide variant | NM_000369.5(TSHR):c.*1053T>C | Familial hyperthyroidism due to mutations in TSH receptor [RCV001118542]|Hypothyroidism due to TSH receptor mutations [RCV001118541] | uncertain significance | 14 | 81145406 | 81145406 | Human | 3 | alternate_id |
| 28888888 | CV872820 | single nucleotide variant | NM_000369.5(TSHR):c.*1262C>T | Familial hyperthyroidism due to mutations in TSH receptor [RCV001120069]|Hypothyroidism due to TSH receptor mutations [RCV001120068] | uncertain significance | 14 | 81145615 | 81145615 | Human | 3 | alternate_id |
| 28889806 | CV872821 | single nucleotide variant | NM_000369.5(TSHR):c.*1486C>T | Familial hyperthyroidism due to mutations in TSH receptor [RCV001120378]|Hypothyroidism due to TSH receptor mutations [RCV001120379] | uncertain significance | 14 | 81145839 | 81145839 | Human | 3 | alternate_id |
| 28874484 | CV872822 | single nucleotide variant | NM_000369.5(TSHR):c.*1496A>G | Familial hyperthyroidism due to mutations in TSH receptor [RCV001115483]|Hypothyroidism due to TSH receptor mutations [RCV001115482] | uncertain significance | 14 | 81145849 | 81145849 | Human | 3 | alternate_id |
| 28874488 | CV872823 | single nucleotide variant | NM_000369.5(TSHR):c.*1559C>T | Familial hyperthyroidism due to mutations in TSH receptor [RCV001115484]|Hypothyroidism due to TSH receptor mutations [RCV001115485] | uncertain significance | 14 | 81145912 | 81145912 | Human | 3 | alternate_id |
| 28878423 | CV872824 | single nucleotide variant | NM_000369.5(TSHR):c.*1807T>A | Familial hyperthyroidism due to mutations in TSH receptor [RCV001116900]|Hypothyroidism due to TSH receptor mutations [RCV001116901] | benign|uncertain significance | 14 | 81146160 | 81146160 | Human | 3 | alternate_id |
| 28878430 | CV872825 | single nucleotide variant | NM_000369.5(TSHR):c.*1845T>G | Familial hyperthyroidism due to mutations in TSH receptor [RCV001116903]|Hypothyroidism due to TSH receptor mutations [RCV001116902] | uncertain significance | 14 | 81146198 | 81146198 | Human | 3 | alternate_id |
| 28877797 | CV876459 | single nucleotide variant | NM_000369.2(TSHR):c.-166C>T | Familial hyperthyroidism due to mutations in TSH receptor [RCV001116689]|Hypothyroidism due to TSH receptor mutations [RCV001116690] | uncertain significance | 14 | 80955515 | 80955515 | Human | 3 | alternate_id |
| 11087746 | CV227754 | single nucleotide variant | NM_145867.1(LTC4S):c.-444A>C | aspirin response - Toxicity/ADR [RCV000211358] | drug response | 5 | 179793637 | 179793637 | Human | | trait |
| 11087713 | CV227781 | single nucleotide variant | NM_024006.5(VKORC1):c.-1639G>T | warfarin response - Toxicity/ADR [RCV000211327] | drug response | 16 | 31096368 | 31096368 | Human | | trait |
| 11087733 | CV227811 | single nucleotide variant | NM_000675.6(ADORA2A):c.-275+1797C>T | caffeine response - Toxicity/ADR [RCV000660765] | drug response | 22 | 24429543 | 24429543 | Human | | trait |
| 12791665 | CV362511 | single nucleotide variant | NM_000675.5(ADORA2A):c.-275+1797C>A | caffeine response - Toxicity/ADR [RCV000417154] | drug response | 22 | 24429543 | 24429543 | Human | | trait |
| 13704364 | CV538599 | single nucleotide variant | NM_001320586.2(ACYP2):c.404+29374G>A | cisplatin response - Toxicity/ADR [RCV000660790] | drug response | 2 | 54168122 | 54168122 | Human | | trait |
| 13704365 | CV538604 | deletion | NM_004119.3(FLT3):c.680del (p.Thr227fs) | sunitinib response - Toxicity/ADR [RCV000660791] | drug response | 13 | 28050157 | 28050157 | Human | | trait |
| 11087687 | CV227762 | single nucleotide variant | NM_006379.5(SEMA3C):c.103+13883A>G | irinotecan response - Toxicity/ADR [RCV000211136] | drug response | 7 | 80902796 | 80902796 | Human | | trait |
| 11087720 | CV227767 | single nucleotide variant | NM_052958.4(C8orf34):c.736+8162C>G | irinotecan response - Toxicity/ADR [RCV000211148] | drug response | 8 | 68476982 | 68476982 | Human | | trait |
| 11087826 | CV227833 | single nucleotide variant | NM_001105564.2(CCHCR1):c.1581-597T>C | nevirapine response - Toxicity/ADR [RCV000211168] | drug response | 6 | 31146405 | 31146405 | Human | | trait |
| 13704369 | CV538600 | single nucleotide variant | NR_103444.1(LOC100996325):n.366+1469G>A | vincristine response - Toxicity/ADR [RCV000660860] | drug response | 5 | 609978 | 609978 | Human | 5 | trait |
| 13704369 | CV538600 | single nucleotide variant | NR_103444.1(LOC100996325):n.366+1469G>A | vincristine response - Toxicity/ADR [RCV000660860] | drug response | 5 | 609978 | 609979 | Human | 5 | trait |
| 11087834 | CV227816 | single nucleotide variant | NM_033394.3(TANC1):c.-125-6169A>C | radiotherapy response - Toxicity/ADR [RCV000211412] | drug response | 2 | 158994911 | 158994911 | Human | | trait |
| 11087836 | CV227822 | single nucleotide variant | NM_033394.3(TANC1):c.61+13908C>A | radiotherapy response - Toxicity/ADR [RCV000211429] | drug response | 2 | 159079879 | 159079879 | Human | | trait |
| 11087828 | CV227823 | single nucleotide variant | NM_033394.3(TANC1):c.62-3284C>G | radiotherapy response - Toxicity/ADR [RCV000211211] | drug response | 2 | 159094353 | 159094353 | Human | | trait |
| 11087832 | CV227824 | single nucleotide variant | NM_033394.3(TANC1):c.61+6948A>G | radiotherapy response - Toxicity/ADR [RCV000211335] | drug response | 2 | 159072919 | 159072919 | Human | | trait |
| 11087829 | CV227831 | single nucleotide variant | NM_033394.3(TANC1):c.-15-22495C>T | radiotherapy response - Toxicity/ADR [RCV000211233] | drug response | 2 | 159043401 | 159043401 | Human | | trait |
| 11087835 | CV227834 | single nucleotide variant | NM_033394.3(TANC1):c.-15-22919G>T | radiotherapy response - Toxicity/ADR [RCV000211418] | drug response | 2 | 159042977 | 159042977 | Human | 2 | trait |
| 11087835 | CV227834 | single nucleotide variant | NM_033394.3(TANC1):c.-15-22919G>T | radiotherapy response - Toxicity/ADR [RCV000211418] | drug response | 2 | 159042977 | 159042978 | Human | 2 | trait |
| 12791677 | CV362505 | single nucleotide variant | NM_006446.5(SLCO1B1):c.1865+4846T>C | methotrexate response - Toxicity/ADR [RCV000417177] | drug response | 12 | 21229685 | 21229685 | Human | 3 | trait |
| 12791677 | CV362505 | single nucleotide variant | NM_006446.5(SLCO1B1):c.1865+4846T>C | methotrexate response - Toxicity/ADR [RCV000417177] | drug response | 12 | 21229685 | 21229686 | Human | 3 | trait |
| 11087745 | CV227765 | single nucleotide variant | NM_130797.4(DPP6):c.244-71279T>C | antipsychotics response - Toxicity/ADR [RCV000211349] | drug response | 7 | 154374935 | 154374935 | Human | | trait |
| 11087732 | CV227796 | single nucleotide variant | NC_000018.9:g.57851097T>C | antipsychotics response - Toxicity/ADR [RCV000211281] | drug response | 18 | 60183864 | 60183864 | Human | 7 | trait |
| 11087732 | CV227796 | single nucleotide variant | NC_000018.9:g.57851097T>C | antipsychotics response - Toxicity/ADR [RCV000211281] | drug response | 18 | 60183864 | 60183865 | Human | 7 | trait |
| 151662541 | CV1330420 | deletion | NM_001204.7(BMPR2):c.2457_2464del (p.Ala820fs) | Pulmonary arterial hypertension [RCV001823957] | not provided | 2 | 202556119 | 202556126 | Human | | alternate_id |
| 151662565 | CV1330434 | single nucleotide variant | NM_001204.7(BMPR2):c.419-1G>T | Primary pulmonary hypertension [RCV002542751]|Pulmonary arterial hypertension [RCV001823971] | likely pathogenic|not provided | 2 | 202513718 | 202513718 | Human | 3 | alternate_id |
| 12791670 | CV362494 | single nucleotide variant | NM_000748.3(CHRNB2):c.*472G>A | nicotine response - Efficacy, Toxicity/ADR [RCV000417150] | drug response | 1 | 154576404 | 154576404 | Human | | trait |
| 8591057 | CV125779 | single nucleotide variant | NM_000767.5(CYP2B6):c.785A>G (p.Lys262Arg) | CYP2B6-related disorder [RCV003974998]|Efavirenz response [RCV000106294]|not provided [RCV004716941] | pathogenic|benign|likely benign|drug response | 19 | 41009358 | 41009358 | Human | 7 | alternate_id |
| 8591057 | CV125779 | single nucleotide variant | NM_000767.5(CYP2B6):c.785A>G (p.Lys262Arg) | CYP2B6-related disorder [RCV003974998]|Efavirenz response [RCV000106294]|not provided [RCV004716941] | pathogenic|benign|likely benign|drug response | 19 | 41009358 | 41009359 | Human | 7 | alternate_id |
| 8591058 | CV125780 | single nucleotide variant | NM_000767.5(CYP2B6):c.329G>T (p.Gly110Val) | Efavirenz response [RCV000106295] | pathogenic|drug response | 19 | 41004158 | 41004158 | Human | 1 | alternate_id |
| 8591059 | CV125781 | single nucleotide variant | NM_000767.5(CYP2B6):c.341T>C (p.Ile114Thr) | Efavirenz response [RCV000106296] | pathogenic|drug response | 19 | 41004303 | 41004303 | Human | 1 | alternate_id |
| 8591060 | CV125782 | single nucleotide variant | NM_000767.5(CYP2B6):c.548T>G (p.Val183Gly) | Efavirenz response [RCV000106297] | pathogenic|drug response | 19 | 41006968 | 41006968 | Human | 1 | alternate_id |
| 8591061 | CV125783 | single nucleotide variant | NM_000767.5(CYP2B6):c.637T>C (p.Phe213Leu) | Efavirenz response [RCV000106298] | pathogenic|drug response | 19 | 41007057 | 41007057 | Human | 1 | alternate_id |
| 9481023 | CV153633 | single nucleotide variant | NM_000767.5(CYP2B6):c.186T>A (p.Tyr62Ter) | Efavirenz response [RCV000133445] | drug response | 19 | 41004015 | 41004015 | Human | 1 | alternate_id |
| 9481024 | CV153634 | single nucleotide variant | NM_000767.5(CYP2B6):c.1132C>T (p.Arg378Ter) | Efavirenz response [RCV000133446] | drug response | 19 | 41012465 | 41012465 | Human | 1 | alternate_id |
| 9481025 | CV153635 | single nucleotide variant | NM_000767.5(CYP2B6):c.593T>C (p.Met198Thr) | Efavirenz response [RCV000133447] | drug response | 19 | 41007013 | 41007013 | Human | 1 | alternate_id |
| 11087755 | CV227749 | single nucleotide variant | NM_025221.5(KCNIP4):c.62-506862C>T | Ace Inhibitors, Plain response - Toxicity/ADR [RCV000211329] | drug response | 4 | 21389571 | 21389571 | Human | | trait |
| 8567845 | CV38626 | single nucleotide variant | NM_000767.5(CYP2B6):c.516G>T (p.Gln172His) | CYP2B6-related disorder [RCV003974851]|Efavirenz response [RCV000022520]|efavirenz response - Metabolism/PK [RCV001787330]|efavirenz response - Toxicity [RCV001787331]|nevirapine response - Metabolism/PK [RCV001787332] | pathogenic|risk factor|likely benign|drug response|conflicting data from submitters | 19 | 41006936 | 41006936 | Human | 1 | trait , alternate_id |
| 12791676 | CV362506 | single nucleotide variant | NM_000743.5(CHRNA3):c.*546C>T | nicotine response - Toxicity/ADR, Metabolism/PK [RCV000417128] | drug response | 15 | 78596058 | 78596058 | Human | | trait |
| 11087684 | CV227789 | single nucleotide variant | NM_001199280.2(HAS3):c.279A>G (p.Ala93=) | anthracyclines and related substances response - Toxicity/ADR [RCV000211138] | drug response | 16 | 69109674 | 69109674 | Human | | trait |
| 11087715 | CV227809 | single nucleotide variant | NM_001236.4(CBR3):c.730G>A (p.Val244Met) | anthracyclines and related substances response - Toxicity/ADR [RCV000211217] | drug response | 21 | 36146408 | 36146408 | Human | | trait |
| 12791678 | CV362501 | single nucleotide variant | NM_001199633.2(SLC28A3):c.862-360C>T | anthracyclines and related substances response - Toxicity/ADR [RCV000417185] | drug response | 9 | 84294635 | 84294635 | Human | | trait |
| 21403825 | CV798981 | single nucleotide variant | NC_000002.12:g.233757136G>A | Gilbert syndrome [RCV000999558]|irinotecan response - Toxicity [RCV001788391] | likely benign|drug response | 2 | 233757136 | 233757136 | Human | 7 | trait |
| 21403825 | CV798981 | single nucleotide variant | NC_000002.12:g.233757136G>A | Gilbert syndrome [RCV000999558]|irinotecan response - Toxicity [RCV001788391] | likely benign|drug response | 2 | 233757136 | 233757137 | Human | 7 | trait |
| 11087724 | CV227805 | single nucleotide variant | NM_000767.5(CYP2B6):c.983T>C (p.Ile328Thr) | CYP2B6-related disorder [RCV003927895]|nevirapine response - Toxicity [RCV001787338] | benign|drug response | 19 | 41012316 | 41012316 | Human | | trait |
| 8600343 | CV31848 | single nucleotide variant | NM_000903.3(NQO1):c.559C>T (p.Pro187Ser) | Benzene toxicity, susceptibility to [RCV000018300]|NQO1-related disorder [RCV003974839] | pathogenic|risk factor|benign|drug response|uncertain significance|not provided | 16 | 69711242 | 69711242 | Human | 3 | trait |
| 126736579 | CV1019440 | single nucleotide variant | NM_000110.4(DPYD):c.1156G>T (p.Glu386Ter) | Dihydropyrimidine dehydrogenase deficiency [RCV001335114]|fluorouracil response - Other [RCV001788460]|fluorouracil response - Toxicity [RCV001788461] | pathogenic|drug response | 1 | 97573943 | 97573943 | Human | 2 | trait |
| 8646517 | CV105990 | single nucleotide variant | NM_000110.4(DPYD):c.557A>G (p.Tyr186Cys) | DPYD-related disorder [RCV003964961]|Dihydropyrimidine dehydrogenase deficiency [RCV000671354]|fluorouracil response - Other [RCV001787913]|fluorouracil response - Toxicity [RCV001787914]|not provided [RCV000086496]|not specified [RCV002222386] | benign|likely benign|conflicting interpretations of pathogenicity|drug response|not provided | 1 | 97699474 | 97699474 | Human | 2 | trait |
| 8595084 | CV15681 | single nucleotide variant | NM_000130.4(F5):c.1601G>A (p.Arg534Gln) | Budd-Chiari syndrome, susceptibility to [RCV000000676]|Congenital factor V deficiency [RCV003764502]|Factor V deficiency [RCV000205002]|Factor V deficiency [RCV001095681]|Inborn genetic diseases [RCV002399305]|Ischemic stroke [RCV000000675]|Ischemic stroke [RCV005049305]|Pregnancy loss, recurrent, s usceptibility to, 1 [RCV000023935]|Susceptibility to severe coronavirus disease (COVID-19) due to an impaired coagulation process [RCV001806997]|Thrombophilia due to activated protein C resistance [RCV000454249]|hormonal contraceptives for systemic use response - Toxicity [RCV003227589]|not provided [RCV003493407]|not specified [RCV000616414] | pathogenic|risk factor|benign|conflicting interpretations of pathogenicity|drug response|uncertain significance|low penetrance|not provided | 1 | 169549811 | 169549811 | Human | 43 | trait |
| 8595084 | CV15681 | single nucleotide variant | NM_000130.4(F5):c.1601G>A (p.Arg534Gln) | Budd-Chiari syndrome, susceptibility to [RCV000000676]|Congenital factor V deficiency [RCV003764502]|Factor V deficiency [RCV000205002]|Factor V deficiency [RCV001095681]|Inborn genetic diseases [RCV002399305]|Ischemic stroke [RCV000000675]|Ischemic stroke [RCV005049305]|Pregnancy loss, recurrent, s usceptibility to, 1 [RCV000023935]|Susceptibility to severe coronavirus disease (COVID-19) due to an impaired coagulation process [RCV001806997]|Thrombophilia due to activated protein C resistance [RCV000454249]|hormonal contraceptives for systemic use response - Toxicity [RCV003227589]|not provided [RCV003493407]|not specified [RCV000616414] | pathogenic|risk factor|benign|conflicting interpretations of pathogenicity|drug response|uncertain significance|low penetrance|not provided | 1 | 169549811 | 169549812 | Human | 43 | trait |
| 11075138 | CV227129 | single nucleotide variant | NM_018283.4(NUDT15):c.415C>T (p.Arg139Cys) | NUDT15-related disorder [RCV003982953]|Thiopurines, poor metabolism of, 2 [RCV000210853]|azathioprine response - Toxicity [RCV001787328]|mercaptopurine response - Dosage [RCV001788069] | likely benign|drug response | 13 | 48045719 | 48045719 | Human | 3 | trait |
| 11087709 | CV227770 | single nucleotide variant | NM_000769.4(CYP2C19):c.-806C>A | citalopram response - Metabolism/PK [RCV000211253]|clopidogrel response - Dosage, Efficacy, Toxicity/ADR [RCV000211201]|escitalopram response - Metabolism/PK [RCV000211375] | drug response | 10 | 94761900 | 94761900 | Human | | trait |
| 11087689 | CV227799 | single nucleotide variant | NM_000767.4(CYP2B6):c.516G>A (p.Gln172=) | efavirenz response - Dosage [RCV000211215]|efavirenz response - Toxicity/ADR [RCV000211341]|methadone response - Dosage [RCV000211243]|nevirapine response - Other [RCV000211158] | drug response | 19 | 41006936 | 41006936 | Human | | trait |
| 11637130 | CV267156 | single nucleotide variant | NM_000110.4(DPYD):c.1774C>T (p.Arg592Trp) | Dihydropyrimidine dehydrogenase deficiency [RCV001004163]|fluorouracil response - Other [RCV001788185]|fluorouracil response - Toxicity [RCV001788186]|not provided [RCV000280781]|not specified [RCV002282099] | likely pathogenic|conflicting interpretations of pathogenicity|drug response|uncertain significance | 1 | 97450190 | 97450190 | Human | 2 | trait |
| 11591529 | CV287200 | single nucleotide variant | NM_001430.5(EPAS1):c.1035-7C>G | EPAS1-related disorder [RCV003972423]|Erythrocytosis, familial, 4 [RCV000329925]|not provided [RCV001613097]|sorafenib response - Toxicity [RCV003227743] | benign|drug response | 2 | 46376532 | 46376532 | Human | 1 | trait |
| 8564441 | CV29785 | single nucleotide variant | NM_033453.4(ITPA):c.94C>A (p.Pro32Thr) | Inosine triphosphatase deficiency [RCV000015867]|not provided [RCV001711071]|not specified [RCV001804735]|peginterferon alfa-2b and ribavirin response - Toxicity [RCV001787323] | pathogenic|affects|benign|likely benign|drug response | 20 | 3213196 | 3213196 | Human | 12 | trait |
| 8564441 | CV29785 | single nucleotide variant | NM_033453.4(ITPA):c.94C>A (p.Pro32Thr) | Inosine triphosphatase deficiency [RCV000015867]|not provided [RCV001711071]|not specified [RCV001804735]|peginterferon alfa-2b and ribavirin response - Toxicity [RCV001787323] | pathogenic|affects|benign|likely benign|drug response | 20 | 3213196 | 3213197 | Human | 12 | trait |
| 8564442 | CV29786 | single nucleotide variant | NM_033453.4(ITPA):c.124+21A>C | Developmental and epileptic encephalopathy, 35 [RCV001730474]|Inosine triphosphatase deficiency [RCV000015868]|not provided [RCV001675581]|peginterferon alfa-2b and ribavirin response - Toxicity [RCV001787329] | pathogenic|affects|benign|drug response | 20 | 3213247 | 3213247 | Human | 5 | trait |
| 8564442 | CV29786 | single nucleotide variant | NM_033453.4(ITPA):c.124+21A>C | Developmental and epileptic encephalopathy, 35 [RCV001730474]|Inosine triphosphatase deficiency [RCV000015868]|not provided [RCV001675581]|peginterferon alfa-2b and ribavirin response - Toxicity [RCV001787329] | pathogenic|affects|benign|drug response | 20 | 3213247 | 3213248 | Human | 5 | trait |
| 8600597 | CV32536 | single nucleotide variant | NM_000745.4(CHRNA5):c.1192G>A (p.Asp398Asn) | Lung cancer susceptibility 2 [RCV000019049]|SMOKING AS A QUANTITATIVE TRAIT LOCUS 3 [RCV000033213]|Susceptibility to severe coronavirus disease (COVID-19) due to high levels of fibrinogen and C-reactive protein [RCV003234914]|nicotine response - Toxicity [RCV001 787807] | risk factor|drug response|uncertain significance | 15 | 78590583 | 78590583 | Human | 17 | trait |
| 8600597 | CV32536 | single nucleotide variant | NM_000745.4(CHRNA5):c.1192G>A (p.Asp398Asn) | Lung cancer susceptibility 2 [RCV000019049]|SMOKING AS A QUANTITATIVE TRAIT LOCUS 3 [RCV000033213]|Susceptibility to severe coronavirus disease (COVID-19) due to high levels of fibrinogen and C-reactive protein [RCV003234914]|nicotine response - Toxicity [RCV001 787807] | risk factor|drug response|uncertain significance | 15 | 78590583 | 78590584 | Human | 17 | trait |
| 8600981 | CV33429 | single nucleotide variant | NM_000690.4(ALDH2):c.1510G>A (p.Glu504Lys) | ALDH2-related disorder [RCV005357155]|AMED syndrome, digenic [RCV001290000]|Alcohol dependence [RCV000020059]|Alcohol sensitivity, acute [RCV000020058]|ESOPHAGEAL CANCER, ALCOHOL-RELATED, SUSCEPTIBILITY TO [RCV000020062]|SUBLINGUAL NITROGLYCERIN, SUSCEPTIBILITY TO POOR RESPONSE TO [RCV000020061]|Sus ceptibility to hangover [RCV000020060]|ethanol response - Toxicity [RCV001787815] | pathogenic|risk factor|drug response|protective|uncertain significance | 12 | 111803962 | 111803962 | Human | 101 | trait |
| 8566899 | CV34164 | single nucleotide variant | NM_002693.3(POLG):c.3428A>G (p.Glu1143Gly) | Association with valproate-induced liver toxicity [RCV000999632]|Fanconi anemia [RCV000386578]|Hereditary spastic paraplegia [RCV001847611]|Inborn genetic diseases [RCV002311518]|Mitochondrial disease [RCV000020476]|POLG-Related Spectrum Disorders [RCV001119316] |Progressive sclerosing poliodystrophy [RCV000469563]|Progressive sclerosing poliodystrophy [RCV000755650]|not provided [RCV000676317]|not specified [RCV000118018] | benign|likely benign|conflicting interpretations of pathogenicity|conflicting data from submitters|not provided | 15 | 89318595 | 89318595 | Human | 13 | trait |